Insulin and Host Resistance to Endotoxemia by Buchanan, Bernard J.
Loyola University Chicago
Loyola eCommons
Dissertations Theses and Dissertations
1975
Insulin and Host Resistance to Endotoxemia
Bernard J. Buchanan
Loyola University Chicago
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in
Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1975 Bernard J. Buchanan
Recommended Citation
Buchanan, Bernard J., "Insulin and Host Resistance to Endotoxemia" (1975). Dissertations. Paper 1435.
http://ecommons.luc.edu/luc_diss/1435
INSULIN AND HOST RESISTANCE TO ENDOTOXEMIA 
by 
Bernard J. Buchanan 
A Dissertation Submitted to the Faculty of the Graduate School 
of Loyola University of Chicago in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 
February 
1975 
LIB Rt., RY 
LOYOLA UNIVERSiTY MEDIC/\L CENTER 
ACKNOWLEDGEMENTS 
The experimental work and subsequent preparation of this dis-
sertation would not have been possible without the efforts of a number 
of individuals, most of whom collectively compose the Physiology De-
partment here at Loyola. My most sincere appreciation goes to Dr. 
James P. Filkins who directed my graduate studies, supervised the pre-
sent work, provided encouragement and sound advice, and set a superb 
example of how a dedicated investigator should qpproach his many tasks. 
The encouragement and aid of the entire staff of the Physiology De-
partment is also greatly appreciated, both for their direct assistance 
in conducting the present studies and for their efforts in my training. 
The technical expertise of Mrs. Georgine Hoppie, Mrs. Ruth 
Namowicz, and Miss Michelle Jordan deserves special comment. Without 
their superb assistance this study could not have been completed. 
The valuable aid of Mr. Thomas Canfield in computer programing 
and data analysis is greatly appreciated. 
Also appreciated is the encouragement and co-operation of 
The Upjohn Company as represented by Mr. James Casey. 
I would also like to thank the members of my dissertation 
committee for their dedication in evaluating my efforts and the con-
structive criticism which they provided. They include Dr. James P. 
Filkins, Dr. Walter C. Randall, and Dr. Robert D. Wurster of the 
Physiology Department, Dr. Hugh J. McDonald of the Biochemistry De-
partment here at our Medical Center, Dr. James J. Smith of the Medical 
ii 
College of Wisconsin, and Dr. Nicholas R. Diluzio of Tulane University 
School of Medicine. 
Finally, I am indebted to Mrs. Mary Berchos for her excellent 
assistance in the preparation of this dissertation> 
iii 
TABLE OF CONTENTS 
Chapter Page 
I. INTRODUCTION. . . . . . . . . . • . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 
II. REVIEW OF ~I'IERATURE, PURPOSE, AND OBJECTIVES ..........• 3 
A. Deranged Carbohydrate Metabolism in Endotoxemia 
and the Occurrence of Hypoglycemia ..........•....... 3 
B. Mechanisms of Carbohydrate Depletion in 
Endo toxemia. . . . . • . • . . . . . . . . . . • . . • . . . . • . . . . • . . . . • • . . . 6 
C. Sub-cellular and Insulin-like Actions of 
Endo toxin in vitro •.................•.••..•....•.••• 22 
D. Hypoglycemic Activity of Endotoxin.in 
Animals Sensitized to Lethal Endotoxin Shock ........ 29 
E. Response of the Endocrine Pancreas to 
Endotoxemia and Shock •.••...•...••..•........•...... 35 
F. Purpose and Objectives ....•........................• 48 
III. METHODS ..•.....•.•.....•.•.............................• 51 
A. Animals and Care ...•.•...............•.......••..... 51 
B. Endotoxin Preparation ........•................•..... 52 
C. Lethality Experiments ........•..•.......•........... 53 
D. Measurements of Gluconeogenesis and 
Glycogenesis in vivo ....•.......•.....•........•.... 54 
E. Intraperitoneal Glucose Tolerance and 
Insulin Response ........•..•.......•..........•.•... 5 7 
F. Recovery of Expired 14c-C02 from Rats given 
Uniformly Labeled 14c-D-Glucose .............•....... 61 
G. Induction of Streptozotocin Diabetes and 
Evaluation of Diabetic State .............•.......... 65 
H. Carbon Clearance Evaluation of RES Phagocytic 
Function ............................................ 66 
I. Evaluation of Endotoxin Clearance in vivo .........•. 68 
J. Evaluation of Endotoxin Clearance in vitro 
by the Perfused Rat Liver .....•... -:-: ...•.....••.•... 70 
IV. RESULTS •.....•.....•........••.•..•.......•....•...•.•.. 73 
A. Effects of Alterations of Insulin Secretion 
on Endotoxin Shock Lethality .•.....................• 73 
B. Effect of Glucose Treatment on Gluconeogenesis 
and Glycogenesis after Endotoxin Treatment .......... 85 
C. Glucose Tolerance and Insulin Responses 
in Endo toxemia •...........•.••............•.....•... 96 
iv 
TABLE OF CONTENTS 
Chapter Page 
D. Glucose Oxidation after Endotoxin as 
Evaluated by 14c-co2 Collection~ ........•........... 124 
E. Carbon Clearance in Insulin Hypoglycemia ............ 142 
F. Endotoxin Clearance in vivo ......•......•........... 147 
G. Endotoxin Clearance by the Perfused Rat Liver ....... 163 
v. DISCUSSION AND CONCLUSIONS .................•..........•• 179 
VI. SUMMARY ..•..•..•...•....••...•.•............•........... 243 
VIL SELECTED BIBLIOGRAPHY .....••.....•..... ~ ................. 251 
VIII. APPENDIX OF COMPUTER PROGRAMS EMPLOYED ...........•..•... Al 
v 
... 
Table 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
LIST OF TABLES 
Page 
EFFECTS OF FASTING, GLUCOSE TREATMENT, AND MANNO-
HEPTULOSE TREATMENT ON ENDOTOXIN SHOCK LETHALITY ....•... 74 
MANNOHEPTULOSE REVERSAL OF GLUCOSE SENSITIZATION 
TO LETHAL ENDOTOXEMIA ...•............................... 83 
EFFECTS OF SULFONYLUREA AGENTS AND INSULIN ON 
ENDOTOXIN SHOCK LETHALITY ........................•...... 86 
EFFECT OF GLUCOSE TREATMENT ON GLUCONEOGENESIS AND 
GLYCOGENESIS IN ENDOTOXEMIC RATS .•...•.••.......•...•.••. 90 
INTRA- AND INTER-ASSAY VARIATION OF INSULIN 
RADIOIMMUNOASSAY PROCEDURE ..................•...•....... 97 
BLOOD GLUCOSE FOLLOWING ENDOTOXIN TREATMENT AND 
COMBINED TREATMENT WITH ENDOTOXIN AND GLUCOSE .•.....•... 100 
EFFECT OF GLUCOSE TREATMENT ON SERUM INSULIN 
FOLLOWING ENDOTOXIN TREATMENT .•...................•..... 106 
BLOOD GLUCOSE TO SERUM INSULIN RATIO AND PRODUCT 
FOLLOWING ENDOTOXIN TREATMENT •....•...•........•........ 113 
LINEAR REGRESSION OF SERUM INSULIN ON BLOOD 
GLUCOSE AFTER ENDOTOXIN TREATMENT .......•..••.......•... 119 
EXPERIMENTAL TREATMENT OF GROUPS OF RATS FOR 
14c-co2 COLLECTION AFTER 14c-D-GLUCOSE EXPERIMENTS ...... 125 
14c-co2 RECOVERY AFTER IP 14c-D-GLUCOSE •....•........... 127 
CARBON CLEARANCE IN INSULIN TREATED RATS .••............. 149 
REGRESSION OF CARBON CLEARANCE HALF-TIME ON 
BLOOD GLUCOSE IN CONTROL AND INSULIN TREATED RATS ....... 151 
ENDOTOXIN CLEARANCE in vivo USING A SERIAL 
SAMPLING TECHNIQUE ••••••••.•..•.•.•••.....•...•.••....•• 155 
ENDOTOXIN CLEARANCE in vivo USING A SINGLE 
----CARDIAC BLOOD SAMPLE ..•..••..••••..•..••.•.........••.•• 15 7 
vi 
,-
LIST OF TABLES 
Table Page 
16. ENDOTOXIN CLEARANCE AFTER SURGICAL STRESS OR 
ACUTE ADRENALECTOMY ••••••••••.••••••••••••••••.••••••••• 164 
17. ENDOTOXIN CLEARANCE .IN FASTED AND INSULIN 
HYPOGLYCEMIC RATS •••••••••••••••••••••••••.••••••••••••• 166 
18. ENDOTOXIN CLEARANCE BY THE RAT LIVER PERFUSED 
WITH A BALANCED SALT SOLUTION ••••••••••••••••••.•••••••• 169 
19. ENDOTOXIN CLEARANCE BY THE RAT LIVER PERFUSED 
WITH 10% RAT SERUM ••••••••••••••••••••.•••••••••••••••••• 172 
20. ENDOTOXIN CLEARANCE BY THE RAT LIVER PERFUSED 
WITH 50% HEPARINIZED RAT BLOOD •••••••••••••••••.•••••••• 174 
21. BILE PRODUCTION BY RAT LIVER PERFUSED WITH 
ENDOTOXIN CONTAINING PERFUSATES ••••••••••••••••••••••••• 177 
vii 
LIST OF FIGURES 
Figure Page 
1. INFLUENCE OF FASTING ON ENDOTOXIN SHOCK LETHALITY ••••••• 78 
2. INFLUENCE OF GLUCOSE TREATMENT ON ENDOTOXIN 
SHOCK LETHALITY IN FED RATS. • • • • • • • • • • • • • • • • • • • • • . • • • . • • 79 
3. INFLUENCE OF GLUCOSE TREATMENT ON ENDOTOXIN 
SHOCK LETHALITY IN FASTED RATS ••••••••• , .••••••••.••••••• 81 
4. EFFECT OF MANNOHEPTULOSE TREATMENT ON 
ENDOTOXIN SHOCK LETHALITY ••••••••••.••.••••••••••••••••• 82 
5. MANNOHEPTULOSE REVERSAL OF GLUCOSE SENSITIZATION 
TO LETHAL ENDOTOXEMIA •••••••••••••••.••••••••••••••••••• 84 
6. TOLBUTAMIDE, TOLAZAMIDE, AND INSULIN SENSITIZATION 
TO LETHAL ENDOTOXIN SHOCK ••••••••••••••••••••••••••••••• 89 
7. BLOOD GLUCOSE RESPONSES TO ENDOTOXIN AND 
GLUCOSE TREATMENT ••••.•••••••••••••••••••••••••••••.•••• 105 
8. SERUM INSULIN RESPONSES TO ENDOTOXIN AND 
GLUCOSE TREATMENT ••••••••••••••••••••••••••••••••••••••• 111 
9. EFFECT OF GLUCOSE TREATMENT ON THE BLOOD GLUCOSE 
TO SERUM INSULIN RATIO IN ENDOTOXEMIA ••••••••••••••••••• 116 
10. EFFECT OF GLUCOSE TREATMENT ON THE BLOOD GLUCOSE-
SERUM INSULIN PRODUCT IN ENDOTOXEMIA •••••••••••••••••••• 118 
11. REGRESSION OF SERUM INSULIN ON BLOOD GLUCOSE 
IN GLUCOSE TREATED RATS ••••••••••••••••••••••••••••••••• 122 
12. EFFECT OF GLUCOSE TREATMENT ON THE LINEAR REGRESSION 
OF SERUM INSULIN ON BLOOD GLUCOSE IN ENDOTOXEMIC RATS ••• 123 
13. EFFECT OF ACUTE ENDOTOXEMIA ON RECOVERY OF 
GLUCOSE CARBON LABEL AS C02 •••••••••••••••••.••••••••••• 135 
14. EFFECT OF PREVIOUS ENDOTOXIN TREATMENT ON 
RECOVERY OF GLUCOSE CARBON LABEL AS C02·················136 
viii 
Figure 
15. 
16. 
17. 
18. 
LIST OF FIGURES 
EFFECT OF MANNOHEPTULOSE TREATMENT ON RECOVERY 
OF GLUCOSE CARBON LABEL AS COz IN RATS ACUTELY 
Page 
TREATED WITH ENDOTOXIN .•..•.....•.....•................. 137 
GLUCOSE CARBON LABEL RECOVERY AS C02 USING A 
TRACER DOSE OF GLUCOSE AND 1WO PROTOCOLS OF 
MANNOHEPTULOSE TREATMENT ................................ 138 
GLUCOSE CARBON LABEL RECOVERY AS COz USING A 400 mg 
DOSE OF LABELED GLUCOSE AND 1WO PROTOCOLS OF 
MANNO HE PTULOSE TREATMENT •.••.....•.••...•..••...•....••.. 13 9 
EFFECT OF P\REVIOUS ENDOTOXIN TREATMENT ON RECOVERY 
OF GLUCOSE CARBON LABEL AS co2 IN MANNOHEPTULOSE 
TREATED RATS •••.••...•..•..•..•..••....•..•...•.•.....• · 140 
19. RECOVERY OF GLUCOSE CARBON LABEL AS COz IN 
STREPTOZOTOCIN DIABETI_C RATS TREATED WITH ENDOTOXIN .•..• 141 
20. COMPARISON OF GLUCOSE CARBON LABEL RECOVERY AS 
C02 IN RATS ACUTELY TREATED WITH 1 OR 3 mg OF 
ENDOTOXIN ..•..•.....•......•.....•..................... · 143 
21. COMPARISON OF GLUCOSE CARBON LABEL RECOVERY AS 
C02 IN RATS PREVIOUSLY TREATED WITH 1 OR 3 mg 
OF ENDOTOXIN ..•......•..•.............•..•.............• 144 
22. INFLUENCE OF DEXAMETHASONE TREATMENT ON GLUCOSE 
CARBON LABEL RECOVERY AS C02 IN CONTROL AND 
ENDOTOXEMI C RATS .........•........•....•....•.....•..... 145 
23. RECOVERY OF GLUCOSE CARBON LABEL AS co2 IN 
IMMOBILIZED AND TRAUMATIZED RATS ••.••....•.•.•....•..... 146 
24. CARBON CLEARANCE IN SALINE TREATED RATS •.•......•....... 143 
25. CARBON CLEARANCE IN INSULIN TREATED RATS ......•..••...•• 152 
26. DOSE-LETHALITY CURVE FOR FIVE DOSES OF ENDOTOXIN 
IN LEAD SENSITIZED RATS .•.....•................••.••...• 154 
ix 
LIST OF FIGURES 
Figure Page 
27. ENDOTOXIN CLEARANCE in vivo AT A DOSE OF 
---500 MICROGRAMS PER RAT ••••••••.•••••••.•.•••••••.••••••• 156 
28. ENDOTOXIN CLEARANCE in vivo AT THREE DOSES OF 
---ENDOTOXIN •••••••••••••••••••••.••.•••••.•••••••••••••••• 160 
29. INFLUENCE OF TOLERANCE AND PRIOR ENDOTOXIN 
TREATMENT ON ENDOTOXIN CLEARANCE in vivo •..•............ 161 
---
30. INFLUENCE OF ENDOTOXIN PRETREATMENT ON ENDOTOXIN 
CLEARANCE in vivo .•......•.....•.....•.....•..•..•...... 162 
31. INFLUENCE OF SURGICAL TRAUMA AND ACUTE ADRENALECTOMY 
ON ENDOTOXIN CLEARANCE in vivo ..........•.....•......... 165 
3 2. ENDO TOXIN CLEARANCE in vivo IN INSULIN 
HYPOGLYCEMIC· RATS ••••••••••••••••••••••••••••••••••••••• 16 7 
33. 95% CONFIDENCE LIMITS OF THE DOSE-LETHALITY 
CURVE FOR ENDOTOXIN CLEARANCE BY THE PERFUSED LIVER .••.• 168 
34. PROPOSED SCHEMA OF THE ROLE OF INSULIN AND 
HYPOGLYCEMIA IN THE PATHOGENESIS OF LETHAL 
ENDOTOXIN SHOCK ••••••.•.••..••.•.•••••••••.••.•••••.•••• 230 
35. KEY ROLE OF INSULIN IN THE PATHOGENESIS OF 
LETHAL ENDOTOXIN SHOCK ••.••••.•.••••••.••.•.••••• · · • • • • · 242 
x 
CHAPTER I 
INTRODUCTION 
The lipopolysaccharide components of the outer wall of Gram 
negative bacteria -- commonly referred to as endotoxins, have long been 
known to possess a wide range of biological activities when introduced 
into either experimental animals or man (27, 346, 352, 379, 488, 489, 
530)~ Prominent among these activities is the capacity to induce a 
lethal shock syndrome -- generally referred to as endotoxic shock. 
Although the cardiovascular actions of endotoxin which result in shock 
have long been studied in some detail (209, 253, 476), only more re-
cently have the metabolic consequences of endotoxemia and their inti-
mate relationship to the pathogenesis of lethal endotoxin shock re-
ceived a comparable degree of emphasis (50, 489). 
Foremost among the metabolic sequele of endotoxemia are pro-
found effects on caloric homeostasis. In particular endotoxemic al-
terations in hepatic function which lead to deranged carbohydrate 
homeostasis have been stressed; thus Berry (49, 50), Agarwal (5, 6) 
and others (204, 434, 458) have implicated depressed hepatic gluconeo-
genesis as a critical determinant in the evolution of a potentially 
lethal endotoxemia. 
While carbohydrate homeostasis is regulated by a host of 
physiologic mechanisms, insulin is generally recognized as the domi-
nant physiological regulatory influence (169, 170, 400, 429, 635, 669) 
1 
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via its' profound influences on both hepatic gluconeogenesis (151, 173, 191, 
192, 196, 418, 463, 609, 669) and the rate of glucose utilization ( 169, 
368, 400, 429, 508, 543, 635, 669). 
The present study evaluated the proposition that insulin is 
involved in the hypoglycemic and carbohydrate depleting action of en-
dotoxin and by influencing the manifestations of endotoxin toxicity it 
plays a critical role in the perpetuation of the shock syndrome. Since 
the reticuloendothelial system plays a critical role in the inununo-
physiologic resistance to potentially lethal s~Qck (65, 132, 209, 536, 
694) and deranged carbohydrate metabolism is a hallmark of endotoxemia, 
(50, 605) the influence of deranged carbohydrate metabolism on the 
host defense functions of the reticuloendothelial system was also 
investigated. 
CHAPTER II 
REVIEW OF LITERATURE, PURPOSE, AND OBJECTIVES 
A. Deranged Carbohydrate Metabolism in Endotoxemia and the 
Occurrence of Hypoglycemia 
In 1923 Me.nten and Manning ( 444) first described the charac-
teristic hyperglycemic response appearing soon after injection of en-
dotoxin; followed by a severe hypoglycemia in animals given a lethal 
dose of endotoxin. An iv injection of a lethal dose of heat-killed 
organisms of the Enteritidis-Paratyphoid B group ~as found to cause an 
almost immediate increase in_ blood sugar to 250 mg per dl in rabbits. 
The hyperglycemic peak was followed by a progressive hypoglycemia until 
the ultimate death of the animals. The authors felt it difficult to 
estimate the role of any specific organ in the alterations in carbo-
hydrate metabolism since pathological changes appeared coincidentally 
in the liver, pancreas, and kidneys. Zeckwer and Goodell ( 692, 693) 
also investigated the changes in carbohydrate metabolism in rabbits 
which were challenged with heat-killed bacteria; they found a biphasic 
response of blood glucose levels. Two possible explanations for the 
rapid hyperglycemia produced by heat-killed bacteria were considered: 
(i) a failure of the utilization of glucose with its accumulation in 
the blood, or (ii) the sudden mobilization of glycogen and hence an 
increase in the amount of glucose entering the blood stream. Zeckwer 
and Goodell (693) dismissed the suggestion of Menten and Manning (44~ 
that the initial hyperglycemia was due to injury of the pancreatic 
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islets and the failure of the tissues of the body to utilize glucose. 
The rapid reversal of the initial hyp·erglycemia within a matter of 
minutes was taken as evidence that the pancreatic islets had not been 
seriously damaged. Available evidence, including microchemical deter-
minations of liver glycogen was interpreted as indicating that the 
initial hyperglycemia was secondary to the activation of glycogenolysis 
and it was thought that the sympathetic nervous system mediated this 
effect. In support of the idea that hypoglycemia was associated with 
lethal endotoxin shock, Zeckwer and Goodell (69;1) did not observe a 
hypoglycemic response in animals given less than a lethal dose of heat-
killed bacteria even though the early hyperglycemic reaction still oc-
curred. 
The study of the mechanism by which endotoxin influences car-
bohydrate metabolism in experimental animals was further pursued by 
Kun and Miller (374) and Kun (372, 373). In the first series of ex-
periments Kun and Miller (374) measured the changes in concentrations 
of glucose and glucose derived metabolites in blood and tissues of 
rabbits given a lethal dose of crude meningococcal or Salmonella endo-
toxin which caused death in 1.5 to 3 hrs. Despite the animals having 
been fasted 24 hrs, a transient hyperglycemia was observed with peak 
values averaging twice control at 30 minutes. By 90 minutes the hyper-
glycemia had subsided to control values; by 120 minutes, all animals 
were hypoglycemic with individual values of blood glucose as low as 
10 mg per 100 ml. Miller and Kun (37~ also reported glycogen deple-
tion, accumulation of lactate and inorganic phosphorous and oepression 
of pyruvate and glucose levels, and suggested either a state of anoxia in 
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tissues or an inhibition of oxygen utilization was present. To pur-
sue the latter possibility, muscle and liver were assayed for cyto-
chrome oxidase and succinic dehydrogenase activities. Cytochrome oxi-
dase activity was not affected by endotoxin treatment; however, endo-
toxin preparations injected in vivo caused a marked depression of 
succinic dehydrogenase activity when assayed in whole tissue homogenates 
of animals sacrificed as soon as only a few minutes after endotoxin in-
jection. Kun and Miller (374) concluded that the inhibition of sue-
cinic dehydrogenase activity produced by endotoxin injection played an 
important role in the mechanism responsible for the changes in carbo-
hydrate metabolites found in the blood and tissues of endotoxin treated 
rabbits. Kun (372) also reported experiments demonstrating an inhi-
bition of the phosphorylation of glucose by endotoxin. It was found 
that the addition of endotoxin to rat muscle extracts inhibited their 
utilization of glucose in vitro. This inhibition of glucose utilization 
observed in the presence of endotoxin did not occur if Zn-free insulin 
was added to the reaction mixture. Since under the conditions employed 
the rate of glucose utilization was believed to be a measure of hexo-
kinase activity, it was concluded that endotoxin may inhibit this en-
zyme. Furthermore, the endotoxin inhibition was reversible by insulin 
treatment. In a subsequent publication, Kun (373.) reported the results 
of experiments on the effect of bacterial endotoxin on glycogen syn-
s 
thesis both in vivo and in vitro. Rats treated with endotoxin 1 hr 
before a glucose load showed no increase in hepatic glycogen while 
control rats increased their liver glycogen. In in vitro studies 
using rabbit liver slices, the, addition of as little as 0.1 mg endotoxin 
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per ml to the incubation media depressed glycogen formation from glu-
cose by over 50% and similarly depressed glyconeogenesis from pyruvate. 
Kun concluded that the inhibition of glycogen formation by endotoxin 
may be related to the inhibition of succinic dehydrogenase observed in 
a previous study (37t+J. Since it was known that insulin increases the 
uptake of glucose by rat diaphragm muscle in vitro, Kun (373) inves-
tigated the possibility of whether the action of insulin was affected 
by endotoxin or vice versa. It was found that insulin still exerted 
its stimulating influence on glucose utilization in the presence of 
Salmonella endotoxin as assessed using the diaphragm assay. 
B. Mechanisms of the Carbohydrate Depletion in Endotoxemia 
The effect of endotoxin on carbohydrate metabolism has been 
studied in some detail over the past 15 years by Berry and coworkers. 
Berry, Smythe and Young (57) reported the carbohydrate depleting action 
of endotoxin in relation to the protective role of cortisone in mice. 
A large dose of cortisone--5 mg per mouse--reduced lethality from about 
90% to about 30%; a smaller dose of 1 mg of cortisone had no effect on 
endotoxin lethality. In mice which were not protected by cortisone 
and then sacrificed just before the first deaths would be expected, 
chemical analysis showed hypoglycemia, depletion of liver and muscle 
glycogen, and a reduction in total body carbohydrate to one fifth of 
control values. Treatment with a protective dose of cortisone main-
tained all of these parameters near control values. Berry et al. (57) 
interpreted this increase in carbohydrate stores to be largely the 
result of stimulated gluconeogenesis from body protein stores. How-
ever, they commented that it was not known whether ~he greater amount 
-------
----------, 
of carbohydrate was due to greater synthesis, to diminished loss, or 
to both. Since dibenzyline treatment did not protect against lethal 
endotoxin sqock and did not prevent the depletion of liver glycogen 
7 
or alter the hypoglycemic response to endotoxin, it was concluded that 
any interaction between the adrenal medulla and bacterial endotoxin was 
of secondary importance and .epinephrine was not responsible for the 
glycogen depleting action of endotoxin. To determine if endotoxin im-
paired the ability of the body to store carbohydrates, seventeen hour 
fasted mice were given a 50 mg glucose load fo~lowing either saline or 
endotoxin pretreatment. Normal mice became hyperglycemic and showed 
a three-fold increase in liver glycogen with no change in muscle gly-
cogen. In contrast, endotoxemic mice were hypoglycemic despite the 
glucose load and showed no change in hepatic glycogen with a small in-
crease in muscle glycogen. In vitro endotoxin treatment of liver mito-
chondria increased the rate of ATP hydrolysis to an extent slightly 
greater than lo-4 molar dinitrophenol. This suggested to the authors 
that an interference with high energy phosphate metabolism offered a 
possible explanation for many of the metabolic changes observed after 
endotoxin poisoning. Berry and Smythe (52) studied the protein-carbo-
hydrate balance following cortisone treatment of endotoxin poisoned 
mice as well as the response to ACTH and gastrointestinal absorption 
in endotoxemia. A 5 mg dose of cortisone given at the beginning of 
the overnight fast increased urinary nitrogen by an amount representing 
52 and 57 mg protein in control and endotoxin poisoned mice respec-
tively. A corresponding amount of carbohydrate could either be spared 
or synthetized. In normal mice cortisone caused the accumulation of 
8 
an amount of carbohydrate which agreed within 8% of the calculated 
amount of protein catabolized. However, endotoxin treated mice showed 
a deficiency in carbohydrate which indicated either (i) an increased 
utilization of. glucose or (ii) an impairment in glucose synthesis from 
non-carbohydrate precursors. Berry and Smythe (52) stated that there 
existed no evidence for the former and they did not further consider 
this possible explanation. However, in a previous study (57) they had 
shown evidence of defects in carbohydrate metabolism in endotoxin treated 
mice and this was assumed to be the mechanism of the failure of endotoxin 
treated mice to exhibit a normal rise in carbohydrate stores following 
cortisone treatment. Investigations of gastrointestinal function in 
endotoxin treated mice showed that either the absorption or utilization 
of intra-gastric injections of tryptone broth was completely blocked. 
Furthermore, when endotoxin treated mice were given a test meal it re-
mained in their stomach and proximal one third of the small intestine; 
in contrast it had traversed to the large intestine in control mice. 
It was concluded that endotoxin treatment caused the gastrointestinal 
tract to become almost completely paralysed. Since cortisone had been 
shown to protect mice from lethal endotoxemia (57), Berry and Smythe 
(52) studied the. effect of ACTH and found that a dose of 8 units un-
expectedly decreased survival from 75% in the control group to 10% in 
the treated animals. Further studies showed that endotoxemia blocked 
the effect of ACTH on metabolism as was observed in the control animals. 
Berry and Smythe (53) later conducted experiments to discri-
minate between several possible explanations for the failure of endotoxin 
treated animals to respond to ACTH. Berry and Smythe (53) concluded 
l 
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that the release of endogenously secreted adrenal corticoids in re-
sponse to the stress of endotoxemia caused an increase in protein ca-
tabolism. However as judged by blood non-protein nitrogen changes and 
changes in urinary nitrogen excretion, excess urea formed from protein 
catabolism did not appear following ACTH treatment of endotoxin poisoned 
mice. It appeared that the kidney was unable to eliminate the additional 
quantities of nitrogenous wastes. In support of this possibility phenol 
red clearance, inulin clearance, and urea clearance were all found to 
be severely depressed in endotoxin poisoned ani~als. 
In 1964 Berry (49) reviewed the literature from his own labo-
ratory as well as others related to the metabolic effects of endotoxemia 
and the influence of endotoxemia on the activities of certain enzymes. 
The earlier work of Woods and associates demonstrating that lipopoly-
saccharides produce a primary metabolic alteration at the cellular and 
subcellular levels in in vitro experiments had suggested that endotoxin 
toxicity may be related to a metabolic derangement as will be further 
discussed below. Work in Berry's laboratory had recently suggested 
that endotoxin produced alterations in metabolism in vivo and that these 
alterations were modified antagonistically by cortisone treatment. 
Cortisone treatment appeared to caus_e an increase in key hepatic en-
zymes either wholly or at least in part by the synthesis of new enzyme 
protein. At this early time it was noted that tryptophan failed to 
protect against endotoxin even though this substrate might be expected 
to serve as a precursor of NAD or NADP synthesis which was thought to 
be one of the significant metabolic pathways suppressed by endotoxin. 
The conclusive evidence that tryptophan itself inhibited gluconeogenesis 
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( ) had not yet appeared, although it had been reported that trypto-
phan had a hypoglycemic activity in vivo (454, 455) and that tryptophan 
prevented the degradation of insulin by liver homogenates when given 
in vivo (454). Berry's hypothesis that cortisone protected against 
lethal endotoxemia by th.e induction of hepatic gluconeogenic enzymes 
was supported by experiments which demonstrated that both actinomycin D 
and ethionine which suppress RNA and protein synthesis respectively, 
prevented cortisone treatment from exerting its protective effects. 
Berry (49) proposed as a generalization that a~ents which inhibit en-
zyme induction both sensitize endotoxin treated animals presumably by 
preventing the endogenous stimulation of enzyme synthesis by adrenal 
corticosteroids and also prevent cortisone from exerting its protective 
effect by the same mechani'sm. It also appeared that endotoxin pre-
vented within 2 hr the de novo synthesis of some enzymes stimulated by 
corticosteroids and by 4 hr cortisone no longer exerted any effect on 
hepatic enzyme synthesis. As would be expected if this hypothesis were 
true, actinomycin D given 4 hr after endotoxin should not affect le-
thality which was found to be the case in contrast to its potentiating 
effect on lethality when given concurrently with endotoxin. 
To better define the applicability of their experimental 
findings in mice the effects of endotoxin and of cortisone on hepatic 
tryptophan pyrrolase activity was also studied in rats, rabbits, and 
guinea pigs (49). As in mouse experiments endotoxin depressed the 
activity of this enzyme in all species studied. Cortisone elevated 
the activity of this enzyme in rat and rabbit liver and protected these 
species from lethal endotoxin shock. In guinea pig liver the enzyme 
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activity was not increased by the dose of cortisone used and this was 
correlated with a failure of cortisone to protect guinea pigs from le-
thal endotoxemia. This was interpreted as support for the relationship 
between enzyme induction and protection from endotoxin shock (49). 
Berry, Smythe, and Colwell (54) compared the inhibition of inducible 
liver enzymes in mice given either endotoxin or actinomycin D. It was 
shown that endotoxin at an LD-SO dose lowered the level of hepatic tryp-
tophan pyrrolase in mice and prevented the induction of this enzyme by 
cortisone for up to 20 hrs. Actinomycin D had a similar effect. When 
either endotoxin or actinomycin D were given during the period of en-
zyme induction they both produced a rapid cessation of further enzyme 
activity increases and enzyme activity. levels soon dropped to or below 
control values. However, not all enzymes were affected similarly by 
endotoxin treatment. Tyrosine-OC- ketoglutarate transaminase was induced 
by either endotoxin or cortisone in intac~ animals but was not induced 
by endotoxin in adrenalectomized animals, which suggested that endo-
genously secreted steroids might have been responsible for the endotoxin 
initiated rise in activity. Actinomycin D depressed the activity of 
this transaminase and prevented corticosteroid induction of the enzyme. 
It was concluded that the site of action of endotoxin and actinomycin D 
may appear to be similar for some enzymes but that endotoxin exhibits 
a specificity in the inhibition of the induction of hepatic enzymes 
which differentiates it from the generalized action of actinomycin D on 
RNA directed protein synthesis (S4). 
In a subsequent study Berry, Smythe, and Colwell (SS) in-
vestigated the effect of endotoxin on the cortisone mediated induction 
L 
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of other hepatic enzymes. In this paper it was stressed that events 
that occur in the first few hours after endotoxin injection are obviously 
important in determining the final response to endotoxin some hours 
later when the animal either succumbs to lethal endotoxin shock and dies 
or is able to resist the stress and survives. This was based on the 
supposition that endotoxin may prevent the synthesis of key enzymes 
with half-lives of only 2 to 3 hrs and thus rapidly limit the metabolic 
potential of the liver in maintaining metabolic homeostasis. In this 
study it was found that endotoxin inhibited the inductive activity of 
cortisone on the key gluconeogenic enzyme phosphoenolpyruvate carboxy-
kinase. Endotoxin also prevented gluconeogenesis in the liver in re-
sponse to cortisone stimulation. Induction of tryptophan oxygenase was 
also inhibited in intact animals and doses as low as one forty thousandth 
of an LD-50 or O.OY<_g significantly inhibited the induction of this 
enzyme following cortisone treatment of adrenalectomized mice thus de-
monstrating the potency of endotoxin in this biological activity. Al-
though it had been indirectly inferred for a number of years that en-
dotoxin prevented the synthesis of certain hepatic enzymes but not of 
other enzymes, the possibility of an inhibitor which depressed the ac-
tivity of certain enzymes under assay conditions was only recently ex-
cluded. Rippe and Berry (542) quantitiated hepatic tryptophan oxygenase 
in the livers of endotoxin treated and control mice using a radial im-
munodiffusion assay. It was consistently found that there was always 
less innnunologically active enzyme protein after endotoxin treatment. 
The conclusion was drawn that endotoxin interfered with the synthetic 
process that resulted in enhanced levels of tryptophan oxygenase. This 
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conclusion was supported by a correlation between the diameter of im-
munoprecipitation ring and the catalytic activity of the enzyme in the 
liver homogenate from which it was taken. The effect of endotoxin on 
hepatic phosphoenolpyruvate carboxykinase was studied using a similar 
immunoprecipitation technique as well as an assay based on inhibition 
of this enzyme's activity by a specific anti-enzyme antibody (51). It 
was found that endotoxin inhibited the synthesis of phosphoenolpyruvate 
carboxykinase and thus reduced the level of assayable enzyme rather 
than inactivating or inhibiting the enzyme already present. Actino-
mycin D treatment resulted in levels of this enzyme not different from 
those observed with endotoxin treatment irrespective of possible dif-
ferences in their mode of action. These experiments confirmed the pre-
vious conclusions of Berry, Smythe, and Colwell (55) that endotoxin can 
inhibit the induction of a key gluconeogenic enzyme to a stimulus which 
would be expected to result in its synthesis. 
Snyder, Deters, and Ingle (598) studied the changes in the 
activity of hepatic pyruvate kinase in mice treated with endotoxin, 
cortisone, and saline. While endotoxin increased the activity of this 
enzyme, cortisone alone depressed it, and the combination of the 2 
agents did not significantly change the activity of pyruvate kinase, 
the authors concluded that increased pyruvate kinase activity may 
limit gluconeogenesis in endotoxemia and thus lead to rapid carbohy-
drate depletion, where as cortisone may exert its protective effect 
at least in part by conserving phosphoenolpyruvate for subsequent 
gluconeogenesis. The demonstration by Pieroni and Levine (514) 
showing synergy between insulin, which induces this enzyme, and 
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endotoxin in producing lethal endotoxin shock was said to support this 
hypothesis. Elliott and Snyder (167) studied the levels of hepatic 
phosphenolpyruvate carboxykinase in mice given endotoxin and suggested 
that the inhibition of this key gluconeogenic enzyme may in part ac-
count for the dramatic loss of body carbohydrate observed in endotoxemia. 
A decrease in the activity of this gluconeogenic enzyme would be ex-
pected to amplify the carbohydrate depleting effect of enhanced glyco-
lysis promoted by increased pyruvate kinase activity demonstrated by these 
workers (598). In mice made tolerant to endot~xin, alterations in he-
patic phosphoenolpyruvate carboxykinase activity did not occur fol-
lowing endotoxin challenge. Mccallum and Berry (434) have recently 
investigated the physiological consequences of endotoxin treatment as 
they relate to gluconeogenesis and glycogen metabolism in mice in vivo. 
Studies were conducted during the period between 12 and 24 hrs of fasting 
during which time control mice exhibited active glycogen synthesis. En-
dotoxin treatment severely depressed liver glycogen levels and prevented 
the secondary rise in liver glycogen levels and hepatic glycogen syn-
thase activity during fasting which was presumed to be due to inhibition 
of enzyme induction. The incorporation of C-14-label from alanine-U-
C~4, pyruvate-2-C-14, or glucose-U-C-14 into blood glucose and liver 
glycogen was substantially i~paired in endotoxin treated mice with de-
creases observed as early as 4 hr after endotoxin. The administration 
of a glucose or pyruvate load to endotoxin treated mice did not restore 
their hypoglycemic blood glucose levels, gluconeogenesis, glycogen syn-
thesis, or liver glycogen synthase activity to normal levels. The data 
indicated that the incorporation of glucose directly into liverglycogen 
-------
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was not as severely depressed following endotoxin as was the conversion 
of alanine or pyruvate to hepatic glycogen. Further experiments led 
Mccallum and Berry (434) to conclude that their results clearly estab-
lished that gluconeogenesis was more severely impaired than was glycogen 
synthesis following endotoxin treatment. 
Aside from the above mentioned reports from the laboratory of 
Berry as well as others which have stressed·alterations in hepatic en-
zyme induction as key events leading to the carbohydrate depletion and 
profound hypoglycemia of endotoxin shock, a nu~ber of other investigators 
have documented other derangements in carbohydrate homeostasis in ani-
mals either given endotoxin or in septic shock. Sanford 
and coworkers (559) studied the mechanism of the glycogenolytic action 
of bacterial endotoxin in rats. As a result of their findings using 
adrenalectomized animals maintained on replacement doses of corticoste-
roid and dietary manipulations they concluded that liver glycogen may 
either rise or fall following endotoxin injection and that derangements 
in carbohydrate metabolism observed following sublethal quantities of 
endotoxin represent not a direct hepatotoxic effect of endotoxin, but 
are rather a consequence of alterations in the secretions from endo-
crine glands. Hamosh and Shapiro (292) pursued the cellular mechanism 
by which endotoxin treatment resulted in hepatic glycogenolysis and 
found that glycogen phosphorylase was near completely converted to the 
active form following the injection of a purified endotoxin. Similar 
changes were observed with liver homogenates and slices incubated 
in vitro with endotoxin. Hamosh and Shapiro (292) concluded that the 
adrenal gland played no important part in the phosphorylas~ activation 
r 
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since similar changes were observed in adrenalectomized animals. Fukuda 
(227) studied the influence of antipyretics on endotoxin shock in in-
tact and adrenalectomized rabbits. It was shown that although anti-
pyretics could inhibit symptoms such as dyspnea and diarrhea and sur~ 
vival could be improved, the metabolic disturbances leading to hypogly-
-r 
cemia were unaltered and this remained the main cause of death in ad-
renalectomized animals. These findings lead to the postulation of a 
dual mechanism of endotoxin intoxication, one relating to the central 
fever mechanism mediated by autonomic pathways.and the other resulting 
from the peripheral metabolic disturbances which lead to carbohydrate 
depletion and are responsible for the late death syndrome. It was fur-
ther found that vagatonia leading to depressor responses was a promi-
nent component of endotoxicosis. Fukuda and Akiyama (228) investigated 
the metabolic basis of endotoxin tolerance in rabbits. Tolerance to 
the lethal action of endotoxin was found to be characterized by a di-
minution of the liver glycogen depleting response to massive doses of 
endotoxin. A decreased response to thyroid extract in the tolerant 
state suggested that the change involved an intrinsic stability of 
hepatic metabolism. In experiments on dogs Fukuda and coworkers (231) 
studied the mechanism by which glucocorticoids protect from endotoxin 
shock. Glucocorticoid treatment prevented the near total depletion of 
hepatic glycogen characteristic of endotoxin shock. It was stressed 
that glucocorticoids must be given early to prevent the release of an 
endogenous "shock-inducing factor" as well as the carbohydrate depletion 
which both follow as a result of endotoxin treatment. Fukuda and 
Fukuda ~29) investigated a suggestion of previous workers that purine 
r 
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nucleotides might be involved in the stress resistance afforded by glu-
cocorticoids. Pretreatment with 3' (2')-GMP or uridine prevented the 
acute deaths however, concurrent corticosteroid treatment was required 
for survival to be insured. In GMP treated dogs hypoglycemia could be 
easily corrected by glucose infusion which was never the case in con-
trol dogs. In rats pretreated with GMP, treatment with glucose pro-
longed survival. Fukuda and Hata (230) studied the anti-endotoxic ef-
fects of endotoxin conditioning and of glucocorticoid treatment in rats 
and stressed that in contrast to the hypoghesi~ of Berry and coworkers 
(57), corticosteroid protection did not relate with liver glycogen 
storing activity nor did it prevent the accumulation of lactate in 
hepatic tissue. Fukuda and Hata found that bilateral vagotomy prevented 
the appearance of the preterminal phase of shock which usually followed 
the hypotensive phase and suggested that the terminal events may be the 
result of progressive central nervous system effects presumably me-
diated by a vagal discharge. Fine and coworkers (208, 209, 518) have 
also stressed the role of the central nervous system in mediating en-
dotoxin toxicity and have recently (127) implicated a corticosteroid 
increase in calcium conductance as a potential mechanism of the protective 
effect on the disturbance of excitable membranes caused by endotoxin. 
In conjunction with the neural mediation of endotoxin toxicity Palmerio 
et al. (502) reported denervation of the abdominal viscera to be an ef-
fective means of treatment of experimental shock induced by either iv 
or intraventricular injection of endotoxin. 
The initial response to endotoxemia or acute gram negative 
sepsis has long been considered to be an early hyperglycemia in 
l 
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association with the vasodilating and hypotensive action of endotoxin. 
This hyperglycemia has long been attributed to an activation of the 
sympathoadrenal system with concomitant hepatic glycogenolysis ( 131, 
282, 302, 374, 444, 476, 559, 693) and an i-nhibition of insulin release 
(136-139, 189, 285, 605) as well as a reflex increase in glucagon se-
cretion mediated by the autonomic nervous system (67, 544, 56~. How-
ever, not all investigators have observed this pattern of events, es-
pecially when less than massive acutely lethal doses of endotoxin were 
administered. Berk et al. (45) administered doses of 0.25 to 2.0 mg 
per kg endotoxin to dogs and monitored metabolic as well as hemodynamic 
parameters .. In slightly over one half of the animals a limited hyper-
glycemia during the first hour was observed. In these animals after 
the modest hyperglycemic response and in all other dogs a steady fall 
in blood glucose to hypoglycemic levels was observed. The data ~ere in-
terpreted as indicating that endotoxin produced a metabolic effect 
which increased glucose utilization above the rate of glucose pro-
duction and thus lead to hypoglycemia. It was suggested that hypogly-
cemia was a factor influencing survival at all endotoxin doses studied 
but with the larger doses glucose treatment was ineffective due to the 
activation of additional lethal factors. Burrows (89) studied endo-
toxemia in the conscious pony given an iv dose of only SO to 200 mi-
crograms of endotoxin per kg. An early hyperglycemia was observed 
with blood glucose levels reaching twice control at 1 or 2 hrs after 
endotoxin. Hypoglycemia rapidly appeared with blood glucose levels 
less than 40 mg per 100 ml attained by 4 to 6 hrs after endotoxin. 
Surviving animals showed a slow return of blood glucose toward normal 
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by 24 hrs. Halper, DiLuzio, and coworkers C'.318) also studied the ef-
fects of lethal doses of endotoxin alone in conjunction with their 
studies of the sensitizing effect of lead acetate treatment on endotoxin 
shock in baboons. They noted an initial hyperglycemia at 3 hrs after 
endotoxin followed by a hypoglycemic state at 24 hrs after endotoxin 
which was said to be dose dependent. Blood lactate showed a dose re-
lated increase which reached higher levels at each sampling time until 
a peak of over 8 times control was attained. Blood pyruvate levels 
showed no significant change thus producing ov~r a 6 1/2 fold increase 
in the lactate to pyruvate ratio which accompanied the onset of severe 
acidosis. Spitzer, Hinshaw and coworkers (605) studied the effects of 
endotoxin shock on the metabolism of the non-hepatic splanchnic area 
in baboons. In samples drawn at greater than 1 hr after endotoxin in-
jection a depression of serum free fatty acids was observed in con-
junction with a hypoglycemia. This was attributed to a depletion of 
liver glycogen coupled with a failure of gluconeogenesis to keep pace 
with the progressively increasing carbohydrate utilization. Decreases 
in the arterial levels of acetoacetate and in the ratio of acetoacetate 
to beta hydroxybutyrate suggested to the authors that the tissues de-
prived of adequate glucose and free fatty acids increased their utili-
zation of ketone bodies. The increase in arterial lactate observed 
both in early and late endotoxin shock was attributed in part to a 
failure of the liver to clear lactate pr in severe cases to the pro-
duction of lactate by the liver. It was concluded that although there 
were interesting differences in the mesenteric vascular response in 
the baboon compared to the caninemodel, the systemic metabolic hallmarks 
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of endotoxin shock, hypoglycemia and lactacidemia, were still present. 
Tissue levels of metabolites in lethal hemorrhagic and endotoxin shock 
were compared by Blackwood and associates (63) using splenectomized 
dogs. The results suggested that tissue changes occur soon after endo-
toxin which produce a rising level of lactate despite a relatively nor-
mal concentration of ATP in liver, small bowel, and muscle. In the en-
suing discussion W. Schumer stressed the failure of gluconeogenesis in 
the conditions of both endotoxic and hypovolemic shock and related this 
to a mitochondrial defect produced by endotoxem~a which might explain 
the ATP depression and lactic acidosis observed by Blackwood et al. (63). 
Tissue substrate fluxes in endotoxemia and hemorrhage were studied by 
Printen et al. (526) who devoted special attention to the role of sym-
pathetic activation evoked by a progressive hypotension. Divergent 
patterns of free fatty acids and glucose were seen with the former being 
more elevated in endotoxin shock and with glucose rising in the hemor-
rhaged animals but a relative hypoglycemia observed in the endotoxin 
shocked dogs. This lead to the conclusion that metabolic responses to 
endotoxin are more complex than the mass sympathetic response to hy-
potension. 
LaNoue et al. (381) studied gluconeogenesis by liver slices 
of animals which had received a lethal dose of endotoxin. Endotoxin 
treatment in vivo severely depressed the ability of the liver slices 
to synthesize glucose from radiolabeled pyruvate and caused a net 
utilization of glucose from the incubation medium which suggested a 
mechanism for the hypoglycemia found in endotoxin treated rats in vivo. 
An increased rate of Oz consumption by liver slices of endotoxin 
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treated rats demonstrated that the depression of gluconeogenesis was 
not due to a generalized decrease in cellular viability. A depression 
in the activity of glucose-6-phosphatase was found in endotoxin poi-
soned rats and it was suggested that a depression of this key gluconeo-
genie enzyme may contribute to the impaired gluconeogenic activity of 
liver slices from endotoxin treated rats. However, it was postulated 
that some factor other than the observed depression of giuconeogenic 
enzymes must be operative to account for the severe hypoglycemia in 
endotoxin treated rats. Williamson, Refino, and LaNoue (670) studied 
the effect of endotoxin on hepatic carbohydrate metabolism using the 
isolated perfused rat liver and analysis of tissue levels of gluconeo-
genie intermediates. The results demonstrated that the energy cost for 
gluconeogenesis was greater in livers of endotoxin treated rats since 
they consumed 02 at an elevated rate and lactate at a normal rate but 
failed to produce glucose. The proposed mechanism of failure of glu-
coneogenesis was believed to be either a failure of fructose diphos~ 
phatase or a stimulation of phosphofructokinase resulting in an ac-
cumulation of fructose-1,6-diphosphate with a depletion of fructose-6-
phosphate and glucose-6-phosphate. The fructose diphosphate would ac-
tivate pyruvate kinase thus diminishing net phosphoenol pyruvate for-
mation and hence net glucose formation while ATP utilization and 02 
consumption remain elevated. A mitochondrial defect was suggested to 
be the underlying cause of the elevated fructose diphosphate levels. 
Also notable wa~ the observation that the infusion of a short chain 
free fatty acid, oleate, increased lactate uptake and doubled glucose 
production in the livers of no.rmal rats but had no such effect in the 
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livers of endotoxin treated rats, further suggesting altered mitochon-
drial metabolism. A recent report from this laboratory (204) has 
stressed the transition from hepatic glycogenolysis to gluconeogenesis 
as a critical stage in the metabolic adaptation and resistance to le-
thal endotoxin shock. In both fed and fasted rats given an LD-100 dose 
of endotoxin terminal hypoglycemia and hepatic glycogen depletion were 
observed. When gluconeogenesis was stimulated by an overnight fast, 
rats were resistant to endotoxin which suggested that the induction of 
gluconeogenesis may be depressed in endotoxin p~isoned rats. When glu-
coneogenesis was evaluated using the method of Cornell et al. (130) en-
dotoxin poisoned rats had an impaired hyperglycemic response and a re-
duced incorporation of C-14-label from alanine-C-14 into blood glucose 
which suggested a defect in hepatic function. That the impaired glu-
coneogenesis involved an intrinsic hepatic metabolic lesion was demon-
strated using hepatocytes isolated from rats given endotoxin in vivo. 
C. Sub-Cellular and Insulin-Like Actions of Endotoxin 
The mechanism by which shock and endotoxemia produce their 
characteristic derangements in cellular metabolism have been the sub-
ject of numerous investigations. Berry and coworkers (57) first re-
ported a dinitrophenol like uncoupling action of endotoxin on isolated 
liver mitochondria. Mela and coworkers (441) studied rat liver mito-
chondrial function after hemorrhagic or endotoxic shock and found the 
abnormalities to be similar. State 4 activity was increased indicating 
loose coupling while state 3 activity was decreased which depressed 
respiratory control ratios to less than one third the control values. 
ADP utilization and ATPase activity were depressed suggesting a possible 
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defect in adenine nucleotide translocase. More recently Mela and 
coworkers (442) found about a 50% loss in mitochondrial Mg++ fol-
lowing endotoxin shock which was accompanied by an almost complete 
loss in the capacity of the isolated mitochondria to transport ca-++. 
Decreases in mitochondrial respiratory control ratios were also cor-
related with apparent rupture of hepatic lysosomes in vivo. When 
ruptured hepatic lysosomes were added to normal mitochondria in vitro 
the respiratory control ratio was found to drop exponentially due to 
an increase state of respiration indicating loose coupling. ATPase 
activity was likewise depressed by adding ruptured lysosomes in vitro. 
It was concluded that the experimental evidence suggested a role for 
lysosomal enzymes in the etiology of the mitochondrial lesions of shock. 
In experiments in which endotoxin was added to isolated mitochondria 
in vitro, Mela (440) reported that some of the effects of endotoxemia 
in vivo were produced including alterations in the energy-dependent 
ca++ uptake which suggested that endotoxin directly affected mitochon-
drial membrane transport. Greer, Epps, and Vail (274) also reported 
inhibition of state 3 respiration and depressed respiratory control in 
rat liver mitochondria. Since these effects were observed in the pres-
ence of 12.5 m Molar Mg Cl2 it was suggested that the loss of mitochon-
drial cations may be an important toxic action of .endotoxin on rat liver 
mitochondria. Schumer and coworkers (565) extended the study of endo-
toxemic alterations in mitochondrial function to skeletal and cardiac 
muscle mitochondria since these tissues are responsible for a major 
fraction of basal oxygen consumption and abnormalities in cardiac 
function are known to occur in shock. State 3 respiration was 
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depressed in the mitochondria of both tissues and there was a marked 
loss of respiratory control. As had been observed in liver mitochondria, 
skeletal muscle mitochondria of endotoxin treated rats showed evidence 
of loose coupling. It was suggested that elevated levels of endogenous 
compounds such as free fatty acid anions or thyroxine may be responsible 
for the mitochondrial alterations observed. 
Baue and coworkers (37) have studied ATP utilizing and ATP 
yielding processes in liver cell fractions isolated from animals in 
early and late shock and found a decrease in ATf yielding reactions as 
reflected by mitochondrial state 3 activity coupled with an increase in 
ATP dependent reactions as evaluated by Na+ - K+ activated ATPase ac-
tivity. It was suggested that these changes may lead to alterations. 
in membrane transport which may be an important etiologic factor in the 
initiation of cell injury in shock. In a subsequent study from the la-
boratory of Baue (109), the effect of low ATP levels on glucose uptake 
was studied in an effort to define the role of ATP as a feedback inhi-
bitor of glucose uptake by skeletal muscle. It was found that anoxia 
alone was a sufficient stimulus to increase glucose uptake in intact 
rat soleus muscle which led to increased lactic acid production. It 
was considered relevant that Gould and Chaudry (275) had shown that in-
r sulin was not necessary for basal glucose uptake by soleus muscle, but 
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insulin was required for anoxia stimulated glucose transport. This 
suggested to the authors that shock ~ ~ did not produce any alteration 
or modification in the function of endogenous insulin. Rutenberg et al. 
~52) studied the hepatic cyclic AMP response to glucagon in shocked 
rabbits. Basal cAMP levels were depressed in shocked rabbits below 
control levels and the cAMP response to a supramaximal dose of glucagon 
in vivo was only one half that observed in control rabbits and not sig-
nificantly greater than basal levels. In contrast, the in vitro response 
to non-specific adenylate cyclase stimulation by NaF was not different 
in the shocked and control liver preparations even though the response 
to a series of glucagon concentrations was severely impaired at all dose 
levels in the shocked livers. ATP levels in shocked livers were about 
ten-fold lower than in controls. It was concluded that the observed 
defect appeared to reside in the glucagon rece~tor without any intrinsic 
malfunction in adenylate cyclase or its catalytic properties; the ATP 
deficit was considered inconsequential to cAMP generation. The re-
ported defect in glucagon stimulated adenylate cyclase activity in shock 
stands in contrast to the studies of Bitensky et al. (62) showing a 
selective stimulation of epinephrine sensitive adenylate cyclase in the 
membrane fraction of the livers of mice given endotoxin. An in vitro 
sensitization of the adenylate cyclase activity of the membrane fraction 
to epinephrine stimulation was also reported. The authors suggested 
that adenylate cyclase may be an initial locus of action of endotoxin 
and may explain the glycogenolytic response to endotoxin as well as the 
well known sensitivity to catecholamines observed in endotoxemia. 
Gimpel and coworkers (254, 255) haye also reported effects of endotoxin 
on hepatic adenylate cyclase activity in guinea pigs. In vivo endotoxin 
treatment significantly stimulated basal adenylate cyclase activity in 
liver biopsies taken 4 hrs after endotoxin injection, however a possible 
residual effect of hormones secreted in vivo was not excluded. Addition 
of endotoxin to liver homogenates in vitro produced a very limited but 
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statistically significant stimulation of adenylate cyclase activity which 
was only a small fraction of the stimulation observed with NaF. It was 
further shown that the increase in cAMP production could not be attributed 
to either an inhibition of phosphodiesterase activity or to the pro-
duction of a dialysable factor which stimulated adenylate cyclase. The 
authors related their findings to the well recognized glycolytic stimu-
lation, glycogenolytic activation, and glycogen synthase inhibition ob-
served after endotoxin treatment which were suggested to be due to a 
direct interaction between endotoxin and membrane bound adenylate cyc-
lase. 
Mitruka (456) has studied influence of gram negative sepsis 
on gluconeogenic and glycolytic enzyme patterns by assaying the levels 
of key enzymes in these pathways in tissues of rats infected with 
S. typhimurium. The glycolytic enzymes--glucokinase, phosphofructokinase, 
and pyruvate kinase--wereall elevated 30 to 170% in kidney, spleen, and 
skeletal muscle of infected animals. S. typhimurium treatment caused 
a 100 to 150% increase in key glycolytic enzymes in liver which was 
accompanied by a 20 to 80% decrease in key hepatic gluconeogenic enzymes. 
Isotopic tracer studies supported the inferences based on enzyme assays 
by showing that the metabolic flux in liver tissue of infected rats was 
increased toward the direction of glycolysis. It was noted that the 
effect of infection. with ~· typhimurium was opposite that of starvation 
when enzyme profiles were compared, especially when the influence on 
hepatic gluconeogenic enzymes was compared. Smith and coworkers (405, 
406, 596) have studied alterations in metabolites in mice given acutely 
lethal doses of non-gram negative bacteria. In experiments similar to 
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those of Berry et al. (57) homogenates were prepared from the carcasses 
of mice and analyzed for various metabolites and enzymes (405). A 
steady downward trend in carcass glucose was observed in mice given S. 
aureus reaching 1/5 of control at 4 hrs and 1 /12 of control at death. 
Further experiments showed the carbohydrate depletion could not be at-
tributed to the bacteria per~ but must be due to a host response. It 
was concluded that as in lethal endotoxemia, severe derangements in 
carbohydrate metabolism were part of the death mechanism in mice dying 
from staphylococcal infection. Smith (596) later reviewed this work and 
presented additional findings. In contrast to endotoxin poisoning which 
similarly depletes blood glucose and body carbohydrate stores, there was 
no increase in blood lactate in staphylococcal infected mice. This sug-
gested that although blood pressure had been observed to be decreased, 
oxygenation of the tissues was still adequate. As in endotoxin shock, 
when the mice were pretreated with insulin a given dose of Staphylococci 
produced a markedly more severe infection. When the oxidative activity 
of mouse liver was investigated in vitro the tissue from infected mice 
showed a much higher rate of Oz uptake as well as evidence of uncoupling. 
In other experiments mice were given exogenous glucose and this pro-
duced a significant lengthening of survival time but no decrease in 
lethality. When given in massive doses testosterone and adrenal gluco-
corticoids were found effective in prolonging survival. Smith con-
cluded that death from staphylococcal infection probably has its ulti-
mate cause in changes in liver function and is intimately related to 
carbohydrate metabolism. Recently this group (466) has carefully 
examined lipid metabolism in mice with lethal Staphylococcus septic 
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shock. Increased plasma free fatty acids in infected mice were a most 
conspicuous feature with levels approaching ten times the normal fasted 
value. The authors suggested that the free fatty acids are probably 
not utilized because of the hypoglycemic state in infected animals. 
The rise in free fatty acids with a proportionately greater rise in 
saturated fatty acids was suggested to be the mechanism leading to mi-
tochondrial damage and an uncoupling of oxidative phosphorylation. 
In investigating the effects of endotoxin on metabolism at the 
cellular and sub-cellular levels, Woods and coworkers (677, 678) as 
well as others (252, 660) have shown striking similarities in the effects 
of endotoxin and those of insulin on carbohydrate metabolism. When tis-
sues were either treated with endotoxin in vitro or obtained from ani-
mals poisoned with endotoxin in vivo, a marked stimulation of glycolysis 
was demonstrated. This glycolytic stimulation was observed only in tis-
sues in which a similar response to insulin treatment was observed. It 
was suggested by Woods and coworkers (677) that endotoxin and insulin 
act as independent entities to stimulate glycolysis by competing for 
the same site of action which appeared to be at the level of glucose 
phosphorylation. These authors (677) concluded that the glycolytic 
stimulation effected by endotoxin like that of insulin, apparently in-
valved an overcoming of the glycolytic restraint imposed by the action 
of a previously described (676) endogenous anti-insulin mechanism pre-
sumably involving endogenous steroid hormones, but which was accentuated 
by the addition of exogenous steroids. The capacity of various native 
endotoxin preparations as well as detoxified endotoxin to stimulate gly-
colysis was shown to parallel the in vivo activity of these preparations 
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in evoking characteristic host reactive responses. This evidence was 
interpreted as indicating that the features of the structure or compo-
sition of endotoxin responsible for the characteristic actions in vivo 
are the same as those involved in the influence on cellular glycolysis. 
It was further suggested that the protective effects of cortisone in 
endotoxemia reported by Berry and coworkers (57) might be explicable 
at least in part by the ability of this steroid hormone at high levels 
·to overcome the stimulation of glycolysis induced by endotoxin and thus 
play a role in the prevention of the severe dep~etion of carbohydrate 
reserves which occurs in endotoxin shock. 
D. Hypoglycemic Activity of Endotoxin in Animals Sensitized 
to Lethal Endotoxin Shock 
The hypoglycemic activity of endotoxin has been found to be 
accentuated in animals made sensitive to lethal endotoxemia by any of 
a number of experimental manipulations (50). The correlation was found 
to be so close that others (574) have suggested that hypoglycemia may 
be the common mechanism by which a number of experimental treatments 
sensitize animals to lethal endotoxin shock. Farrar and Watson (182) 
observed what they described as a progressive and profound hypoglycemia 
in carbon tetrachloride treated guinea pigs given a lethal dose of en-
dotoxin. In control 12 hr fasted guinea pigs given a lethal dose of 
endotoxin a characteristic biphasic blood glucose response of hyper-
glycemia followed by a decline below control values was observed as 
the shock syndrome progressed. In guinea pigs treated with carbon-
tetrachloride an immediate and progressive fall in blood glucose fol-
lowed the endotoxin injectioh, reaching a mean value of 4 mg per 100 ml 
r 
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at 4 hrs after endotoxin. The blood glucose response was not recognizably 
different in the carbon tetrachloride treated guinea pigs when the endo-
toxin dose was reduced to a level just sufficient to kill 90 to 95% of 
the sensitized animals. Glucose tolerance studies in carbon tetrachloride 
treated guinea pigs with and without endotoxin treatment showed no dif-
ference in rate of disappearance of glucose from the blood irrespective 
of endotoxin treatment which was interpreted as indicating that endotoxin 
treatment did not accelerate the rate of glucose removal at an early 
time after treatment with endotoxin. A failure. in hepatic glucose pro-
duction following endotoxin was felt to be the most likely explanation 
for the severe hypoglycemia in these animals with pre-existing liver 
damage. The impairment appeared to be in gluconeogenesis rather than 
a defect in glycogen storage which was elevated in carbon tetrachloride 
poisoned guinea pigs. Attempts were made to protect the animals from 
lethal hypoglycemia elicited by endotoxin by a constant infusion of 20% 
glucose at a rate of 50 mg glucose per 100 gm per hr. Glucose did not 
protect the animals and the small increase in mean survival time was not 
statistically significant. It was concluded that where as hypoglycemia 
may be the cause of the early deaths following endotoxin in carbon te-
trachloride sensitized guinea pigs, there appeared to be more complex 
changes which ultimately induced a lethal outcome even if exogenous 
glucose was supplied. Berry and coworkers (56) confirmed the original 
observations of Suter et al. (623) that mice infected with BCG were 
hyperreactive to bacterial endotoxin, and the time of maximal sensitivity 
to endotoxin the reticuloendothelial system was known to be activated 
026). On this basis it was felt that BCG infection may be expected 
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to cause a resistance to endotoxin 56 ). However, it was found that 
the metabolic responses of BCG infected mice were abnormal and exhibited 
certain similarities in their metabolic responses to those previously 
found in endotoxin poisoned normal mice (53). Berry and coworkers (56) 
found that BCG infection depleted mice of liver and muscle glycogen and 
total body carbohydrate which were at a minimum when mice were most sen-
sitive to endotoxin. It was suggested that the earlier approach of car-
bohydrate levels of endotoxin treated BCG infected mice to those found 
at death in normal animals given a lethal dose .. of endotoxin may explain 
why BCG infected mice die as early as 4 hrs after endotoxin where as 
normal survive usually about 18 hrs or more. Glucose injections were 
incapable of protecting BCG infected mice from the lethal effects of 
endotoxin. It was suggested that perhaps BCG infected mice have an 
impairment also in their ability to metabolize glucose. Finkelstein 
(210) studied the mechanism of the lethal effect of minute doses of 
endotoxin in chick embryos during their period of maximal sensitivity 
at 10 to 11 days incubation. In contrast to epinephrine, norepinephrine, 
histamine, serotonin, and acetylcholine, insulin in small amounts was 
very toxic to the embryos. A decrease in insulin sensitivity paralleled 
the increased resistance to endotoxin as chicks matured. Blood glu-
cose studies showed that both insulin and endotoxin caused a severe 
hypoglycemia coincident with death. Finkelstein (210) observed that 
the chick embryo develops the capacity to handle exogenous insulin at 
the same time it becomes capable of coping with endotoxin and that the 
gross and microscopic pathology of embryos succumbing to insulin is 
similar to that observed in emoryos given a lethal dose of endotoxin. 
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More recently, Shands and coworkers (574) have hypothesized 
and presented supporting evidence that it is the hypoglycemic activity 
of endotoxin which is responsible for the many fold sensitization to 
lethal endotoxemia produced by a variety of experimental manipulations 
known to markedly lower the resistance of animals to lethal endotoxin 
shock. This was supported by the observation of severe potentially le-
thal hypoglycemia in mice or rabbits made hyperreactive to endotoxin by 
BCG infection, zymosan treatment, or adrenalectomy. Detailed studies 
designed to delineate the mechanism of the hypo~lycemic response to en-
dotoxin in BCG infected mice were reported by Shands et al. (575). It 
was in these studies that the possibility of a role of insulin in the 
development of the lethal hypoglycemia induced by endotoxin was first 
given serious consideration. In addition the possibilities that endo-
toxin rapidly induces a hypermetabolic state or that it caused a block 
in gluconeogenesis in BCG infected mice were considered. However, 
Shands et al. (575) concluded from their studies in BCG infected mice 
that 
The possibilities of an induced hypermetabolic state and an induced 
release of insulin in response to endotoxin as causes for the hy-
poglycemic responses were essentially ruled out. In addition, no 
clear-cut evidence of an insulin like action by endotoxin was found 
in the in vivo setting. 
They interpreted their evidence as implicating an impairment of gluco-
neogenesis to be the mechanism by which BCG infection rendered mice 
hyperreactive to endotoxin. The persistence of a hypoglycemic activity 
of endotoxin in alloxan-diabetic BCG infected mice and the failure to 
observe a rise in mean blood glucose in mannoheptulose treated BCG in-
fected mice following endotoxin poisoning were presented as evidence 
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that endqgenous insulin secretion was not a requisite for endotoxin to 
exert its hypoglycemic activity in BCG infected mice. Based on the re-
port of Pieroni and Levine (514) which demonstrated a marked sensitiza-
tion to lethal endotoxin shock in normal mice by prior treatment with 
a sublethal dose of insulin, Shands and coworkers (577) re-examined the 
possible role of endogenous insulin secretion in the development of the 
profound hypoglycemia observed in BCG infected mice poisoned with endo-
toxin. The possibility was considered that although BCG infected mice 
per~ were not markedly sensitive to insulin, perhaps endotoxin ren-
dered such mice exquisitely sensitive to insulin. It was found that 
in combination with insulin a sub-lethal dose of endotoxin rapidly pro-
duced a severe convulsive hypoglycemia which was not produced by either 
agent alone when administered to BCG infected mice. Further studies 
were designed to examine the possibility that endogenous insulin secre-
tion may have played a role in the previously reported (574 575) un-
. ' 
successful attempts to protect endotoxin poisoned BCG infected mice 
from lethal endotoxemia by the parenteral administration of glucose. 
Since mannoheptulose prevented the abrupt fall in blood glucose to le-
thal levels following an intravenous dose of glucose it was suggested 
that endogenous insulin secretion played a role in this reactive hypo-
glycemia. The authors concluded that both the insulin sensitivity and 
the reactive hypoglycemia in response to exogenous glucose were attri-
butable to an impairment of gluconeogenesis in endotoxin poisoned BCG 
infected mice and there were situations in vivo in which insulin may 
play a role in the development of a lethal hypoglycemia in endotoxin 
poisoned BCG infected mice. In search of the mechanism underlying the 
34 
endotoxin induced depression of gluconeogenesis and marked sensitivity 
to lethal shock in BCG infected mice, Shands and Senterfitt (570) studied 
the morphologic changes and the release of liver enzymes to serum in 
BCG infected mice given endotoxin. ECG infection alone caused an ele-
vation in serum levels of hepatic enzymes which was maximal at the time 
the infected mice weremost susceptible to endotoxin. Other experiments 
demonstrated that endotoxin treatment of ECG infected mice caused an 
acute elevation hepatic transaminases as well as lysosomal enzymes in 
the serum. Elevations in serum enzyme activities also occurred in nor-
mal animals given endotoxin. In morphological studies Shands and 
Senterfitt (576) found that BCG infection alone disturbed normal liver 
architecture by producing granulomas in the parenchymal tissue. After 
endotoxin treatment there was evidence of severe focal injury and cir-
culatory stasis in the liver as well as glycogen depletion. Shands 
and Senterfitt concluded that their observations of morphological changes 
in BCG infected mice given endotoxin were comparable to what had been 
previously observed by others when endotoxin was given to non-sensitized 
animals but differed in that the changes occurred more rapidly and 
with a much smaller dose of endotoxin. 
Work from our laboratory has sought to determine the mechanism 
by which lead acetate causes a 2,000 fold sensitization to the lethal 
effects of endotoxin in rats. After finding that lead acetate treat-
ment did not affect the intravascular clearance of endotoxin nor did 
it impair the ability of liver homogenates to detoxify endotoxin,it 
was suggested that the mechanism of lead sensitization may relate to 
leads ability to alter metabolic responses during endotoxemia (20~· 
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In a subsequent publication the metabolic alterations induced by endo-
toxin in lead sensitized rats were reported to be a profound hypoglyce-
mia, bctacidemia, and depletion of hepatic glycogen (200). In studies 
with hepatocytes isolated from rats treated with lead acetate in vivo 
a depression of gluconeogenic capacity was found. It was suggested 
that the alterations in carbohydrate metabolism, in particular the de-
pressed hepatic gluconeogenesis, were responsible for the sensitization 
to endotoxin produced by lead acetate. A preliminary report has also 
demonstrated a sensitization to insulin produced by lead acetate treat-
ment (84) and this may play a role in the pathogenesis of lethal endo-
toxemia in lead sensitized animals. Endotoxin induced hypoglycemia has 
also been observed in subhuman primates sensitized to endotoxin. In 
a recent report from the laboratory of Diluzio (318) the results of 
studies on the interaction between lead acetate and bacterial endotoxin 
were presented. The results clearly demonstrated that in presence of 
lead acetate, trace amounts of endotoxin can produce acute death. Al-
though hypoglycemia and hyperlactic acidemia were observed in baboons 
given a lethal dose of endotoxin alone, only a more severe hypoglycemia 
with more nearly normal lactate levels were observed in lead sensitized 
animals. It was suggested that the finding of rapid onset of hypogly-
cemia and hypotension in the baboon contributed to the possibility of 
such a response in man. 
E. The Response of the Endocrine Pancreas to Endotoxemia 
The response of the endocrine pancreas to clinical as well 
as experimental hemorrhagic, traumatic, cardiogenic, and burn shock 
has been-the topic of a number of published studies. However, few 
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investigators have studied the pancreatic control of carbohydrate meta-
bolism in endotoxemia and the related.conditions of sepsis and infection. 
Bloom and associates (68) studied the influence of stress on the plasma 
levels of glucagon in baboons and rhesus monkeys. When conscious monkeys 
were given an iv injection of a small amount of endotoxin over a three-
fold elevation of plasma glucagon was observed in samples collected 2 
hrs after endotoxin treatment. No change in blood glucose was observed 
I 
and insulin levels showed only minimal deviation from the control values. 
The authors believed the increase in glucagon in response to endotoxemic 
stress was due to adrenergic stimulation of the pancreatic alpha cells 
mediated by the autonomic innervation known to richly supply the islets 
(680). Rocha and coworkers (544) studied glucagon secretion in clini-
cal and experimental bacterial infections. Severe or moderate infec-
tions were found to be associated with striking hyperglucagonemia and 
a related increase in the insulin requirement to maintain norrnoglycemia. 
Glucagon was also believed to play a role in the catabolic response to 
infection as reflected by increased urinary nitrogen excretion and pre-
sumably an increased rate of gluconeogenesis. In the severely in-
fected patients plasma insulin was more than doubled over control values 
but the greater relative increase in plasma glucagon caused the insulin 
to glucagon molar ratio to be depressed below normal values. This 
was thought to be the factor largely responsible for the negative ni-
trogen balance observed during infection. Lindsey et al. (406) studied 
the response of the pancreatic alpha cells in traumatized patients with 
and without accompanying shock. Hyperglucagonemia associated with 
hyperglycemia and an insignificant elevation of plasma insulin were 
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observed soon after the onset of shock. Patients undergoing surgical 
trauma who did not have associated hypotension had normal plasma gluca-
gon levels. It was concluded that the injury induced modifications in 
pancreatic endocrine function, i.e., a relative hypoinsulinemia and an 
absolute hyperglucagonemia, must be regarded as protective physiological 
responses, and therapeutic efforts to correct the elevated glucagon to 
insulin ratio would be contra-indicated on theoretical grounds. Also 
noted were the risks Qf administering glucose to sho~ked patients with 
their relatively fixed insulin to glucagon ratio. 
Shambaugh and Beisel (573) were the first to report the insulin 
response to a glucose stimulus during acute infection of humans with 
Pasteurella tulaiemia. Within 8 to 24 hrs of the onset of clinical 
illness a significant decrease in glucose tolerance was observed in 
conjunction with a slight but statistically significant fasting hyper-
glycemia. By 2 weeks after antibiotic treatment glucose tolerance was 
found ~ot to reflect the insulin response to the glycemic stimulus. 
The three hour insulin output following the glucose load was signifi-
cantly greater during gram negative infection than during the control 
studies. Since the magnitude of the insulin response was inversely 
related to the rapidity of glucose disappearance during the infection 
as it was during control studies, the authors suggested that the ef-
fectiveness of insulin was dampened during sepsis by a peripheral in-
hibition of insulin action. From the observations of altered glucose 
tolerance and elevated insulin responses associated with an exaggerated 
rise in blood pyruvate following glucose, the authors attributed the 
changes to be due at least in part to a glucocorticoid excess. Also 
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suggested was a possible role of glucagon in the enhanced insulin re-
sponse during sepsis. Beisel (40) reviewed the work from his laboratory 
and of others on the interrelated changes in host metabolism during 
generalized infections illness. He stress~d that a number of models 
had been used to study acute infectious disease the metabolic response 
to these diverse diseases developed in a stereotyped manner. In all 
diseases plasma amino acids were depressed, and in some cases the prin-
ciple gluconeogenic amino acids--especially alanine, were more severely 
depressed. The apparent increase in flow of amino acids from muscle 
and peripheral tissues to liver during infection was confirmed using 
the non-metabolized amino acid cycloleucine as a tracer in experiments 
with rats. Beisel (40) suggested that in early infection gluconeogenesis 
is increased at the expense of plasma amino acids. In terminal stages 
of overwhelming infection or endotoxemia it is Beisel's view that blood 
sugar values can not be maintained, tissue carbohydrate stores become 
exhausted, and plasma glucose precursor levels rise as hepatic gluco-
neogenic function fails. Felig and associates (193) have presented 
evidence that pattern is not limited to gram negative septicemia but 
may also be observed in acute viral disease. Rayfield et al. (533) 
recently studied plasma glucagon and insulin during a self-limiting 
viral infection in human volunteers. As had been previously reported 
there was a depression of glucose tolerance and a marked increase in 
the insulin response to an iv glucose load. Plasma glucagon was sig-
nificantly elevated during the infection in the fasting state but was 
significantly depressed by the hyperglycemia following glucose loading 
as it had been in control studies. Growth hormone was tripled in the 
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fasting infected patients and exhibited a paradoxical increase following 
iv glucose in infected patients, whereas no change was observed in con-
trol studies. Urinary cortisol was increased 3 times over control values 
in the infected patients. Free fatty acids showed a two-fold rise during 
the infection. Hyperinsulinemia following glucose during the infection 
was considered compatible with the elevated plasma levels of glucagon, 
growth hormone, and free fatty acids. Rayfield and coworkers (532) 
recently reexamined the hypersecretion of growth hormone in response to 
iv glucose in conscious rhesus monkeys infected with Diplococcus 
pneumoniae or with Salmonella typhimurium. There were neither glucose 
intolerance or FFA abnormalities during the height of the illness. 
The paradoxical large increase in growth hormone following iv glucose 
was also observed in this model. Alpha adrenergic blockade by phento-
lamine did not block the growth hormone response, however an extended 
period of chlorpromazine treatment prevented it suggesting that it was 
mediated by a central nervous system mechanism. In a similar study 
this group (247) investigated the glucoregulatory hormonal responses 
during acute sepsis in rhesus monkeys. No differences in fasting 
growth hormone, fasting glucose, or the disappearance rate of glucose 
were found when control studies were compared with those following 
the induction of sepsis. However, during sepsis there was a relative 
hyperinsulinemia in response to glucose as well as a fasting hyper-
glucagonemia. Plasma amino acid levels were markedly lowered during 
sepsis. O'Donnell et al. (490) studied the relationships of hind limb 
energy fuel metabolism to the circulatory responses to sepsis in un-
anes thetized fasted pigs. On ,the basis of cardiovascular responses 
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3 days after cecal ligation the septic pigs were assigned to either a 
high flow group or a low flow group. Mean blood glucose was depressed 
in both septic groups compared to control values, but the depression 
was less severe in the low flow group. In the high flow septic group 
plasma insulin was significantly increased to over 4 times control levels. 
This elevation in plasma insulin was present despite a significant de-
pression of blood glucose to 30 mg per 100 ml below control fasting 
levels. In the low flow septic group the insulin elevation was not 
statistically significant. Hindlimb glucose uptake was the same in all 
three groups suggesting a peripheral insulin resistance in the high flow 
septic group. Hind limb lactate production was strikingly elevated in 
the low flow septic group but not. in the high flow septic animals. 
Arterial lactate levels reflected their rates of production. In both 
groups of septic pigs arterial free fatty acids were markedly depressed 
below the control fasting level. In sepsis the hind limb released 
fatty acids into the plasma in contrast to its net removal of circulating 
free fatty acids in control pigs. Glycerol release wts depressed in 
high flow sepsis but was markedly elevated in low flow sepsis. The 
authors indicated that their study had demonstrated sepsis to be as-
sociated with 2 distinct patterns of substrate fuel utilization for 
energy production both of which differed significantly from the meta-
bolic pattern of starvation. The metabolic pattern in sepsis appeared 
to be related to the circulatory status. The role of insulin as a 
key regulator of the flow and utilization of substrates was stressed 
by the authors. Insulin was viewed as play1ng a critical role in 
modulating fuel utilization in the high flow septic state, however 
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peripheral insulin resistance was also recognized. In the low flow 
septic state peripheral anaerobic glycolysis was the major fate of glu-
cose in peripheral tissues. It was proposed that the factor responsible 
for the difference in the metabolic pattern in high and low flow sepsis 
was that catecholamine activity was enhanced in the low flow septic 
state but not elevated in high flow sepsis. Clowes et al. (120) ex-
tended the previous work. of O'Donnell et al. (440) to include clinical 
observations of human sepsis. To examine the effect of glucose, po-
'tassium, and insulin on the high output and low output responses to 
septic peritoniti~ experiments were carried out as previously described 
up through the baseline measurements in septic pigs. The pigs were 
then infused over a 10 min. period with 1 gm glucose per kg, 1.5 units 
of insulin per kg, and 10 m Eq potassium per kg. At 15 min. and 2 hrs 
after the infusion circulatory and metabolic measurements were repeated. 
In response to the infusion of glucose, potassium, and insulin there 
was an increase in cardiac output in both low and high flow septic 
pigs. Both groups also demonstrated an increase in hind limb oxygen 
consumption and in glucose uptake. In the clinical study Clowes et 
al. (120) classified patients as high flow or low flow sepsis on the 
basis of if they were normotensive or hypotensive. Both groups were 
markedly hyperglycemic, however this parameter may have been influenced 
by previous iv treatment with glucose. In the high flow septic patients 
plasma insulin was elevated to over twice the control value. Ten 
patients were treated with glucose, insulin and potassium using the 
doses which had been used in the pigs. It was reported that the in-
fusion caused a rise in both mean arterial blood pressure and in cardiac 
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index. Th~ infusion caused a fall in plasma free fatty acids. A hypo-
thesis was proposed that certain of the phenomena observed in the high 
output septic state may be protective mechanisms to prevent the hypo-
insulinemia associated with cardiovascular insufficiency which charac-
terizes the low output state. It was envisioned that reduced insulin 
may play a role in producing the low flow state. It was noted that in 
other studies these investigators found that the hypoinsulinemia and 
prolonged severe proteolysis could be averted or ameliorated by infusions 
of amino acids instead of glucose. Clowes et al. (120) proposed the 
possibility that low plasma insulin depressed cardiovascular function 
in septic patients, however stated that the mechanism underlying this 
relationship was not clear. 
Griffiths, Groves, and Leung (280) reported a study designed 
to gain added insight into the relationship between plasma glucose, 
serum triglycerides, and hormones regulating the levels of these me-
tabolites in dogs subjected to gram negative septicemia. In dogs which 
died within 12 hrs there were wide variations in the plasma insulin 
levels. Values as high as four times the control insulin level were 
observed at 4 hrs following bacteremia. In these dogs dying rapidly 
a fall in plasma glucose was associated with the increases in mean 
plasma insulin. In dogs surviving greater than 12 hrs a progressive 
hypoglycemia was associated with no change in plasma insulin. It was 
hypothesized that the rise in insulin observed in this study may have 
been antagonized by other hormones such as glucagon and growth hormone 
as well as the rise in cortisol observed in this study. The hypogly-
cemia observed in this study was attributed to a combination of 
l 
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accelerated glucose utilization coupled with an impaired hepatic gluco-
neogenic function. Elevated insulin levels were suggested to be one 
factor which impaired gluconeogenesis by limiting peripheral amino acid 
release. Cryer, Herman, and Sode (137) initiated a study of carbohy-
drate metabolism in baboons subjected to gram-negative septicemia. Each 
animal was given a dose of 10 ml per kg of a suspension of lol 1 washed 
E. coli per kg by iv injection. Animals surviving beyond the 2 hr point 
were given 500 ml of 5% albumin in saline every 30 minutes until the 4 
hr point was reached.. Following~ coli injection significant hyper-
glycemia was observed and blood glucose remained elevated until the 120 
min. point. By 240 min. significant hypoglycemia was observed. De-
spite the transient hyperglycemia plasma insulin dropped below the mean 
level observed in saline treated controls but the difference was not 
statistically significant until 2 hrs after~ coli. Regression analysis 
showed that the change in plasma insulin was significantly correlated 
to the changes in plasma glucose in septic baboons. The hyperglycemic 
phase following_!.. coli injection was suggested to be due at least in 
part to a lack of the expected insulin response. The suppression of 
insulin release was thought to be due to catecholamine suppression of 
the beta cell response to hyperglycemia and it was considered likely 
that this effect was mediated by the islets' sympathetic innervation 
rather than attributable to elevation of plasma epinephrine arising 
from the adrenal medulla. It was further suggested that the hypo-
insulinemia could not be explained on the basis of either an increased 
distribution space or an increase in the rate of degradation and that 
the depressed plasma levels truly reflected a ,decreased pancreatic 
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insulin secretion. Cryer and coworkers (138) conducted experiments to 
further clarify the mechanism of the initial hyperglycemia and hypoin-
sulinemia in septic baboons. Intravenous glucose tolerance tests with 
0.5 gm of glucose per kg at 20 min. after E. coli injection showed the 
insulin response to be suppressed compared to the insulin response in 
non-septic controls. During septicemia the half-time for glucose dis-
appearance following the iv load was.increased nearly two-fold from 41 
to 75 min. In insulin tolerance tests 0.2 Units of regular insulin was 
given iv 20 min. after the induction of sepsis. In these experiments 
the insulin treated septic baboons all became severely hypotensive and 
usually died before the 2 hr point was reached. Both the control and 
septic baboons exhibited decreases in blood glucose following insulin. 
Although initially hyperglycemic the septic baboons exhibited a greater 
depression of blood glucose in response to insulin, thus demonstrating 
that they were not insulin resistant at this early time after sep~is. 
In septic baboons the half-time for iv insulin disappearance was in-
creased over two-fold from a control value of 16 min. in the controls 
to 33 min. in the septic animals. It was concluded that insulin re-
sistance was not a significant factor in the hyperglycemia observed 
after E. coli injection. It was further indicated that insulin could 
prevent the hyperglycemia, however the data showed that insulin treated 
animals died more rapidly and as noted by the authors exhibited a more 
rapid and profound hypotensive response. In a later study Cryer et al. 
(136)reported the influence of phentolamine induced alpha adrenergic 
blockade on septicemia in the baboon. When phentolamine was infused 
throughout the period of septicemia the depression in serum insulin 
~·-
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and hyperglycemia did not develop in the 2 1/2 hr observation period. 
The relationship between the degree of suppression of insulin secretion 
and survival time was studied using smaller doses of 3.0 to 4.2 x lolO 
E. coli per kg and all animals were volume loaded with large quantities 
of albumin in saline. With this reduction in dose from 1011 E. coli 
per kg used in the previous studies only one half of the animals had 
depressed insulin levels. The duration of survival ranged from 2.1 t~ 
24.3 hrs and was significantly correlated with the serum insulin levels 
expressed as a percent of the mean basal level at 30, 45, or 60 min. 
after E. coli. Five additional animals were given infusions of albumin 
containing insulin, glucose, and potassium. Despite evidence of a me-
tabolic effect of the infused insulin as indicated by a 75% reduction 
in plasma free fatty acid concentration the mean overall survival of 
the treated baboons was 9.8 hrs compared to a mean survival time of 
9.7 hrs for the controls given only albumin solution. In reviewing 
their work the authors noted that their evidence indicated that, 
"Stress-induced inhibition of insulin secretion appears to be a rela-
tively high-threshold phenomenon. Definite suppression of insulin se-
cretion occurred in only 3 of 6 septicemic baboons given a smaller but 
still lethal dose of E. coli." It was concluded that their observations 
did not support the pharmacologic use of insulin in the treatment of 
septic states. Cryer et al. (139) further considered the possibility 
that depressed insulin secretion may well be a component of a coordi-
nated adaptive metabolic response to life threatening stress; however 
it was felt essential to examine the possibility that insulin lack 
may be detrimental to survival in baboons with severe sepsis. Baboons 
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were injected with 3.0 to 4.4 x lolO ~- coli per kg and treated with 
either.2.5% albumin in saline or 2.5% albumin containing glucose, in-
sulin, and potassium. Mean arterial blood pressure showed little dif-
ference between the animals treated with glucose, insulin, and potassium 
and those given only the albumin. In septic baboons infused with glu-
cose,insulin,. and potassium a marked hyperinsuliemia and hyperglycemia 
were maintained. Blood lactate was severely elevated in all septic 
baboons and glucose, insulin, and potassium treatment had no effect on 
this metabolic parameter. Following the 30 min. sample the mean plasma 
pH of the insulin infused group was consistently lower than that of the 
septic controls at all sampling times. The overall duration of survival 
was not improved by glucose, insulin, and potassium infusion. It w,as 
claimed that it appeared that glucose, insulin, and potassium infusion 
prolonged the survival of a sub-group of animals which showed evidence 
of more severe initial stress of septicemia as reflected by a greater 
inhibition of insulin release. The meaning of this depression from 
control values is not readily interpreted since the authors conceded 
from experiments in which phentolamihe was infused that their animals 
were already stressed to the point of inhibited insulin release and 
accompanying hyperglycemia in the control restrained state. More re-
cently this group (129) has investigated changes in serum free fatty 
acids during~· coli septicemia using their previously described 
baboon model. The dose of E. coli was the lower yet still lethal dose 
of 5 x 1010 organisms per kg. In these experiments no significant 
hyperglycemia was observed, however hypoglycemia was evident by 90 
min. after E. coli.injection. Mean serum insulin was reduced early in 
-, --
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the course of septicemia, but by 90 min. after injection the septic ani-
mals were no longer hypoinsulinemic when compared to controls despite 
their reduced mean serum glucose levels. The controls showed no signi-
ficant changes in serum free fatty acids. In the septic animals serum 
free fatty acids showed significant decreases to 72% of.basal values at 
60 and 90 min. after E. coli injection. The reduction in free fatty 
acids occurred despite the early depression of mean serum insulin levels. 
All septic baboons died within 2 hrs of E:· coli injection. It was sug-
gested that the depression of serum free fatty.acid levels may have been 
due to the elevation of mean plasma lactate to values of about 80 and 
130 mg per 100 ml at 60 and 90 min. after~· coli injection respectively. 
Again the authors explained that the stress the animals were subjected 
to prior to shock induction may have influenced the control values. 
The reports of Cryer et al. (136, 137, 139) of severe hyper-
glycemia accompanied by a hypoinsulinemia in acute gram-negative septi-
cemia in the baboon are contrasted by recent studies of clinical sepsis. 
Gump and coworkers (285) studied the iv glucose tolerance in patients 
with indwelling hepatic vein catheters which permitted measurement of 
hepatic blood flow by a dye infusion technique. In the septic patients 
in the basal state a slightly elevated arterial glucose level (94 ± 14 
mg per 100 ml) was associated with an elevation of basal serum insulin 
to 150% of control values, an elevated hepatic glucose production, and 
an increase in forearm glucose consumption. Following the infusion of 
0.5 gm glucose per kg there was a reversal of hepatic glucose pro-
duction to glucose uptake in control subjects which was accompanied 
by an increase in forearm glucose utilization. Following glucose 
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infusion peripheral glucose uptake was also evident in the septic pa-
tients, however hepatic glucose production was not suppressed. Serum 
insulin determinations from hepatic as well as peripheral blood samples 
showed an exaggerated insulin response in the septic patients. The 
authors concluded that failure of insulin secretion does not appear to 
be a factor in the failure of glucose infusion to reverse hepatic glu-
cose production in septic patients since splanchnic insulin release was 
significantly greater in the septic patients. It was concluded that 
the failure of insulin to shut down hepatic gl~cose production was a 
key factor in the altered carbohydrate metabolism observed in clinical 
sepsis. 
,F. Purpose and Objectives 
The overall objective 'of this stud¥ was to evaluate the re-
lationships between deranged homeostatic control of carboh~drate meta-
bolism in endotoxemia, endogenous insulin secretion in endotoxemia, and 
host defense to lethal endotoxin shock. Special emphasis was directed 
toward answering the question of whether endogenously secreted insulin 
might play a role in the development of the profound hypoglycemia and 
glycogen depletion known to accompany endotoxin shock. In addition, 
the possible role of altered carbohydrate homeostasis in the perpetua-
tion of the shock syndrome and ultimate demise of the challenged host 
via influences on the reticuloendothelial system was explored. 
Specifically, the objectives of the present study were: 
(1) to evaluate and establish whether a significant relation-
ship between the parameters of glycemic state, insulin secretory state, 
and the susceptibility to the induction of lethal endotoxin shock in 
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normal fed and fasted rats, 
(2) to investigate the gluconeogenic capacity and glycogenic 
functions of the liver in vivo in endotoxin-treated rats and to deter-
mine the influence of prior glucose treatment on these parameters, 
(3) to determine the temporal responses of both blood glucose 
and serum insulin in rats challenged with a potentially lethal dose of 
endotoxin and to relate these dynamic responses to resistance to the 
lethal effects of endotoxin, 
(4) to evaluate the glucose tolerance and insulin secretory 
response to a glycemic stimulus in rats previously treated with endo-
toxin, 
(5) to determine if endotoxin treatment induces a hypermetabolic 
state with respect to carbohydrate oxidation and to evaluate if this 
response is influenced by treatment with exogenous glucose, 
(6) to determine the role of insulin in the control of aerobic 
glycolysis in endotoxin poisoned rats by manipulations which are known 
to influence insulin secretion, 
(7) to determine the influence of insulin as well as insulin 
induced hypoglycemia on the phagocytic activity of the reticuloendothe-
lial system and to relate this to resistance to experimentsl shock 
induction, and 
(8) to determine the rate of disappearance of biologically 
active endotoxin from the vascular compartment of normal rats and to 
investigate how this is influenced by procedures known to sensitize 
rats to the lethal effects of endotoxin; lastly, to consider the pos-
sibility that the hypoglycemia of shock may play a role in the patho-
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genesis and perpetuation of the shock syndrome at the level of reticulo-
endothelial host defense. 
L 
CHAPTER III 
METHODS 
A. Animals and Care 
Adult male rats of the Holtzman strain were obtained directly 
from the Holtzman Company (Madison, Wisconsin). All rats--with the ex-
ception of those made diabetic with streptozotocin--(vida infra)--
weighed 300 + 20 grams when used in the fed state and approximately 15 
grams less when used after an overnight fast. All rats were received 
at least 7 to 10 days prior to use and thus they were allowed to ac-
climate to our laboratory animal quarters. Throughout this period and 
during the experimental periods--except when overnight fasting is de-
signated---Purina Laboratory Chow (Ralston Purina, St. Louis, Missouri) 
and fresh tap water were available ad libitum. Water bottles were not 
removed during overnight fasting or during experimental periods---except 
in the experiments dealing with the clearance of endotoxin from the vas-
cular compartment; with these rats access to water terminated at the 
time of iv endotoxin injection. 
Overnight fasting consisted of removing the food from the rat 
cages at approximately 6 PM on the evening immediately preceding the 
experiment. 
Temperature in the animal room was maintained at 27 + lOC 
throughout these experiments and was monitored with a recording thermo-
meter (Tempscribe, Bacharach, Pittsburgh, Pennsylvania). A lighting 
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schedule of alternating 12 hr light-dark periods was employed with lights 
on from 7:00 AM to 7:00 PM. The rats were routinely kept in hanging 
stainless .steel wire mesh cages with 5 animals per cage (7xl0xl7 inches). 
B. Endotoxin Preparation 
The endotoxin used was the Boivin lipopolysaccharide prepared 
from Salmonella enteritidis and purchased from Difeo Laboratories 
(Detroit, Michigan). A single batch of this commercial preparation was 
used in all lethality and metabolic studies. This batch was distributed 
under the supplier's control numbers #275421 a~d #503046. In the ex-
periments concerning the clearance of endotoxin in vivo and in vitro; 
another batch was used which had been assigned the control number #216338. 
In all cases the endotoxin was dispersed in sterile pyrogen-free 0.9% 
saline (Baxter, Travenol Laboratories Inc., Deerfield, Illinois) prior 
to either in vivo injection or addition to in vitro perfusion media. 
The endotoxin was weighed on a Cahn electrobeam balance (Model G, Cahn 
Division of Ventron Corporation, Paramount, California). In all le-
thality experiments and metabolic studies the endotoxin was prepared in 
saline on the day of the experiment such that a 1 ml volume contained 
the, desired dose. In in vivo clearance studies the endotoxin was simi-
larly prepared each day at a concentration of 500 micrograms per ml of 
saline and a volume to achieve the specified dose was administered. 
In the in vitro clearance studies a stock solution of 200µg endotoxin 
per ml saline was prepared and stored frozen in glass tubes. On the 
day of the experiment one tube was thawed and dilutions of this stock 
solution were prepared as known endotoxin standards; a 1.5 ml aliquot 
was also added to the 150 ml volume of perfusion media. There was no 
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evidence of deterioration of the lethal properties of endotoxin stored 
frozen in saline for the three month period during which these studies 
were in progress (Tables 18, 19, and 20). 
C. Lethality Experiments 
The specific protocols of the lethality experiments are given 
in the "Results" section. In general rats were given known doses of 
endotoxin suspended in 1 ml of saline by intravenous injection under 
light ether (Anaesthesia Grade, Mallinckrodt, St. Louis, Missouri) 
anaesthesia. All intravenous injections were made via the dorsal vein 
of the penis as employed in this laboratory for a number of years. This 
route of injection has been recently evaluated by Nightingale and 
Mouravief (486) and was found to give the same pharmacokinetic data as 
intracardiac injection. These investigators found no evidence of 
shunting of blood from this site to the hepatic portal system prior to 
entering the systemic circulation. Control groups received either no 
further treatment or were treated with saline or the diluent of the 
agent used in experimental groups. Agents given subcutaneously were 
injected under the skin overlying the scapular region. Intraperitoneal 
injections were made at midabdominal level on the right side of the mid-
line with care to avoid damage to vital organs. In all cases lethality 
was tabulated at 48 hrs following injection of endotoxin as in previous 
studies from this laboratory (198, 202). The vast majority of the shock 
deaths occurred at 12 to 24 hrs after endotoxin injection as was found 
in previous studies (202). In selected experiments survival was fol-
lowed up to 10 days and it was found that deaths beyond the 48 hr in-
terval were seldom observed. 
54 
For lethality experiments the results were totaled for each day 
that a particular protocol was repeated. When the number of groups pro-
hibited all groups being tested on the same day a fraction of the ex-
perimental groups were evaluated along with the appropriate control 
groups. By including controls for the experimental groups on any one 
day it was considered justifiable to total all animals in any one group 
when a particular experimental series was completed. The totals were 
used for all further data analysis. 
The significance of difference between groups was assessed using 
the.chi-square test with the correction factor of Yates for small sam-
ples included where appropriate (603 ). The chi-square tests were run 
on a PDP-12 digital computer (Digital Equipment Co., Maynard, Mass.) 
using the programs appended (p. A2 ). These programs compute the value 
6f chi-square and the degrees of freedom. The statistical significance 
of the chi-square values for the specified degrees of freedom was read 
from conventional tables ( 158, 545). A "p" value of 0.050 or less was 
considered statistically significant. 
D. Measurements of Gluconeogenesis and Glycogenesis in vivo 
The gluconeogenic capacity and hepatic glycogenic function was 
studied in endotoxin treated and control rats in vivo. For this test 
rats were anaesthetized with an ip dose of approximately 12.5 mg of 
pentobarbital or a somewhat smaller dose if their condition dictated. 
The pentobarbital solution used in this and subsequent experiments con-
sisted of 1 part Nembutal (pentobarbital sodium, 50 mg/ml, Abbot Lab-
oratories, North Chicago, Illinois) mixed in 3 volumes of normal saline 
on the morning of the experiment. 
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A control sample of 0 .1 ml of blood was collected from the cut 
end of the tail in a spot plate which had been prepared by drying one 
drop of 5,000 U per ml heparin (Hog gut, Sigma, St. Louis, Missouri) in 
water in each spot. Each rat then received an iv load of 100 mg L-
alanine (Sigma) containing 414Ci of uniformly labeled L-alanine-U-C-14 
(Amersham/Searle, Arlington Heights, Illinois) in a volume of 1 ml sa-
line adjusted to pH 7.4. The dose of L-alanine-U-C-14 was verified by 
counting an aliquot of the solution prepared for injection on each oc-
casion the experiment was repeated. Thirty minutes after the alanine 
load the rat was bled by cardiac puncture. The abdomen was rapidly 
opened and the majority of the large right lobe of the liver was ex-
cised and placed in ice cold saline. The excised liver lobe was then 
rapidly blotted, two samples were cut, weighed on a Roller Smith balance, 
and immediately immersed in 15 ml graduated centrifuge tubes each con-
taining 2 ml of 30% KOH. The sample for chemical glycogen determination 
weighed between 100 and 200 mg while the sample for C-14 labeled gly-
cogen weighed about 500 mg. 
Blood glucose was determined on a deproteinized aliquot of the 
initial control sample and on one portion of the cardiac blood by a 
glucose oxidase endpoint colorimetric method (Glucostat 4X, Worthington 
Biochemicals, Freehold, New Jersey). Carbon-14 incorporation into 
blood glucose was determined in Ba (OH)2 - Zn S04 supernatants extracted 
in a mixed resin slurry as originally described by Exton and Park (176). 
The resins employed were 100 mg Dowe~-50X and 200 mg of Dowex-lX and 
were washed twice in distilled deionized water before use. They were 
purchased through Sigma Chemical Company (St. Louis, Missouri). 
-----
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In view of the results of Herrera, Knopp, and Freinkel (305) who 
performed essentially identical experiments with the exception of using 
a 1 millimole dose of C-14 pyruvate in female rats, further purification 
of blood glucose from the resin supernatant was deemed unnecessary. 
Using intervals between isotopic labeled substrate injections to time 
of sampling as long as 30 min, as used in the experiments of the present 
study, Herrera et al., showed that non-resin extracted C-14 activity 
other than glucose accounted for less than 0.1% of the radioactivity 
present in the initial resin eluates. In their.study less than 0.07% 
of the alanine-C-14 applied to the resin was found in the eluate. Based 
on their data these authors also argued that an interval of up to 30 
min was sufficiently soon after injection to minimize artifacts due to 
reutilization of labeled glucose synthesized from the labeled precursors. 
The loss of labeled glucose in the resin was determined by pro-
cessing a sample of glucose-U-C-14 in the exact same manner as the blood 
samples and results were corrected accordingly. 
Liver glycogen was isolated for chemical analysis by a slight 
modification of the method of Good et al. (268), hydrolysed in 1 N H2-
so4 in a boiling water bath for 3 hrs, and the liberated glucose de-
termined on a neutralized aliquot by the glucose oxidase technique em-
ploying Tris buffer as described by Dalqvist (147) as was used in the 
blood glucose determinations. Carbon-14 incorporation into liver gly-
cogen was determined by isolating the liver glycogen by a sodium sul-
fate-ethanol method (261, 498), suspending the washed glycogen in 
water and determining the radioactivity. 
Both blood glucose and .liver glycogen samples for 14c 
f._1 
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determination were incorporated into a conunercial solubilizer (PCS, 
Amersham/Searle) and counted in a Searle/Analytic (Des Plaines, Ill.) 
IsoCap 300 liquid scintillation system. The blood glucose samples 
which correspond to the glucose recovered from one twenty-second of a 
ml blood were counted for 20 minutes. The liver glycogen samples which 
corresponded to the glycogen recovered from one-sixteenth of a gram of 
liver were counted for 100 minutes. Background count rate was sub-
tracted from the observed count rates. Counting efficiency was deter-, 
mined using the samples channels ratio method and a commercial (Amer-
sham/Searle) set of C-14 quenched standards. Each sample was corrected 
to its corresponding DPM. All analyses were carried out in duplicate. 
The means and standard errors of mean were calculated for the 
various parameters measured or calculated from measured values for all 
rats in each experimental treatment group using the computer program 
in the appendix (p. A4 ). Differences between groups were evaluated 
for statistical significance by the unpaired Students "t" test using 
the program given in the appendix which calculates both the "t" value 
and the corresponding "p" value for the specified degrees of freedom. 
A "p" value of less than 0 •. 050was taken as a statistically significant 
difference. 
E. Intraperitoneal Glucose Tolerance and Insulin Response 
Overnight fasted rats were given an iv injection of 1 ml 
volume at time zero which consisted of either isotonic saline or en-
dotoxin in saline. At two hours after the iv injection all rats were 
given an ip injection of 2 ml saline or 400 mg glucose in that volume 
of saline. At intervals from the time of iv injection to 12 hours, 
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subgroups of the 4 groups of treated rats were anaesthetized with ap-
proximately 12.5 mg of pentobarbital ip, prepared in saline as des-
cribed for the gluconeogenesis experiments. Immediately upon loss of 
the righting reflex the rats were bled by cardiac puncture into dispo-
sable 10 cc plastic syringes. Large (18 gauge) needles were used to 
avoid hemolysis. Only the first 3 to 4 ml of blood which could be 
rapidly withdrawn was collected. The needle was removed from the 
syringe and a few drops of blood were placed in a heparinized spot-
plate, the remainder being expelled and allowe~ to clot in disposable 
glass culture tubes on ice. One tenth ml of the heparinized blood was 
pipetted from the spotplate for glucose determination by a glucose oxi-
dase technique after hemolysis and deproteinization with Ba (OH) 2 and 
Zn S04. The blood samples in the glass culture tubes were kept on ice 
prior to centrifugationat not more than 2 hrs after collection. Serum 
was prepared by centrifuging the. clotted blood in a refrigerated cen-
trifuge at 4°c. The serum was aspirated into small glass vials, im-
mediately frozen, and stored at -45°c. 
Innnunoreactive Insulin Assay 
Irnrnunoreactive insulin was determined on duplicate 100).t). 
aliquots of the serum samples through the employment of commercial 
radioimmunoassay kits in which guinea pig anti-porcine insulin anti-
bodies are covalently coupled to Sephadex particles (Phadebas Insulin 
Test, Pharmacia Laboratories, Uppsala, Sweden). Since rat insulin was 
not available for use as a standard, porcine insulin was used as a 
relative reference. A single batch of anti-insulin antibody was used 
in all studies to avoid possible differences in immunologic cross 
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reactivity of rat and porcine insulin. 
Seven insulin standards of 3.2, 8, 16, 32, 80, 160, and 320 
microunits per ml were prepared using the lyophilized porcine insulin 
standard supplied with the commercial kits and following the dilution 
procedure described by the manufacturer (Phadebas Insulin Test, Clinical 
and Technical Information, 1973) which utilizes a combination of sin-
gle and serial dilution steps. All details of the assay procedure were 
as described by the manufacturer. Serum samples, radioiodinated in-
sulin, and standards were pipetted with Oxford Samplers. One ml ali-
quots of the Sephadex anti-insulin serum were pipetted with a 2 ml 
Cornwall syringe dispenser. The assay mixtures were incubated for 18 
to 24 hrs at room temperature in 12 x 55 mm plastic tubes purchased 
from Pharmacia on a horizontal RIA Shaker (Pharmacia). After incuba-
tion the capped tubes were centrifuged for 2 minutes in a 96 position 
IEC swinging bucket head at 1,500 xg for 2 minutes. The caps were re-
moved and the tubes were centrifuged at 1,500 xg for 5 minutes to sedi-
ment the Sephadex coupled anti-insulin serum and bound insulin. All 
except the bottom 5 mm of fluid was aspirated from each tube using a 
pipette with an adjustable collar coupled to a water vacuum pump. The 
sedimented Sephadex was washed 3 times using 2 ml volumes of 0.9% 
saline adjusted to pH 7.0-7.5 with 1 N Na OH. Each tube was counted 
for 10 minuted in a Searle/Analytic model 1185 gamma crystal counter 
with preset discriminator windows for Iodine-125. 
Each time the test was repeated, duplicates of the buffer blank, 
the 7 insulin standards, a Pharmacia lyophilized pooled human serum, and 
aliquots of 2 different pools ~f rat serum and plasma which had been 
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stored at 45°c were run both preceding the experimental samples and 
again following the samples. This permitted assessment of both the 
intraassay and interassay variation. All experimental samples were run 
non-diluted in duplicate. If the coefficient of variation for any pair 
of samples was greater than 20% the results were discarded from further 
consideration. 
A linear transform for the assay was found through the limits 
of 3;2 and 320,JJ...Units insulin per ml when the insulin concentration was 
expressed on a log scale on the abscissa and the percent of the amount 
of I-125 labeled insulin bound in the absence of added non-labeled in-
sulin was expressed on a linear ordinate. Using this transform a com-
puter program was written to evaluate the experimental results. This 
program calculated the apparent amount of insulin in each tube of the 
replicates. The values for each of the replicates of any one sample 
were then used to calculate the mean insulin concentration, the stan-
dard deviation, the standard error of the mean, and the coefficient of 
variation for that sample. Using this method of calculation the cal-
culated mean insulin concentration of the replicates is not biased by 
the binding of the iodinated insulin being a function of the logarithm 
of the non-labeled insulin concentration. The computer program is 
given in the appendix (p. A7). 
This immunoassay system was also evaluated to be certain that 
endotoxin itself did not influence ,the antigen-antibody reaction or 
influence ~he apparent level of ins~lin in rat serum. 
The mean and standard error of the mean were calculated for 
each of the subgroups using the mean insulin value for the serum of 
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each rat. The non-paired Students "t" test was used to evaluate the 
significance of differences between groups. The programs used for these 
calculations appear in the appendix (p. AS). 
F. Recovery of Expired 14c-co2 from Rats given Uniformly Labeled 
14c-D-Glucose 
The recovery of glucose carbon label as expired C02 was studied 
in rats for a 4 hour period immediately following the ip injection of 
20.){_Ci of uniformly labeled D-glucose-C-14. The glucose dose consisted 
of either a tracer amount (less than 16 microgr.ams) of D-glucose-U-C-14 
(Arnersham/Searle) in 2 ml of normal saline or of this amount of labeled 
glucose mixed with 400 mg of carrier glucose in 2 ml of saline. 
All rats were fasted overnight preceding the experiment to 
minimize glycogen stores. Immediately after receiving the 2 ml ip in-
jection containing the labeled glucose, the rats were placed in 2 liter 
volume bottles containing about 750 ml of wood shavings to absorb 
moisture. The bottle had 2 fittings for the attachment of tubing to 
holes in its cover. The inlet had approximately 15 cm of tubing at-
tached to the inner side of the cover to aid in mixing the air in the 
bottle during the experiment. The outlet of the jar was connected by 
approximately 45 cm of Tygon tubing (3/8" o.d., 1/4" i.d.) to the in-
let of a commercial C02 trapping bubble apparatus (liver perfusion 
accessory, MRA Corp., Boston, Massachusetts). The inlet of the co 2 
trapping apparatus was led to a frittedglass cone submersed in the 
bottom of a column of the trapping solution about 17 cm in depth. 
The outlet of the C02 bubble trap was connected by Tygon tubing to a 
suitable gas flow meter. The outlet of the flow meter was connected 
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through a needle valve to the laboratory vacuum source. The rate of 
airflow through the system was regulated at 500 ml per min. by ad-
justment of the needle valve and determined on the gas flow meter in 
series with the bottle and the C02 trap. 
In another series of experiments on 34 rats with two of the 
C02 bubble traps in s~ries, it was found that issentially no C-14 
labeled C02 passed into the second trap. In almost all cases the count 
rate of the samples were near that of background. The activity foupd 
in the second trap was always less then 0.3% of that in the first trap 
even at the time of the final sample. Thus, in the experiments reported 
here only one co2 trap was used. 
The C02 trapping solution consisted of 2 volumes of 2-methoxy-
ethanol and 1 volume of ethanolamine as described by Jeffay and Alvarez 
(338). The initial volume in the C02 traps was 52 ml. Duplicate 1 ml 
samples were collected just before and at the designated times after the 
rats were placed in the bottles. The trapping fluid remaining in the 
system was thoroughly mixed prior to each sample collection. A 1 ml 
Oxford Sampler with disposable tips was used to pipette the samples. 
The samples collected immediately prior to placing the rat in the 
bottle served as the background count rate which was subtracted from 
all subsequent samples. The mean count rate of the background samples 
rarely exceeded 25 CPM demonstrating that the C-14 label was not carried 
over from one experiment to the next. The other pairs of samples were 
collected at 15 min. intervals for the first 60 min. and then at 30 
min. intervals until 240 min. after the rat had been placed in the 
bottle. 
--
--
, 
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Into each one ml sample of C02 trapping solution contained in 
a liquid scintillation vial (Spectravial, Amersham/Searle) wad added 
10 ml of a fluor consisting of 70% (by volume) toluene (AR grade, 
Mallinckrodt, St. Louis, Missouri), 20% 2-methoxyethanol (99%, Aldrich 
Chemical Company, Milwaukee, Wisconsin), and 10% ethanolamine (95%, 
Aldrich) plus 7.0 grams per liter PPO (2,5-Diphenyloxazole, Scintillation 
Grade, Amersham/Searle) and 0.15 gm per liter POPOP (p-bis- 2-(5 phenyl-
oxazolyl) benzene, Scintillation Grade, Amersham/Searle). This fluor 
efficiently counts C-14 C02 trapped in ethanola~ine; C-14 C02 was not 
liberated from the ethanolamine even when the C02 content of the sam-
ples was high. Both cormnercial fluors (PCS, Amersham/Searle) and sim-
ple toluene fluors were found to liberate ethanolamine bound C02 when 
they are added to high concentrations of C02. Furthermore, commercial 
fluors containing Triton are not suitable for they give rise to a long 
life chemiluminescence when they are added to strong bases including 
ethanolamine. 
Counting efficiency was determined by the method of internal 
standards utilizing toluene-C-14 which had been calibrated against a 
National Bureau of Standards certified standard (Amersham/Searle). In 
representative experiments 50)-ll aliquots were pipetted into samples 
after they had been counted as well as into vials containing only 
fluor. The samples were recounted and the efficiency was calculated. 
There was no change of counting efficiency with time of sample col-
lection and the mean efficiency of 77.87% was used for all further data 
analysis. 
The actual dose of C-14 glucose administered to each rat was 
L 
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determined by counting aliquots of the solution injected and correcting 
for counting efficiency and fraction of the dose counted. Thirty 10){1 
replicates of each glucose solution were pipetted in scintillation vials 
using an Oxford sampler. Ten ml of PCS (Arnersham/Searle) was added to 
each vial and they were each counted to 800,000 counts. Efficiency was 
estimated by the samples channel ratio method and the disintegration 
rate was multiplied by 200 to give the amount of C-14 per 2 ml dose ex-
pressed as DPMs. 
All experimental samples were counted f.or at least 10 minutes 
or usually for 20 minutes or to 800,000 counts with the low count per 
minute reject set to terminate the counting program of samples that did 
not reach 100 counts in either channel within the first minute. Re-
peated countings of the same samples over a matter of days showed there 
to be no detectable phosphorescence or chemiluminescence. Results were 
expressed as the percent of the injected dose of C-14 recovered in the 
C02 trapping fluid at each specified sampling time. The percent re-
covery was calculated from the mean count rate of the duplicate one ml 
samples on a specially written computer program which incorporates 
corrections for background subtraction, counting effi.ciency, removal 
of label in previous samples, and volume of trapping fluid remaining 
at the time a particular pair of samples were drawn. This program is 
given in the appendix (p. AS). 
The mean and the standard error of the mean were calculated for 
each group of rats at each of the specified times of sample collection. 
These were entered onto a magnetic tape storage system along with the 
rats weights before and after an overnight fast and with the blood 
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glucose values for the diabetic rats. By means of specially written 
computer programs unpaired Student's "t" tests were performed on the 
percent Carbon-14 label recovered at each of the corresponding times. 
The programs for the storage_ of data and its recall and the "t" test 
computations appear in the appendix (p. A9 and p. AlO). 
G. Induction of Streptozotocin Diabetes and Evaluation of the 
Diabetic State 
Rats of a mean body weight of 330 gm in the fed state at the 
time of treatment were made diabetic by the intravenous injection of 
25 mg streptozotocin per rat. This experimental agent was kindly sup-
plied by W.E. Dulin of the Upjohn Company, Kalamazoo, Michigan. The 
streptozotociq. was dissolved in citrate buffer (0.1 Molar in saline) 
at pH 4.5 as described by W.E. Dulin (personal communication). The 
streptozotocin was dissolved at a concentration of 100 mg per ml not 
more than 2.5 minutes before its injection into rats lightly anaesthe-
tized with pentobarbital to facilitate rapid handling. At either 6 or 
7 days following the streptozotocin treatment and after an overnight 
fast the rats were of a mean body weight of about 270 gm when used in 
the experiments. The polydipsia, polyphagia, and polyuria evident in 
these rats as well as the mean weight loss of 60 grams suggested a 
diabetic state. Urine from all rats so treated was positive for glu-
cose by the Ames test tape evaluation. Only those rats were used which 
had a blood glucose of greater than 300 mg per 100 ml after an overnight 
fast as judged by the Ames Dextrostix reflectance meter (Ames Company, 
Division of Miles Laboratories, Elkhart, Indiana) method of estimating 
blood glucose. The blood sample used was obtained from the freshly 
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cut tip of the tail. The applicability of the use of this reflectance 
meter method of blood glucose analysis on rat blood has been documented 
in the literature (336). 
H. Carbon Clearance Evaluation of RES Phagocytic Function 
Carbon clearance in both fed and overnight fasted rats was 
evaluated by the method of Biozzi et al. (61) as modified by Filkins 
and Di Luzio (205). A special preparation of biological ink (Cll/143a, 
Guenther Wagner, Hanover, West Germany) was diluted with normal saline 
to a concentration of 32 mg of carbon per ml. The carbon concentration 
was determined in a Beckman DU spectrophotometer using 1 x 1 cm cu-
vettes at a wavelength of 675 millimicrons. The previously published 
(205) conversion factor of 0.040 optical density units per mg carbon 
per liter of solution was used in calculating the carbon concentration 
of dilutions of the stock solution. All experiments reported were con-
ducted using the same diluted stock solution of 32 mg per ml carbon. 
All rats were anaesthetized.with approximately 12.5 mg of pentobarbital 
ip at least 15 min. prior to carbon injection. This anaesthesia does 
not alter the rate of carbon clearance in rats (348). A dose of 8 mg 
of carbon per 100 gm body wt. was given by iv injection via the dorsal 
vein of the penis. All doses were calculated from the weight of the 
rat on the evening before the test irrespective of whether they were 
fed or fasted overnight. Following carbon injection tail blood sam-
ples were collected in a spot plate containing dry heparin at 2 or 3 
minute intervals until 30 minutes after the carbon injection. Samples 
for the densitometric determination of carbon consisted of 25){1 of 
fresh heparinized blood lysed in 5 ml of 0.1% sodium carbonate in 
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distilled water in 13 x 100 nun Hycel cuvettes. Samples were read 
against a blank consisting of 25A,l of tail blood from that rat ob-
tained just prior to carbon injection and similarly lysed in 5 ml of 
the sodium carbonate solution. A Klett-Sununerson photoelectric color-
imeter (Klett Mfg. Co., New York, New York) was used to read samples 
with a red filter (#66, approximate spectral range 640 to 700 milli-
microns) in place. Semilogarithmic plots of the densitometric values 
expressed in Klett Units were constructed with the time after carbon 
injection plotted on the linear abscissa. The .best straight line was 
~· .. 
~ fitted through the 10 to 15 points by visual inspection di~regarding 
any single aberrant points. The rate of disappearance was expressed 
as a half-time in minutes in the conventional manner. 
Tail blood samples of 0.1 ml were collected immediately pr~or 
to carbon injection and at the time of collection of the final sample 
30 minutes later. These samples were analyzed for glucose by the glu-
cose oxidase method previously described. A mean.blood glucose value 
of 30 mg per 100 ml or less was defined as hypoglycemia. 
The statistical significance of the differences in carbon 
clearance half-times were evaluated by the unpaired Student's "t" test. 
The tendency of the blood glucose to fall or rise in each group was 
assessed for statistical significance by the paired Student's "t" test. 
The relationship between the parameters of carbon clearance half-time 
and mean blood glucose was assessed by calculating Pearson's coefficient 
of correlation and computing the p value for the appropriate number of 
degrees of freedom. The computer programs for each of these statistical 
tests or calculations are given in the appendix (p. All and p. Al3). 
68 
I. Evaluation of Endotoxin Clearance in vivo 
The clearance of biologically active endotoxin from the vas-
cular compartment of the rat was assessed through the employment of 
the lead treated rat lethality bioassay as described by Filkins (198). 
Following an initial iv injection of either 250, 500, or 1,000)(.g of 
endotoxin in saline freshly prepared on the day of the experiment at 
a concentration of 500.)(g per ml, blood samples were collected at 
various times from 15 min. to 240 min. after the endotoxin injection. 
In one series of experiments repeated 0.5 ml samples were collected 
from the tail of each clearance rat at 15, 30, 60, 120, and 240 min. 
after the injection of 500/(..g endotoxin. In all other experiments 
single samples were collected from each clearance rat by open chest 
cardiac puncture after rapid induction of ether anaesthesia. All 
clearance rats were of a weight of 300 ± 1 grams and were in the fed 
state with the exception of the insulin hypoglycemic rats and their 
controls which were of a body weight of 300 + 1 gm on the evening pre-
ceding their overnight fast. 
The blood samples were either collected directly into hepa-
rinized spot plates (tail blood) or collected in glass syringes pre-
pared by rinsing in 5,000 units per ml heparin in water and dried in 
an oven. The blood samples were appropriately diluted to 2.5% to 10% 
blood in saline prior to assay in groups of 300 ± 20 gm fed rats which 
received an iv injection of 13 micromoles of lead acetate in 1 ml of 
distilled water immediately following 1 ml of the diluted endotoxin 
containing blood. Other groups of assay rats received known doses of 
endotoxin in saline immediately preceding the dose of lead acetate. 
Lethality in all assay groups was tabulated at 48 hrs after the in-
jections. 
The probit transform as described by Finney Qll, 21V was 
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found to give a linear relationship between the log of the endotoxin 
dose and the probit of the assay group lethality throughout the range 
of endotoxin doses of interest in lead treated rats. Using this trans-
form the mean dose of endotoxin per assay rat was estimated from the 
lethality in that group of assay rats as compared to the probit line 
determined in other assay groups given known do.ses of endotoxin. The 
endotoxin content of the blood samples was then calculated from the 
dilution factor for those samples. 
Using a semilogarithmic analysis comparable to that used in 
the carbon clearance experiments the mean half-time for the disappear-
ance of biologically active endotoxin from the vascular compartment 
was calculated. Regression by the least squares method and interpo-
lation programs used in these calculations appear in the appendix 
(p. All, Al3, Al4, Al5, Al6, and Al7). 
Tolerance to endotoxin was induced by the iv injection of 
1 mg of endotoxin in 1 ml of saline on days 1, 3, and 5. These rats 
were used for clearance experiments on day 7. 
Bilateral adrenalectomy was performed through a single dorsal 
midline incision one hour before the clearance dose of 500.>tg endo-
toxin. Surgical trauma control rats underwent a similar operation 
with the exception of extripation of the adrenal glands. Both pro-
cedures were conducted with the rats anaesthetized with ether. 
Insulin hypoglycemia was produced by the injection of 0.5 units 
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of Lente insulin subcutaneously into overnight fasted rats one hour 
before the clearance of endotoxin. Control overnight fasted rats re-
ceived 12.5.><,.l of saline sc one hour prior to the same 500)lg dose of 
endotoxin. In this group the statistical significance of difference 
in lethality of the assay rats receiving similarly diluted blood sam-
ples was assessed by the chi-square test at 3 hours after the test 
dose of endotoxin. 
J. Evaluation of Endotoxin Clearance in vitro by the Perfused 
.Rat Liver 
Livers were surgically isolated from approximately 300 gm fed 
male rats and perfused in a commercial modification (Metalloglass 
Corporation, Boston, Massachusetts) of the recirculating liver per-
fusion apparatus first described by Miller (448). The basal perfusion 
media consisted of a balanced salt solution formulated by Schimassek 
(563) without pyruvate or lactate but with glucose at a concentration 
of 100 mg per 100 ml. When the perfusate consisted of Schimassek's 
solution only, 150 ml containing endotoxin at a concentration 2p.g per 
ml was the initial media. In a second series of experiments 10% rat 
serum was incorporated into the perfusate. On the day before the ex-
periment 50 ml of fresh rat blood was collected by cardiac puncture 
without the use of heparin. After the blood had begun to clot in the 
glass centrifuge tubes they were ringed and stored overnight in a re-
frigerator at 4°C. On the day of the experiment the tubes were cen-
trifuged and the serum collected. In a final series of perfusion ex-
periments 50% heparinized rat blood in Schimassek's solution was used. 
Fed rats of about 300 gm body weight were anaesthetized with ether. 
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They were given an iv injection of 500 Units of heparin in saline and 
after 2 minutes for mixing of blood they were bled by cardiac puncture 
on the morning of the perfusion experiment. 
All samples of perfusate which originally contained 2.)lg per ml 
of endotoxin were diluted one to one with saline before being assayed 
for endotoxin in lead sensitized rats as described above. Throughout 
these experiments samples were kept on ice from the time they were re-
moved from the perfusate and diluted with saline until they were bio-
assayed in the lead treated rats. When it was ·specified that samples 
were incubated they were incubated in the perfusion chamber at 37°c 
for the specified time. In each experiment appropriate controls were 
included to be certain that the endotoxin did not adhere to the per-
fusion apparatus or tubing and that the endotoxin was not inactivated 
by any of the perfusion media independent of the liver. 
In these experiments never more than 3 minutes elapsed between 
the time Qf cannulation of portal vein and initiation of perfusion in 
the chamber. During the major part of this period the liver was being 
perfused with glucose free Schimassek's solution from a Mariette bottle. 
The temperature of the perfusion system was monitored with a small 
thermistor probe placed between the lobes of the liver and maintained 
at 37°c. The viability of the liver was assessed by its gross ap-
pearance, the rate of perfusate flow, the rate of bile secretion from 
the duct cannulated at the time of preparation of the liver for per-
fusion, and by histological slides prepared from each liver after the 
perfusion experiment was completed. 
The significance of difference between assay group lethality 
L 
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was assessed in two ways. First, chi-square comparisons were made using 
raw lethality data. Secondly, the method of probit analysis was ap-
plied using 95% confidence intervals about the best regression line 
calculated as described by Finney (212). 
l 
l 
CHAPIBRIV 
RESULTS 
A. Effects of Alterations of Insulin Status on Endotoxin Shock 
Lethality 
Initial experiments evaluated the influence of insulin on 
endotoxin shock lethality. Fasting and treatment with mannoheptulose 
were used to depress insulin secretion; while glucose (Chapter IV, 
Section C) was used to increase insulin secretion. The experimental 
design, results, and a statistical analysis are presented in Table 1. 
As shown in both Table 1 and Figure 1 doubling the endotoxin 
dose (i.e., from 1 to 2 mg/rat) significantly increased lethality in 
both fed (Groups 1 vs 6) and fasted (Groups 11 vs 16) rats. Over-
night fasting significantly reduced lethality compared to fed rats; 
the decrement was significant (p<0.001) at the 2 mg dose but not 
significant (p 0.374) at the 1 mg dose. 
The influence of an insulinogenic dose of glucose on endo-
toxin shock lethality in fed rats given 1 mg endotoxin is presented 
in Table 1 (Groups 1-4) and depicted in Figure 2. Glucose treatment 
significantly increased lethality when given either at 1 or 2 hours 
after endotoxin. The weighted mean of all glucose treated rats 
(Group 21) also reflected a significant sensitizing effect of glu-
cose treatment. As shown in Table 1 in fed rats given the 2 mg dose 
(Groups 6-9), the increase in lethality in glucose treated animals, 
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TABLE 1 
EFFECTS OF FASTING, GLUCOSE TREATMENT, AND MANNOHEPTULOSE TREATMENT ON 
ENDOTOXIN SHOCK LETHALITYa 
Group 
Numberd 1 2 3 4 5 6 7 8 9 10 
Fed/Fasted FED 
Endo toxin 
Dose (mg/rat)1 1 1 1 1 2 2 2 2 2 
Treatment 
Saline Glucose Manno- Saline Glucose Manno-(400mg) heptuloseb (400mg) heptulose 
Time Treated 
(hr after 0,1,2 0 1 2 (b) 0,1,2 0 1 2 (b) 
LPS) 
Number 
Tested 45 36 21 23 43 55 38 32 45 so 
% Lethality 22.2 33.3 61.9 47.8 9.3 69.1 81.6 78.l 82.2 47.8 
Weighted Mean 
of Glucose 
Treatedc (Group f/21)d (Group if 22) 
Number Tested 80 115 
% Lethality 45.0 80.9 
-...J 
~ 
r 
Group 
Number 11 12 13 
Fed/Fasted 
Endo toxin 
Dose (mg/rat) 1 1 1 
Treatment 
Saline Glucose 
(400mg) 
Time Treated 
(hr after 0,1,2 0 1 
LPS) 
Number 
Tested 40 40 25 
% Lethality 12.5 40.0 42.1 
Weighted Mean 
of Gluc~se 
Treated (Group :ff23) 
Number Tested 88 
% Lethality 42.05 
TABLE 1 (cont'd) 
14 15 16 17 18 
FASTED 
1 1 2 2 2 
Manno- Saline- Glucose 
heptulose b (400mg) 
2 (b) 0,1,2 0 1 
23 22 65 28 20 
47.8 o.o 36.9 so.a 40.0 
(Group :/f24) 
64 
42.2 
19 
2 
2 
16 
31.2 
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. . . . . , .• , '""111111 
20 
2 
Manno-
heptulose 
(b) 
84 
5.95 
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TABLE 1 (cont'd) 
STATISTICAL ANALYSIS OF DATA PRESENTED IN TABLE 1 
Control Group Experimental Chi-Square Significance Change in % 
Group Value of differencee Lethality when 
sj gni fj capt f 
1 2 1.25 0.264 
3 8.26 0.004 +39.7 
4 4.68 0.031 +14.1 
5 1.86 0.173 
6 21. 78 0.001 +46.9 
11 0.79 0.374 
- 9.7 
22 6.42 0.011 +22.8 
6 7 1.24 0.265 
8 0.44 0.507 
9 1. 78 0.182 
10 4.82 0.028 -21.1 
16 12.34 0.001 -32.2 
24 2.92 0.088 
11 12 - 6 .46 0.011 +27.5 
13 5.10 0.024 -f.29.6 
14 7.84 0.005 +35.3 
15 1.54 0.215 
16 6.22 0.013 +24.4 
26 9.59 0.002 +29.5 
16 17 1.38 0.240 
18 o.oo 1.000 
19 0.02 0.888 
20 20.49 0.001 -30.9 
28 0.37 0.543 
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Footnotes to Table 1 
a. Groups of rats were fed or fasted overnight and on the following morning were given the 
indicated dose of endotoxin intravenously. They were treated at 0, 1, or 2 hrs after 
endotoxin with either 2 ml of saline, or 400 mg of glucose dissolved in saline, or with 
mannoheptulose as indicated below. Lethality was recorded at 48 hrs. 
b. Mannoheptulose treatment of fed rats consisted of subcutaneous injections of 50 mg at 
-2 hr, 100 mg at -15 min., and 25 mg at +2 hr. Fasted mannoheptulose treated rat~ fol-
lowed the same schedule with the exception that the -15 min. dose was reduced to SO mg. 
The mannoheptulose was prepared in saline at a concentration of 50 mg per ml. 
c. Weighted mean of glucose treated consists of summation of the 3 groups of glucose treated 
animals irrespective of time after endotoxin within anyone dose of endotoxin and fed or 
fasted state. 
d. Arbitrary group number assigned for reference in text and st9tistical analysis. 
e. Significance of difference by 2 tailed test. 
f. Change in percent lethality, + indicates increase in experimental group over control group, 
- indicates decrease in lethality of experimental group compared to control. 
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FIGURE 1 78 
INFLUENCE OF FASTING ON ENDOTOXIN SHOCK LETHALITY 
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LPS DOSE= 1 2 1 2 
(mg/rat) 
Rats were either allowed food ad libitum or fasted overnight 
prior to an iv challenge of 1 or 2 mg endotoxin per rat as described 
in Table 1. The two fed groups are shown on the left. The endotoxin 
doses (mg/rat) and the number of. rats in each group (N) are indicated 
below each bar. LPS indicates endotoxin in this and in the following 
figures. 
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FIGURE 2 79 
INFLUENCE OF GLUCOSE TREATMENT ON ENDOTOXIN 
SHOCK LETHALITY IN FED RATS 
FED 1mg LPS per Rat 
45 36 21 23 80 
saline 
0,1,0R2 
-400 mg glucose-----
0 1 2 wt mean 
Fed rats were treated with 1 mg of endotoxin (LPS) iv and 
then an ip injection of 400 mg glucose at 0,1, or 2 hr. The weighed 
mean (wt mean) lethality in the 3 glucose treated groups was computed 
as the total number of deaths per total number of rats treated with 
glucose and endotoxin. The number of rats in each group (N) is given 
below each bar. 
-
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although consistent in all 3 groups, did not reach statistical sig-
nificance (O.l>p>0.05). 
Similarly, the influence of glucose on lethality in overnight 
fasted rats treated with a 1 mg endotoxin is presented in Table 1 
; 
f 
t 
!' 
(Groups ll-i4) and depicted in Figure 3. Lethality was increased 
over three-fold at all 3 glucose regimens. At the 2 mg endotoxin 
• dose glucose treatment inconsistently increased lethality (Table 1, 
Groups 16-19). 
The influence of mannoheptulose - a selective depressant of 
insulin secretion - on endotoxin lethality is presented in Table 1 
(Groups 5, 10, 15, and 20) and depicted in Figure 4. At the 1 mg 
endotoxin dose mannoheptulose decreased lethality from 22% to 9% in 
fed rats and from 12% to 0% in fasted rats; these decrements were 
however not statistically different. In contrast, mannoheptulose 
significantly reduced lethality to 2 mg endotoxin from 69% to 48% in 
fed rats (p=0.028; Table 1, Groups 6 vs 10) and from 37% to 6% in 
fasted rats (p<0.001; Table 1, Groups 16 vs 20). 
In order to determine if it was the insulin response to glu-
cose treatment or the glucose per se which sensitized rats to endo-
toxin combined treatments with glucose and mannoheptulose were evalu-
ated (Table 2 and Figure 5). As in the previous experiment (Table 1) 
glucose treatment significantly increased lethality (p=0.008; Table 2, 
Groups 1 vs 2). Mannoheptulose provided a striking protection with 
lethality reduced to 6%. In Group 4 treatment with both mannoheptu-
lose and glucose reduced endotoxin shock lethality to 12%. This 
finding supports the notion that glucose sensitization to lethal 
FIGURE 3 
INFLUENCE OF GLUCOSE TREATMENT ON ENDOTOXIN 
SHOCK LETHALITY IN FASTED RATS 
FASTED 1mg L PS per Rat 70 
60 
50 
> 40 
... 
..J 30 
~ 
:I: 20 ... 
w 
..J 
~ 
10 
0 
N= 40 40 25 23 
ip Treatment saline -400 mg glucose 
time treated (hr after LPS) 0,1,0R 2 0 1 2 
... 
. . 
. . . 
. . 
. . . 
. . 
. . . 
.. 
. . . 
. . 
. . . 
.. 
. . . 
. . 
... 
. . 
... 
. . 
. . . 
. . 
... 
. . 
. . . 
.. 
. . . 
.. 
. . . 
. . 
... 
. . 
. . . 
. . 
. . . 
. . 
... 
. . 
88 
wt 
mean 
Overnight fasted rats were treated with endotoxin (LPS) iv 
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and then an ip injection of 400 mg glucose at 0,1, or 2 hr. The 
weighted mean (wt mean) lethality in the 3 glucose treated groups was 
computed as the total number of deaths per total number of rats treated 
with glucose and endotoxin. The number of rats in each group (N) is 
given below each bar. 
FIGURE 4 
EFFECT OF MANNOHEPTULOSE TREATMENT ON ENDOTOXIN SHOCK LETHALITY 
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MANNOHEPTULOSE 
Fed or overnight fasted rats were challenged with 1 or 2 mg 
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of endotoxin (LPS) iv as indicated in the figure and then treated with 
either saline or mannoheptulose as described in Table 1. The number 
of rats in each group is indicated below each bar. The corresponding 
saline and mannoheptulose treated groups (with respect to fed or fasted 
and endotoxin dose) are coded with bars of the same pattern. 
r--
TABLE 2 
MANNOHEPTULOSE REVERSAL OF GLUCOSE SENSITIZATION TO LETHAL ENDOTOXEMIAa 
Group Number 
2mg LPS iv plus 
ip treatmentb 
sc treatmentC 
Number Tested 
% Lethality 
Chi Square and 
p value vs. 
Group 1 
Vs. Group 2 
Vs. Group 3 
1 
Saline 
' Saline 
6S 
32.3 
2 
Glucose 
Saline 
6S 
S6.9 
7.ood 
o.oose 
3 
Saline 
Mannoheptulose 
so 
6.0 
10.30 
0.001 
30.10 
p<0.001 
4 
Glucose 
Mannoheptulose 
so 
12.0 
S.41 
0.020 
22.48 
p<0.001 
0.49 
0.484 
a. After fasting overnight rats received 2 mg of endotoxin and the treatment indicated below. 
b. Either 400 mg glucose in 2 ml of saline at time zero or an equivalent volume of saline. 
c. Either 2 ml saline at -2 hr and 1 ml of saline at -lS min. or 100 mg mannoheptulose in 2 ml 
of saline and SO mg mannoheptulose in 1 ml saline. 
d. Chi-square value using Yates' correction factor. 
e. Level of statistical significance for two tailed test corresponding the indicated Chi-square value. co 
w 
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FIGURE 5 
MANNOHEPTULOSE REVERSAL OF GLUCOSE SENSITIZATION 
TO LETHAL ENDOTOXEMIA 
o/o L ET H AL I T Y 
TREATMENT 9 10 20 30 40 
2mg LPS iv plus 
Saline sc 
Saline i p 
Saline sc 
Glucose 400mg iP 
Mannoheptulose 150 mg sc 
Saline i p 
Mannoheptulose 150mg sc 
Glucose 400mg i p 
N I I . 
65 11111Bll 
65 
50. 
50111 
84 
50 
I 
Overnight fasted rats were treated with either saline or 
mannoheptulose sc and saline or glucose ip as indicated in the figure 
using the ~rotocol described in Table 2. All rats were given 2 mg 
endotoxin (LPS) iv. The number of animals in each group is given to 
the left of each bar. 
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endotoxin shock is related to insulin secretion. 
To further evaluate the possible role of insulin in the re-
sponse to endotoxin, shock lethality was evaluated after treatment 
with the beta cell cytotropic sulfonylurea agents, tolbutamide or 
tolazamide or with insulin~~· Both tolbutamide and tolazamide 
significantly increased lethality to 84% and 100% respectively. In-
sulin administered at the same time as endotoxin increased lethality 
to 88% (250 mU/rat) and 94% (500 mU/rat). When given one hour after 
endotoxin insulin (500 mU/rat) increased lethality to 100%. None of 
these agents,which produced a four-fold increase in lethality in en-
dotoxin challenged rats,were lethal when given to saline treated rats 
(Table 3 and Figure 6). 
B. Effect of Glucose Treatment on Gluconeogenesis and 
Glycogenesis after Endotoxin Treatment 
Since profound hypoglycemia and near total hepatic glycogen 
depletion are characteristic of endotoxemia, the influence of glu-
case treatment on gluconeogenesis and hepatic glycogenesis was 
studied in·endotoxin treated rats (Table 4). Gluconeogenic capacity 
and hepatic glycogenic function were evaluated 4 to 5 hours after iv 
saline or endotoxin. 
Prior to the alanine load mean blood glucose was 77.81 ± 
1.45 mg/dl in the saline control rats (Group 1). Blood glucose was 
increased by 21 mg/dl following glucose treatment (Group 2). Endo-
toxin treated rats (Groups 3 and 4) were significantly hypoglycemic. 
Following alanine injection blood glucose increased in Group 
1 controls by an average of 26 mg/dl. No further increment in blood 
TABLE 3 
EFFECTS OF SULFONYLURE~ AGENTS AND INSULIN ON ENDOTOXIN SHOCK LETHALITYa 
Group 
Number 1 2 3 4 5 6 7 8 
iv Treatment 2mg Endotoxin lml Saline 
ip or sc 
Tolbut.d Tolaz.e Insulinf treatmentb SalineC Tolbut. Tolaz. 
250mU 500mU 500mU 
Time given 
ip or sc 
treatment 
(hr after iv 
injection) 0 0 0 0 0 1 0 0 
Number 
Tested 35 25 20 25 35 15 20 20 
% Lethality 22.9 84.0 100.0 88.0 94.3 100.0 0.0 0.0 
------ ' I< .. 4 ; < 
9 
Insulin 
500mU 
0 
20 
o.o 
co 
0\ 
r 
Groups Compared 
---
Group 1 
vs. 
Group 2 
Group 3 
Group 4 
Group 5 
Group 6 
Group 5 
vs. 
Group 4 
Group 6 
TABLE 3 (cont'd) 
STATISTICAL ANALYSIS OF DATA OF TABLE 3 
Chi-Square 
Valueh 
19.45 
27.30 
22.22 
33.91 
22.15 
0.16 
0.02 
Significancei 
p<-0.001 
p<D.001 
p<0.001 
p<0,001 
p<0.001 
0.689 
0.888 
Change in Lethality 
where significantJ 
+61.1 
+77.1 
+65.1 
+71.4 
+77.1 
a. Overnight 'fasted rats were given iv injection of either 2 mg endotoxin in 2 ml saline or that 
volume of saline alone. They were subsequently treated ip or sc with the agents shown at the 
indicated times. Lethality was recorded at 48 hrs. 
b. ip or sc treatment given at the indicated time after endotoxin. 
c. 1 ml ip or 12.5_xl sc. 
d. 50 mg Sodium Tolbutamide (Orinase Diagnostic) in 1 ml, ip. 
e. 50 mg Tolazamide (Tolinase) in suspension in 1 ml saline ip. 
f. Lente crystaline zinc insulin, 40 Units per ml, 6.25)-(.1 per 250 mU, or 12.5,..4(.1 per 500 mU. 
00 
"-I 
~ 
Footnotes for Table 3 (cont'd) 
g. Time after iv injection when ip or sc agent was administered. 
h. Chi-square value using Yates' Correction Factor. 
i. Statistical significance of difference for two tailed test of difference. 
j. Increase (+) or decrease (-) in lethality where statistically significant difference. 
co 
co 
'"'1111 
r 
FIGURE 6 89 
TOLBUTAMIDE, TOLAZAMIDE, AND INSULIN SENSITIZATION 
TREATMENT 
2mg LPS iv plus 
Saline 
Tolbutamide 50mg 
Tolazamide 50 mg 
Insulin 250 mU 
Insulin 500mU 
Insulin 500mU 
1 hr after LP S 
Saline iv plus 
Tolbutamide 50mg 
Tolazamide 50mg 
Insulin 500m U 
TO LETHAL ENDOTOXIN SHOCK 
% LETH ALI TY 
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Overnight fasted rats were treated with 2 mg endotoxin (LPS) 
iv or saline iv followed by ip tolbutarnide, tolazamide, or saline; sc 
insulin or saline were given as indicated in the figure and described 
in Table 3. Sc or ip treatments were given at the same time as endo-
toxin except in the one group given sc insulin at 1 hr after endotoxin. 
The number of rats in each group is shown at the left of each bar. 
r··· 
Group Number 
iv Treatment 
at time zero 
ip treatment 
at 120 minutes 
Body weightb 
(grams) 
L . . h c iver weig t 
(grams) 
(% Body Weight) 
Blood Glucose 
(mg per lOOml) 
at Alanine inj. 
at 30 min. post 
Alanine 
increase in 30 min. 
following Alanine 
TABLE 4 
EFFECT OF GLUCOSE TREATMENT ON GLUCONEOGENESIS AND 
GLYCOGENESIS IN ENDOTOXEMIC RATsa 
1 2 3 
-Saline, lml -Endotoxin, lmg 
Saline, 2ml Glucose, 400mg Saline, 2ml 
lsd 16 15 
287.47e 289.06 285.07 
+2.74f +2.35 +1.88 
15 16 15 
9.40 9.99 8.69 
+0.13 +0.18 +0.13 
Ts l6 15 
3.27 3.46 3.05 
0.04 +0.05 +o.05 
15 16 15 
77 .81 98.39 64.80 
+1.45 +2.99 +5.62 
15 16 15 
103.33 105.46 83.70 
+2.14 +3.18 +5.40 
15 16 15 
25.51 6.82 18.89 
+2.35 +4.65 +4.90 
:· ->"""'":"""""'""""', i "'*' ··'~*A\1111 114 IK n aq 
4 
Glucose, 400mg 
16 
285.62 
+2.32 
~ 
16 
8.64 
+0.13 
16 
3.02 
+0.04 
16 
60.60 
+8.17 
16 
71. 22 
+7.42 
16 
10.62 \0 
+4.09 0 
"""'!I 
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TABLE 4 (cont'd) 
Group Number 1 2 3 4 
Blood Glucose C-14 15 16 15 16 
(DPM ~er ml 16.23 11. 92 19.32 14.79 
x 10 ) +0.29 +0.43 +0.90 +0.71 
(DPM per mg 15 16 15 16 
glucose x 15.80 11. 39 22.42 20.04 
103) +0.45 +0.46 +1.59 +L 76 
Liver Glycogen 14 8 13 16 
(mg glucose ·l.08 13.43 0.08 0.12 
equivalents/gm) +0.19 +0.70 +0.01 +0.02 
(mg glucose 14 8 13 16 
equivalents 10.18 136.34 0.72 1.05 
per liver) +l.85 +11.01 +0.12 +0.18 
Liver Glycogen C-14 15 16 14 16 
(DPM/~m wet weight 19.62 18.30 2.34 2.16 
x 10 ) +2.94 +1.56 +o.23 +0.37 
(DPM/liver 15 16 14 16 
x 103) 184.65 182.53 20.36 18.93 
+27.97 +15.38 +2.13 +3.31 
Liver Glycogen 14 8 12 16 
Specific Activity 26.19 1. 25 34.29 23.50 
(DPM/mg glucose +5.57 +o.16 +5.61 +3.59 
equivalents) 
Mean % of Alanine 2.08 2.06 0.23 0.21 
'° I-' C-14 recovered as 
Glycogen C-14 (%) 
r 
'~li~'l'!'F'W.1'i"i,~),, '4 
TABLE 4 (cont'd) 
STATISTICAL ANALYSIS OF DATA PRESENTED IN TABLE 4~ 
Groups Compared 1 and 2 1 and 3 2 and 4 3 and 4 
Body weighth 29i 28 30 29 
(grams) 0.443j o. 722 1.060 0.168 
o .. 661 k 0.476 0.298 0.868 
Liver weight 29 28 30 29 
(grams) 2.672 1.305 6.070 0.106 
0.012 0.202 <0.001 0.916 
(% Body weight) 29 28 30 29 
3.046 3.525 6.587 0.426 
0.005 0.002 <0.001 0.673 
Blood Glucose 29 28 30 29 
(mg per lOOml) 6.185 2.240 4.338 0.423 
at Alanine inj. <0.001 0.033 <O. 001 0.675 
at 30 min. 29 28 30 29 
post alanine 0.556 3.380 4.242 1.360 
0.583 0.002 <0.001 0.184 
increase in 30 29 28 30 29 
min. following 3.5~0 1. 218 . 0.614 1. 295 
alanine 0.0012 0.233 0.544 0.206 
Blood Glucose C-14 29 28 27 26 
(DPM 3er ml) 8.391 3.281 3.448 3.954 
x 10 '<0.001 0.003 0.002 <O. 001 l.O 
N 
.,,.,,..,."P!"'-,r~·:-~~--¥4,.UW'.#A 
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TABLE 4 (cont'd) 
Groups Compared 1 and 2 1 and 3 2 and 4 3 and 4 
Blood Glucose C-14 
· (DPM per mg 29 28 27 26 
glucose) 6.884 4.016 4.769 1.007 
x 103 <0.001 <0.001 -<o. 001 0.323 
Liver Glycogen 20 25 22 27 
(mg glucose 17.029 5.105 19.035 1.437 
equivalents/gm) <0.001 <0.001 <0.001 0.162 
(mg glucose 20 25 22 27 
equivalents 11. 299 5.106 12.284 1.505 
per liver) <0.001 <0.001 <0. 001 0.144 
Liver Glycogen C-14 29 27 30 28 
(DPM/jm wet weight) 0.395 5.862 10.071 0.403 
x 10 0.696 <0.001 <0.001 0.690 
(DPM/liver) 29 27 30 28 
x 103 0.090 5.857 10.398 0.360 
0.920 -<o. 001 <0.001 0.721 
Liver Glycogen 20 24 22 26 
Specific Activity 4.476 1.024 6.187 1. 619 
x 103 
(DPM/mg glucose <0.001 0.316 < 0. 001 0.118 
equivalents) 
\.0 
w 
r--
Group 
Degrees of Freedom 
"t" value 
"p" value 
TABLE 4 (cont'd) 
STATISTICAL SIGNIFICANCE OF CHANGES IN BLOOD GLUCOSE IN 
30 MINUTES FOLLOWING ALANINE SHOWN IN TABLE 4i 
1 2 3 
28 30 28 
9.874 1.619 2.424 
<0.001 0.116 0.022 
4 
30 
0.962 
0.344 
a. Overnight fasted rats were given an iv injection of 1 ml saline or 1 mg endotoxin as 
indicated. At 120 minutes following the iv injection all rats received an ip injection 
of 2 ml of saline or 2 ml of 20% glucose (400 mg) in saline. In the period between 4 to 
5 hrs after the iv injection (2 to 3 hrs after the ip injection) gluconeogenic capacity 
and hepatic glycogenic function were evaluated and a 100 mg load of L-alanine plus 4 
micro Curies of L-alanine-U-C-14 as described in the methods section. 
b. Body weight at time of iv injection 
c. Liver weight at 30 minutes following alanine injection 
d. Number of animals in group; so indicated throughout the Table 
e. Mean value 
f. Standard error of mean 
g. 
h. 
i. 
j. 
k. 
Comparison of groups presented in Table 4 by unpaired Student's "t" test. 
correspond to those given in Table 4. 
Parameters as given in Tabie 6 
Degrees of freedom 
T value 
p value 
Group numbers 
1. Student's "t" test of difference in blood glucose before and 30 minutes after alanine 
injection within 4 groups shown in Table 4. 
l.O 
~ 
-,,"......._ 
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glucose was observed in manifestly hyperglycemic Group 2 rats. Rats 
which had received endotoxin without glucose (Group 3) had an in-
crease i,n blood glucose which averaged 19 mg/dl which was not sig-
nificantly different from the control group (Group 1). In contrast 
to the Group 3 rats, the rats treated with both endotoxin and glu-
cose (Group 4) showed no significant change in blood glucose at 30 
after alanine. 
In correspondence to the blood glucose determinations, glu-
cose treatment of saline iv treated rats (Group 2) significantly 
decreased both the net conversion of alanine-C-14 to blood glucose-
C-14 and the blood glucose specific activity. However, in the Group 
3 rats, blood glucose-C-14 activity and specific activity were both 
increased over the values observed in controls (Group 1). In the 
Group 4 rats blood glucose-C-14 activity and specific activity were 
both increased over the values in Group 2 rats. However, blood glu-
cose activity was depressed in the Group 4 rats to values signifi-
cantly below the values observed in Group 3 rats. 
Liver glycogen content and C-14 activity were determined 30 
minutes after alanine injection. As shown in Table 4 the mean 
liver weight of saline treated rats which had received glucose was 
significantly increased. In endotoxin treated rats liver weight was 
reduced below that of their corresponding saline controls and no 
difference in liver weight was evident when the ip glucose (Group 4) 
and ip saline (Group 3) rats were compared. In view of these sig-
nificant differences in liver weight all estimates of liver glycogen 
content and liver glycogen-C-14 were calculated both per gram and 
per total organ. In Group 1 rats liver glycogen averaged 10 mg of 
glucose equivalents per total liver and 2.08% of the alanine label 
96 
was present as liver glycogen. In the Group 2 rats 125 mg of the glu-
cose load was recovered as liver. glycogen which was increased to 
136 mg glucose equivalents per liver. Similar to Group 1, 2.06% of 
the injected alanine dose was found in liver glycogen. In Group 3 
there was near total depletion of liver glycogen--mean 0.7 mg glucose 
equivalents per liver--and only 0.23% of the alanine label was in-
corporated into liver glycogen. In Group 4 th~re was no significant 
increase in liver glycogen over the values found in rats given endo-
toxin and saline (Group 3). The value found was less than 1% of that 
observed in glucose treated rats not given endotoxin (Group 2). Both 
liver glycogen specific activity and the % of the alanine carbon 
label recovered as glycogen were insignificantly less than the values 
in Group 3 rats. 
C. . Glucose Tolerance and Insulin Response in Endotoxemia 
Prior to evaluating the glucose tolerance and insulin re-
sponse during endotoxemia, the insulin radioinununoassay procedure 
(Pharmacia, Phad~bas Insulin Test) was evaluated (Table 5). Seven 
point standard curves were linear with a mean Pearson's r of -0.9970 
and showed minimal deviations in slope (M) and intercept (B) on a 
semi-logaritlunic plot. The mean intra-assay coefficients of vari-
ation were 6.75% and 6.10% for the Pharmacia lyophilized human serum 
and the pooled rat serum respectively. Pooled heparinized rat plasma 
consistently showed a higher coefficient of variation. The inter-
assay coefficients of variatio.n for the serum pools were respectively 
, --""'"""'~.-~''-~"«i'EWf¥•aauxaa1;.:_zus_a1. 
TABLE 5 
INTRA- AND INTER-ASSAY VARIATION OF INSULIN RADIOIMMUNOASSAY PROCEDUREa 
Intra-assay variation 
Mean Standard 
Date IRI Deviation 
Sample N (flJ/ml) ~U/ml) 
5-7-74 
PLHSb 4 102.82 10.56 
S-3-7-74c 4 72.64 5.98 
P-4-12-74d 4 47.28 2.97 
5-9-74 
PLHS 4 84.34 5.23 
S-3-7-74 4 66.84 4.18 
P-4-12-74 4 39.44 8.55 
5-13-74 
PLHS 4 93.41 3.27 
S-3-7-74 4 67.56 4.44 
P-4-12-74 4 36.15 2.96 
5-14-74 
PLHS 4 85.09 3.60 
S-3-7-74 4 67.87 4.90 
P-4-12-74 4 43.72 6.29 
5-15-74 
PLHS 4 91.73 8.75 
S-3-7-74 4 80.00 1. 73 
P-4-12-74 4 40.91 3.04 
Inter-assal variation 
PLHS 5 91.48 7.49 
S-3-7-74 5 70.98 5.54 
P-4-12-74 5 41.50 4.23 
Coefficient 
of Variation SEM 
(%) (xU/ml) 
10.27 6.09 
8.24 3.46 
6.28 1. 71 
6.20 3.02 
6.25 2.41 
21.69 4.94 
3.51 1.89 
6.58 2.57 
8.18 1. 71 
4.23 2.08 
7.24 2.84 
14.38 3.63 
9.54 5.05 
2.17 1.00 
7.44 1. 76 
8.19 3.35 
7.80 2.48 
10.19 1.89 
SEM as 
io Mean 
(%) 
5.93 
4.76 
3.62 
3.58 
3.61 
12.52 
2.03 
3.80 
4.72 
2.44 
4'.18 
8.31 
5.51 
1. 25 
4.30 
3.66 
3.49 
4.55 
Standard Curve Parameters 
re Mf 
-0.9978 -35. 778 
-0.9974 -36.433 
-0.9972 -34.657 
-0.9967 -35.236 
-0.9956 -34.860 
Bg 
113.872 
113.582 
110.505 
111.386 
112 .127 
\0 
-....I 
:uq 
TABLE 5 (cont'd) 
Mean intra-assay parameters from 5 runs of assay 
Mean Standard Coefficient 
Date IRI Deviation of Variation 
Sample N (KU/ml) (xU/ml) (%) 
Coefficients of 
PLHS 5 
S-3-7-74 5 
P-4-12-74 5 
variation 
6.75 
6.10 
11.59 
(%s) 
3.06 
2.32 
6.46 
Mean inter-assayj 
Standard Curve 
r 5 
M 5 
B 5 
Parameters 
-0.9970 0.0009 
-35.393 0.7212 
112. 294 1. 4320 
SEM 
(K_U/ml) 
1.37 
1.04 
2.89 
0.0004 
0.3224 
0.6404 
SEM as 
% Mean 
(%) 
Standard Curve Parameters 
re Mf Bg 
a. Two pools of serum and one pool of plasma were assayed in duplicate both before and following the 
experimental samples on each of the 5 occasions on which the assay was repeated to obtain the data 
presented in Table 7. 
b. Pharmacia reconstituted lyophilized human serum. 
c. Pooled rat serum stored at -45°c. 
d. Pooled heparinized rat plasma stored at -45oc. 
e. Pearson's r of correlation of 7 point standard curve. 
f. Slope for equation (B/Bo) x 100 == [Mxln(.u.U/ml)] +B. 
g. Intercept for equation (B/Bo) x 100 = [Mxln(J.t.U/ml)] +B. 
h. Mean and variation about the mean for the IRI values found in the 5 repetitions of the assay. 
i. Mean and variation for coefficients of variation for each of the 5 assay repetitions. 
j. Mean and variation for standard curve parameters of each of the 5 assay repetitions. 
·~~· 
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8.19% and 7.80% which are within 95% confidence limits of the mean 
intra-assay coefficients of variation for these samples. 
Blood glucose responses following 1 mg of endotoxin iv are 
presented in Table 6 and depicted in Figure 7. As indicated in 
Figure 7 no marked changes in blood glucose were manifest following 
control saline injections (Group 1, Table 6) throughout the 12 hour 
observation period. Glucose treatment of saline control rats (Group 
'-2, Table 6) resulted in a prompt hyperglycemia which steadily de-
clined within 2 hrs to a plateau of 90 to 100 ~g/dl. Blood glucose 
then remained significantly greater than the values for the Group 1 
rats until 10 hrs after glucose treatment. Administration of 1 mg 
of endotoxin (Group 3) elicited a hyperglycemia which was not manifest 
at 15 min. but was pronounced by 45 min. The peak mean value was ob-
served at 90 min. when blood glucose approached twice control values 
and remained significantly elevated until 240 min. after which it did 
not differ from control values in Group 1. In endotoxemic rats which 
received glucose at 120 min. (Group 4, Table 6) the initial hyper-
glycemic zenith was similar to that observed in Group 2. However, 
aft'er 240 min .. glucose values of Group 4 declined to values not dif-
ferent from those of Group 1 or Group 3 rats. 
Serum insulin responses following 1 mg endotoxin are pre-
sented in Table 7 and depicted in Figure 8. The saline - saline 
control group (Group 1, Table 7) had mean insulin values in the range· 
of 15 + 2.5 U/ml. Serum insulin in rats which received saline iv 
and glucose ip (Group 2, Table 7) was increased to 383% of the cor-
responding value in Group 1 within 15 min. after glucose treatment. 
Group 
iv treatment 
at time zero 
ip treatment 
at ;1.20 min. 
Time after (min.) 
iv inj. ip inj. 
0 
15 
45 
90 
120 0 
135 15 
'"' .. " ... ,,,_,"i~ii<'·®>+iijis 1:;;:;;zn1;;_:4u1JJ44; JJLULLZH Q J~ 
TABLE 6 
BLOOD GLUCOSE FOLLOWING ENDOTOXIN TREATMENT AND 
COMBINED TREATMENT WITH ENDOTOXIN AND GLUCOSEa 
1 2 3 4 
_____ l ml Saline-------- ____ l mg Endotoxin,__ ____ _ 
2 ml Saline 400 mg Glucose 2 ml Saline 400 mg Glucose 
------------~--24b 89. 29c +2. 07d ---------,-- . 
10 
______ 88. 30 ------
+2. 34 
-6 
______ 88.33 _____ _ 
+2.08 
8 
------86.62 _____ _ 
+1. 21 
9 
______ 82.67-____ _ 
9 
81.11 
+2.98 
+3.06 
10 
203.50 
+6.38 
8 
____ 91.00 -------
+3 .15 
8 
____ 126 .88 -------
±5 .59 
12 
____ 157 .42 -------
+18. 98 
-16 
--.----124.44 -------
10 
111.40 
+5.21 
+4.89 
10 
215.80 
+8.21 I-' 
0 
0 
r 
TABLE 6 (cont'd) 
Group 1 2 
Time after (min.) 
iv inj. ip inj. 
10 9 
150 30 82.40 154.22 
+4. 74 +6.77 
8 8 
180 60 76.25 137.12 
+2.25 +14.29 
10 9 
240 120 74.50 96.67 
+2.46 +2.56 
9 10 
300 180 75 .07 92.20 
+2.98 +2.39 
9 8 
360 240 74.78 97.25 
+3.28 +3.75 
8 7 
480 360 81.38 93.29 
+3.04 +2.59 
9 4 
720 600 83.31 102.75 
+3.15 +8.91 
3 
10 
105. 27 
+4.51 
10 
88.10 
+3.35 
10 
80.20 
+3.12 
10 
77.20 
+3.20 
7 
74.29 
+4.63 
8 
76.75 
+2.58 
8 
84.88 
+2.07 
4 
10 
166.75 
+11.13 
10 
110. 00 
+5.00 
10 
87.00 
+8. 71 
Io 
72.10 
+5.99 
8 
79.62 
+9.36 
8 
81.88 
+3.07 
8 
89.62 
+5.61 
I-' 
0 
I-' 
..... 
TABLE 6 (cont'd) 
STATISTICAL COMPARISONS OF BLOOD GLUCOSE DATA PRESENTED IN TABLE 6e 
Time after Groups Compared f 
iv injection 1 vs 2 1 vs 3 2 vs 4 
15 -- 16g 
o.68oh 
o.5o6i 
45 -- 12 
6.463 
<0.001 
90 -- 18 
3. 723 
0.002 
120 
-- 23 
7.241 
<0.001 
135 17 17 18 
17.381 5.047 1.191 
<O. 001 <0.001 0.249 
150 17 19 19 
8.690 3.496 0.962 
< 0. 001 0.002 0.348 
"'w"''""~~'~""IMJ@4J.j iii.£ q 
3 VS 4 
18 
10.737 
<:0.001 
21 
5.120 
<0.001 
I-' 
0 
N 
r 
Time after 
iv injection 
180 
240 
300 
360 
480 
720 
1 vs 2 
14 
14.208 
<O: 001 
17 
6.244 
<0.001 
17 
4.484 
<0.001 
15 
4.510 
~ 0. 001 
13 
2.982 
0.011 
11 
2.057 
0.064 
TABLE 6 (cont'd) 
Groups Comparedf 
1 vs 3 
16 
2.936 
0.010 
18 
1.435 
0.168 
17 
0.487 
0.632 
14 
0.086 
0.932 
14 
1.161 
0.265 
15 
0.416 
0.683 
2 vs 4 
16 
1. 791 
0.092 
17 
1.065 
0.302 
18 
3.117 
0.006 
14 
1.748 
0.102 
13 
2.841 
0.014 
10 
1.247 
0.241 
.,f_ ~~ 2,""·"" '""'~"'~"'":::zw~;?'i~~~)!"i~, ,.,4.09;:01,; .. WWW iJIJMQ lQfaQ@ 
3 vs 4 
18 
3.639 
0.002 
18 
0.735 
0.472 
18 
0.751 
0.462 
13 
0.510 
0.618 
14 
1. 279 
0.222 
14 
0.793 
0.441 
I-' 
0 
w 
. . ""'Ill 
, . ,J ~ ~ . '.· ·-'f'•·'~"'!°'C~ ~· "'<C. ' . """""'lf~~·;eri,..,,smn:;:@m.~," "" "3~ 
Footnotes to Table 6 
a. Overnight fasted rats were injected iv with one ml saline or 1 mg endotoxin as indicated. 
At 120 minutes following the iv injection all remaining rats received either 2 ml saline 
or 400 mg glucose in this volume of saline as shown. At the designated times after iv 
injection the indicated numbers of rats of each treatment group were bled by cardiac 
puncture and blood glucose and serum insulin were determined as described in the methods 
section. The blood glucose data are shown in this table; Table 7 presents the insulin data. 
b. Number of samples. 
c. Mean blood glucose (mg/100 ml). 
d. Standard error of mean of blood glucose. 
e. Comparison of data presented in Table 6 by two tailed non-paired Student's "t" test. 
f. Groups, numbered as shown above, evaluated for statistical significance of differences 
in mean blood glucose values. 
g. Degrees of freedom. 
h. Student's "t" value. 
i. Corresponding p value for 2 tailed test. 
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FIGURE 7 
BLOOD GLUCOSE RESPONSE TO ENDOTOXIN AND GLUCOSE TREATMENT 
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Overnight fasted rats were given an iv dose of saline or 1 mg 
endotoxin (LPS) at time 0 min. and an ip dose of saline or 400 mg glu-
cose at 120 min. after the iv injection as indicated in the figure and 
described in Table 6. The four combinations of treatment shown on the 
figure correspon9 from top to bottom to Groups 1-4 of Table 6. The 
standard error of mean blood glucose values are shown as a vertical 
line. The mean number of animals for each point in time for each of 
the 4 Groups is shown following the treatment schedule in the upper 
right corner of the figure. 
. ,,.~''"'fl''~~... . 
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TABLE 7 
EFFECT OF GLUCOSE TREATMENT ON SERUM INSULIN FOLLOWING ENDOTOXIN TREATMENT8 
Time after Groupb 
iv injection ip injection 1 2 3 4 
0 29e 
13.47d 
+0.88e 
15 7 8 
14.53 15. 34 
+1.68 +0.92 
5 7 
45 13.57 34.39 
+2.86 +2. 71 
7 12 
90 17.60 129.98 
+3.42 +14.29 
9 16 
120 0 12.20 9.55 
+1.67 +8.26 
10 10 10 10 
135 15 14.99 57.75 43.37 182.45 
+0.48 +6.90 +5.61 +20.79 
10 11 11 10 
150 30 12.48 34.95 39.59 128.12 
+1.32 +2.98 +12 .18 +11. 93 
8 7 10 9 
180 60 15.78 29.60 28.90 64.89 
+2.05 +4.89 +1.64 +9.00 
I-' 
0 
°' 
r~ 
TABLE 7 (cont'd) 
Time after Group 
iv injection ip injection 1 2 
10 10 
240 120 15.40 22.87 
+1.04 +2.73 
8 10 
300 180 15.67 14.57 
+l.06 -i-1. 72 
9 8 
360 240 15.38 17.24 
+1.52 +1.59 
To 9 
480 360 17.21 16.88 
+o. 72 +1.67 
9 4 
720 600 16.40 13.35 
+1.05 +1.46 
b 
3 
9 
32.86 
+7. 70 
9 
32.46 
+2.57 
6 
27.98 
+4.67 
8 
35.02 
+4.30 
7 
30.27 
+3.19 
-~,w,,, .. ,,.--~,""·~-·--.:"",<;I''"':"'"'·~ a (..,,,.;;;; "'%# ;Zf!@?f::U M9¥?i\41l 
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4 
10 
53.41 
+10.55 
10 
50.03 
+9.19 
8 
49.07 
+11.55 
8 
29.39 
+2.04 
8 
37.04 
+3.38 
t-' 
0 
....... 
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TABI.E 7 (cont'd) 
STATISTICAL COMPARISONS OF SERUM INSULIN DATA IN TABI.E 7 
Time after Groups Comparedg 
iv injection 1 vs 2 1 vs 3 2 vs 4 3 vs 4 
15 -- uh 
0.423~ 
0.679j 
45 -- 10 
5.284 
<0.001 
90 -- 17 
7.648 
<.0.001 
120 -- 23 
5.619 
<0.001 
135 18 18 18 18 
6.182 5.040 5.693 6.459 
.C::0.001 40.001 -'0.001 ~0.001 
150 19 19 19 19 
6.894 2. 213 7 .577 5.193 
..::0.001 0.039 <O. 001 <0.001 
180 13 16 14 17 
2.606 4.998 3.440 3.934 t-' 
0.022 <0.001 0.004 0.001 0 et::> 
Time after 
iv injection 1 vs 2 
-
240 18 
2.557 
0.020 
300 16 
0.544 
0.594 
360 15 
0.846 
0.411 
480 17 
0.182 
o_.858 
720 11 
1. 696 
0.118 
TABLE 7 (cont'd) 
Groups Compared8 
1 vs 3 2 VS 4 
17 18 
2.247 2.802 
0.038 0.012 
15 18 
6.040 3.793 
<0.001 0.001 
13 14 
2.566 2.730 
0.023 0.016 
16 15 
4.085 4.745 
<0.001 <0.001 
14 10 
4.130 6.434 
< 0.001 <0.001 
_, .. ._., •·.-·e,,_,.".!""; ·>!.I IJl!W iJ 
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3 vs 4 
17 
1.573 
. 0 .134 
17 
1.841 
0.083 
12 
1.693 
0.116 
14 
1.183 
0. 257 
13 
1.457 
0.169 
...... 
0 
'° 
""""'""~,,~,~~""¥!,- k.!IJ 
Footnotes to Table 7 
a. Assays of serum insulin were performed on the same blood samples from which blood glucose 
data were presented in Table 6. 
b. Treatment groups are designated as in Table 6. 
c. Number of rat serum samples. 
d. Mean innnunoreactive insulin (IRI) value 
e. Standard Error of Mean serum IRI. 
f. Data were analyzed by means of the 2 tailed non-paired Student's "t" test. 
g. Evaluated for statistical significance of difference in mean serum IRI. 
h. Degrees of freedom 
i. Student's "t" value 
j. Corresponding p value for 2 tailed test 
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Mean and standard error of the mean of serum insulin values 
are shown. See Table 7 and legend to Figure 7 for details. 
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As blood glucose declined serum insulin similarly declined. Serum in-
sulin was not different from the values in Group 1 at 300 min. and 
beyond despite the presence of a significant hyperglycemia (Table 6). 
Rats treated with endotoxin (Group 3, Table 7) developed an insulin-
emia which paralleled the endogenously generated hyperglycemia i.e., 
as blood glucose rose to a peak value at 90 min. and subsequently de-
clined until 180 min., serum insulin likewise reached a peak at 90 min. 
and declined until the 180 min. sampling period. However, despite the 
return of blood glucose to values not different from Group 1, serum 
insulin remained significantly elevated throughout the 12 hr obser-
vation period in the endotoxemic rats. In endotoxemic rats which re-
ceived glucose at 120 min. (Group 4, Table 7) serum insulin was 
markedly elevated to a peak mean value of 182)(,U/ml. Subsequently, 
serum insulin declined as blood glucose decreased; however in the 
period from 60 to 240 min. after glucose treatment, blood glucose de-
clined while serum insulin remained elevated at 50-65).(.U/ml. As in 
Group 3 the persistent elevation of serum insulin in Group 4 was 
associated.with blood glucose values not different from those of 
Group 1 and significantly less than those of Group 2. 
In order to evaluate the relationship of serum insulin to 
blood glucose in experimental endotoxemia in the ra~ the glucose to 
insulin ratio and the product of blood glucose times serum insulin 
were calculated (Table 8). As seen in Figure 9 the glucose to in-
sulin ratios of Group 1 ranged from 4.73 to 6;77 and later plateaued 
at 5.00 + 0.25. In Group 2 the ratio initially decreased following 
glucose treatment but then increased during the ensuing 6 hr to values 
n. ' . hJ z 2 . 34i l2i . iii . !SJ. j j 1 111111111111111 
TABLE 8 
BLOOD GLUCOSE TO SERUM INSULIN RATIO AND PRODUCT FOLLOWING ENDOTOXIN TREATMENT 
Grouo 1 Group 2 
a Glucose 
b Glucose 
Time After Blood Serum Glucose x Blood Serum Glucose x 
Injection Glucose Insulin Insulin Insulin Glucose Insulin Insulin Insulin 
0 89.29 13.47 6.63 1,203 
15 88.30 14.53 6.07 1, 283 88.30 14.53 6.07 1,283 
45 88.33 13.57 6.50 1,198 88.33 13.57 6.50 1,198 
90 86.62 17.60 4.92 1,525 86.62 17.60 4.92 1,525 
120 82. 67 12.20 6. 77 1,009 82.67 12.20 6. 77 1,009 
135 81.11 14.99 5.41 1,216 203.50 57.75 3.52 11, 752 
150 82.40 12.48 6.61 1,028 154.22 34.95 4.41 5,390 
180 76.25 15.78 4.83 1,203 137.12. 29.60 4.63 4,059 
240 74.50 15 .40 4.84 1,147 96. 67 22.87 4.22 2, 211 
300 75.07 15.67 4. 79 1,176 92.20 14.57 6.32 1,343 
360 74.78 15.38 4.86 1,070 97.25 17.24 5.64 1,676 
480 81.38 17.21 4.73 1,401 93.29 16.88 5.52 1,575 
720 83.31 16.40 5.08 1,366 102.75 13.35 7.69 1, 372 
I-' 
I-' 
w 
~ 
TABLE 8 (cont'd) 
Group 3 Group 4 
Glucose b Glucose 
a 
Time After Blood Serum Glucose x Blood Serum Glucose x 
Injection Glucose Insulin Insulin Insulin Glucose Insulin Insulin Insulin 
--
0 
15 91.00 15.34 5.93 1,396 91.00 15.34 5.93 1,396 
45 126.88 34.39 3.68 4,363 126.88 34.39 3.68 4,363 
90 157.42 129.98 1. 21 20,461 157.42 129.98 1.21 20,461 
120 124.44 59.55 2.08 7,410 124.44 59.55 2.08 7,410 
135 110.40 43.37 2.56 4,831 215.80 182. 45 1.18 39,372 
150 105.27 39.59 2.65 4,168 166.75 128.12 1.30 21,364 
180 88.10 28.90 3.04 2,546 110. 00 64.89 1.69 7,138 
240 80.20 32.86 2.45 2,635 87.00 53.41 1.62 4,647 
300 77. 20 32.46 2.37 2,506 72.10 50.03 1.44 3,607 
360 74.29 27.98 2.65 2,079 79.62 49.07 1. 62 3,907 
480 76.75 35.02 2.19 2,688 81.88 29.39 2.78 2,406 
720 84.88 30.27 2.80 2,569 89.62 37.04 2.41 3,320 t-' t-' 
+:-
Footnotes to Table 8 
a. Blood glucose to serum insulin ratio in mg per 100 ml per Unit per ml or mg per 100 
These values were derived from the mean values presented in Tables 6 and 7. 
Units. 
b. Blood glucose time serum insulin product in mg per 100 ml times Units per ml or mg x Units 
per 100 ml 2 . These values were derived from the mean values presented in Tables 6 and 7. 
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FIGURE 9 
EFFECT OF GLUCOSE TREATMENT ON THE BLOOD GLUCOSE TO 
SERUM INSULIN RATIO IN ENDOTOXEMIA 
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The mean blood glucose to mean serum insulin ratios were 
computed for the 4 groups listed in Tables 6 and 7 using the data 
of Table 8. 
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greater than those seen in Group 1. During endotoxemia (Group 3, 
Table 8) the ratio was not changed initially but with the onset of 
hyperglycemia it declined abruptly to a nadir of 1.21 at 90 min. and 
remained depressed throughout the experimental period. During endo-
toxemia glucose administration (Group 4, Table 8) maintained the ratio 
at the low value of about 1.5. 
The glucose-insulin product in endotoxemia is shown in Figure 
10. Group 1 displayed little varfation over the 12 hr period. Group 
2·manifested an increase in the product following glucose treatment 
with a return to values not distinguishable from the rats given only 
saline (Group 1) at 3 hr after glucose injection. After endotoxin 
treatment (Group 3, Table 8) the product increased in a pattern similar 
to the serum insu_lin values (Figure 8) and also remained elevated 
throughout the 12 hrs of observation. During endotoxemia glucose ad-
ministration (Group 4, Table 8) resulted in a large increase in the 
product, i.e., over 3 times that of Group 2, with elevated levels 
throughout the ensuing 10 hrs. 
Table 9 and Figure 11 indicate the linear regression of serum 
insulin oµ blood glucose in the rats which received saline followed 
by ip glucose (Group 2). No difference in the regression existed 
whether all 12 points were included or if only those points after 
glucose treatment were used in determining the equation (Table 9). 
The regression lines for Groups 3 and 4 are given in Table 9 and 
shown on Figure 12; as in Group 2, the 12 point relationship was used 
for Group 4 since there was no difference between this and the re-
lationship defined by the 8 points following glucose treatment 
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Table 8. 
The mean blood glucose and mean serum insulin products were 
for the 4 groups listed in Tables 6 and 7 using the data in 
Note the change in scale of the ordinate. 
TABLE 9 
LINEAR REGRESSION OF SERUM INSULIN ON BLOOD GLUCOSE AFTER ENDOTOXIN TREATMENT 
Group or a Mb d Subgroup N Bc r Dfe pf 
--
1 Group 2, 
all 12 points 12 0.3541 -17.0323 0.9732 10 ..::0,001 
Group 2, only 
after ip glucose 8 0.3621 -18.3231 0.9719 6 ""0.001 
Group 3, 
all 12 points 12 0.9231 -49.6662 0.8092 10 0.0014 
Group 4, 
all 12 points 12 1.0434 -52.4772 0.9069 10 <:0.001 
Group 4, only 
after _ip glucose 8 1. 0131 -40.0255 0.9791 6 <:0.001 
Xaxis 
interceptg 
48.10 
50.60 
50.80 
50.29 
39.51 
....... 
....... 
'° 
-~ 
TABLE 9 (cont'd) 
STATISTICAL COMPARISON OF REGRESSION EQUATIONS GIVEN IN TABLE 9 
h Groups Compared 
Group 2, all 12 points 
vs. 
Group 2, points after 
ip glucose 
Group 3, all 12 points 
Group 4, all 12 points 
Group 2, points after 
ip glucose 
vs. 
Group 4, points after 
ip glucose 
Group 3, all 12 points 
vs. 
Group 4, all 12 points 
Group 4, all 12 points 
vs. 
Group 4, points after 
ip glucose 
Dfi 
16 
20 
20 
12 
20 
16 
t valuej p valuek 
0.452 0.657 
6.492 <0.001 
8. 218 c:0.001 
12.918 <0.001 
0.998 0.330 
0.317 0.755 
I'-' 
N 
0 
.. 
Footnotes to Table 9 
a. Number of points 
b. Slope of regression line of serum insulin on blood glucose 
c. Y-axis (serum insulin) intercept of regression line of serum insulin on blood glucose 
d. Pearson's coefficient of correlation for indicated regression lines 
e. Degrees of freedom of regression line i.e., N-2 
f. p value for indicated value of Pearson's r for the number of degrees of freedom shown. 
g. X-axis (blood glucose) intercept of regression line of serum insulin on blood glucose 
h. Lines for groups indicated in table were compared for significance of difference using 
the computer program given in the appendix. 
i. Degrees of freedom for test of significance of difference of lines, 
j. t value of significance of difference between lines 
k. p value corresponding to the indicated value of t at the specified number of degrees of 
freedom. 
1. Groups as defined in Tables 6 and 7. 
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REGRESSION OF SERUM INSULIN ON BLOOD GLUCOSE 
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The relationship of mean blood glucose to mean serum insulin 
in the rats of Group 2 of Tables 6 and 7 at the 12 times after iv 
saline is shown. The equation and the significance of the coefficient 
of correlation are given in Table 9. 
FIGURE 12 
EFFECT OF GLUCOSE TREATMENT ON THE LINEAR REGRESSION OF 
SERUM INSULIN ON BLOOD GLUCOSE IN ENDOTOXEMIC RATS 
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Mean serum insulin is plotted against mean blood glucose for 
the rats of Groups 3 and 4 of Tables 6 and 7. Both groups were given 
endotoxin and Group 3 was treated with saline at 120 min. while Group 
4 was given 400 mg glucose ip at 120 min. There is no difference in 
the 2 lines as shown in Table 9 where the significance of the co-
efficients of correlation is also given. 
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(Table 9). The regression line for Group 2 was significantly dif-
ferent from that of either Group 3 or Group 4 (Table 9). There were 
no differences in the regression lines for Groups 3 and 4 (Table 9) 
which indicates that glucose treatment did not significantly alter 
the relationship between serum insulin and blood glucose in endotoxin 
treated rats. As shown in Table 9 the slopes of the regression lines 
were increased to 261% to 295% of control (Group 2) in the endotoxin 
treated rats (Groups 3 and 4, respectively). A greater than doubling 
of the increase in serum insulin for any given.increment in blood 
glucose occurred in endotoxemia. In marked contrast to the changes 
in slope (gain), the intercept of the regression lines on the blood 
glucose abscissa showed no difference after endotoxin (Table 9) with 
all values within the range of 48 to 51 mg/dl. This set of findings, 
i.e., increased slope and unaltered intercept on the blood glucose 
axis, may signify that while the threshold for insulin remains un-
affected, the responsivity (gain) of the system to hyperglycemia is 
enhanced by endotoxin. 
D. Glucose Oxidation after Endotoxin as Evaluated by 14c-co2 
Collection 
In order to examine the possible role of enhanced glucose 
oxidation in the derangements of carbohydrate metabolism in endo-
toxemia, glucose oxidation was studied by recovery of expired 14co2 
from uniformly labeled glucose in 26 experimental treatments (Table 
10). The data for these groups with selected key statistical com-
parisons are indicated in Table 11 and for ease of interpretation 
the data are also depicted in Figures 13 to 23. 
Group 
Symbol b 
A 
B 
c 
D 
E 
F 
G 
H 
I 
J 
K 
L 
M 
N 
0 
p 
Q 
R 
s 
T 
u 
v 
TABLE 10 125 
EXPERIMENTAL TREATMENTr OF GROUPS OF RATS FOR 
14c-co2 COLLECTION AFTER 4c-D-GLUCOSE EXPERIMENTSa 
Carrier 
Glucose 
Dose (mg) 
0 
400 
0 
400 
0 
400 
0 
400 
0 
400 
0 
400 
0 
400 
0 
0 
0 
400 
0 
400 
0 
0 
c Further Experimental Treatment 
1 ml saline iv at t=2 hr or at t=O hr. 
1 mg LPSd iv at t=O hr 
1 mg LPS iv at t=-2 hr 
100 mg MHe SC at t=-1 hr; 100 mg MH SC 
at t=O hr; 1 ml saline iv at t=O hr 
100 mg MH sc at t=-1 hr; 100 mg MH ss 
at t=O hr; 1 mg LPS at t=O hr 
100 mg MH SC at t=-4 hr; 50 mg MH SC at 
t=-2 1/4 hr; 1 ml saline at t=-2 hr; 
50 mg MH at t=-15 min. 
100 mg MH SC at t=-4 hr; 50 mg MH SC at 
t=-2 1/4 hr; 1 mg LPS iv at t=-2 hr; 
50 mg MH sc at t=-15 min. 
Diabetic Ratsf 1 ml saline iv at t=O hr 
Diabetic Rats 1 mg LPS iv at t=O hr 
3 mg LPS iv at t=O hr 
3 mg LPS iv at t=-2 hr 
100 g Dexamethasone Acetateg ip at 
t=-15 min; 1 ml saline at t=O 
100 g Dexamethasone Acetate ip at t=-15 
min; 1 mg LPS iv at t=O 
r 
Group b 
Symbol 
w 
x 
y 
z 
Carrier 
Glucose 
Dose (mg) 
0 
400 
0 
400 
TABLE 10 (cont'd) 126 
Further Experimental Treatmentc 
Trauma Controlsh, feet taped at -30 min. 
Trauma in Noble-Collip i Drum , 425 
revolutions 
a. Prior to experiments all rats were fasted overnight. Uniformly 
labeled C-14-D-glucose (20.)(Ci) was then given ip in 2 ml saline 
as either a tracer dose or with 400 mg carrier D-glucose im-
mediately prior to the collection of expired C02. 
b. Designation for each group of rats used in ~able 11, text, and 
figures 13-23. 
c. Groups of rats were treated with the indicated agents at the speci-
fied time relative to ip injection of C-14 labeled glucose and 
initiation of C02 collection. All injections were given without 
anaesthesia. 
d. Endotoxin (LPS) prepared daily and given in 1 ml of saline. 
e. Mannoheptulose (MH) prepared as 50 mg per ml solution in saline 
as injected sc. 
f. Diabetic rats treated with 25 mg streptozotocin 6 or 7 before C02 
collection experiment. 
g. Dexamethasone acetate prepared as 100.f(.g per ml suspension in 
saline immediately before ip injection. 
h. Feet taped at 30 min. prior to ip C-14 glucose. 
i. Tumbled 425 revolutions in a Noble-Collip tumbling apparatus at 
33 revolutions per minute 30 to 15 min. prior to ip C-14 glucose. 
~ 
TABLE 11 14c-co~ RECOVERY AFTER IP 14c-D-GLUCOSE 
Group Symbola A B c D E F G H I 
Dose of Carrierb 0 400 0 400 0 400 0 400 0 
Number in Groupe 9 9 8 9 8 8 8 7 5 
Weight (grams) 
297.33h Befored 299.45 297.50 298.00 300.12 298. 75 298.12 297.29 297.60 
0.47i 1. 63 1.30 0:47 1.34 1.06 1. 32 1. 70 1.50 
On Daye 281.89 284.56 283.00 281.56 283.38 283.88 281. 00 279.29 282.40 
1.06 2.23 0.91 1.03 2.46 1. 22 1.94 1. 77 2.58 
Changef 15.44 15.00 14.50 16.44 16.75 14.88 17.12 18.00 15.20 
0.91 0.78 1.02 1.08 1. 67 0.81 1.59 1.09 2.75 
% Dose Recoveredg 
min. after ip glucose 
15 0.232 0.114 0.318 0.143 0.594 0.240 0.160 0.087 0.094 
0.021 0.016 0.028 0.021 0.042 0.037 0.026 0.019 0.010 
30 1.542 0.860 1. 749 0.912 3.651 1. 701 0.612 0.349 0.466 
0.148 0.033 0.162 0.085 0.158 0.266 0.087 0.042 0.098 
45 3.964 2.449 4.420 2.549 8.260 4.399 1.402 0.970 1. 318 
0.250 0.121 0.274 0.194 0.210 0.507 0.156 0.084 0.197 
60 7.023 4.499 7.948 4. 724 13.464 7.818 2.534 1.880 2.626 
0.397 0.303 0.402 0.303 0.462 0.797 0.254 0.188 0.326 
90 14.631 9.012 15.408 10.748 23.809· 16.044 5.656 3.656 6.024 
0.555 0.503 0.582 0.743 0.781 0.894 0.494 0.299 0.629 
120 21. 932 12.788 22.609 16.597 32.549 23.784 9.649 6.357 9.736 
o. 712 0.518 0.733 1.106 0.788 0. 726 0.706 0.430 0.903 
150 28.068 17 .138 30.531 23.324 39.302 30.669 13.948 9.864 13.870 
0.995 0.764 0.767 1. 283 0.871 0.507 0.778 o. 382 1.126 
180 33.007 20. 779 37.440 30.494 44.060 36.051 18.592 13.536 18.170 
0.977 o. 787 o. 711 1. 353 0.888 0.393 0.913 0.560 1.384 
210 37.594 24.106 42 .168 36.934 48.071 ' 40.592 23.174 17.333 23.016 
1.070 o. 963 0.539 1.417 0.886 0.668 0.889 0.743 1.867 
240 40.949 27.078 46.461 43.102 51.584 44.945 27.072 21. 364 26.830 I-' N 
1.047 1.050 0.512 1.492 o.962 - o. 763 0.923 0.819 1.640 
" 
-,...,,.... 
TABLE 11 (cont'd) 
Group Symbola b 
J . K L M N 0 p Q R 
Dose of Carrier 400 0 400 0 400 0 0 0 400 
Number in Groupe 5 8 7 7 6 8 8 7 8 
Weight (grams) 
Befored 299.00 299.12 298.43 298.00 298.67 324.71 333.50 295. 71 297.17 
1.64 1.41 2.54 1.15 2.25 3.03 4.30 1.15 1.38 
On Daye 282.40 278.88 280.43 283.14 284.17 268. 14 271. 62 281.43 283,.67 
1.17 1.54 2.26 1. 28 1.60 4.01 4.99 1. 74 1.14 
Changef 16.60 22.75 19.43 14.86 14.50 406.43f 4o5.oof 14.29 13.67 
1.08 1.18 1. 29 1.53 1.99 20.95 21.04 1.46 0.67 
% Dose Recoveredg 
min. after ip glucose 
15 0.056 0.362 0.119 0.133 0.070 0.177 0.101 0.743 0.097 
0.007 0.058 0.017 0.026 0.008 0.029 0.022 0.050 0.014 
30 0.256 1.692 0.627 0.791 0.403 0.557 0.504 2.391 0.847 
0.040 0. 222 ' 0.060 0.130 0.031 0.049 0.059 0.147 0.076 
45 0.940 3.966 1.626 1.954 1.015 1.163 1.334 5.650 2.475 
0.052 0.483 0.129 0.243 0.062 0.102 0.104 0.311 0.191 
60 1.912 6 .518 3.306 3.589 1.953 1. 976 2.525 9.937 4.835 
0.086 o. 714 0.277 0.398 0.120 0.150 0.123 0.465 0.285 
90 4.152 12. 922 7.574 7.893 4.480 4.083 . 4.986 18.190 10.302 
0.194 1.123 0.601 0.705 0.300 0.336 0.198 0.692 0.559 
120 6.742 18.829 12.067 13.004 7.837 6.456 7.732 26.883 17.227 
0.342 1.285 0.798 1.078 0.622 0.622 0.303 0.756 0.938 
150 9.826 24.179 16.127 18.341 11. 768 8.897 10.496 34. 967 25.253 
0.537 1.348 0.920 1.340 0.900 0.846 0.431 0.745 1. 373 
180 13.608 28 .571 19.564 23.850 16.238 11. 241 13.289 41.821 33.520 
0.782 1.364 0.992 1. 619 1. 232 1.082 0.528 0.733 1.566 
210 17.268 32.380 22.444 29.090 20.848 13. 776 15. 982 47 .440 41. 323 
1.158 1.193 1.047 1. 698 1.532 1.418 0.665 0.688 1.607 
240 21.784 35.484 24.976 33.571 25.378 16.217 18.530 51. 589 47.122 
1.473 1.049 1.014 1.825 1.844 1.693 o. 779 0.557 1. 212 I-' N 
00 
"""'II 
TABLE 11 (cont'd) 
Group Symbol a , s T u v w x y z 
Dose of Carrierb 0 400 0 0 0 400 0 400 
Number in Groupe 6 6 9 8 9 6 8 7 
Weight (grams) 
Befored 293.83 297.83 300.67 298.88 305.44 308.67 301.00 305.57 
1.42 1. 94 1.39 0.69 1.67 0.88 2.05 1. 77 
On Daye 279.33 281. 67 285.56 282;62 288.44 293.83 286.12 289.86 
Changef 
1.02 1.12 1.07 1.38 1.80 1.54 1.88 2.31 
14.50 16.17 15 .11 16.25 17.66 14.83 14.88 15. 71 
1.67 1.60 1. 25 1. 72 1.55 1.30 1. 78 1.58 
% Dose Recoveredg 
min. after ip glucose 
15 o. 778 0.177 0.312 0.246 0.649 0.137 0.838 0.177 
0.135 0.029 0.053 0.035 0.047 0.018 0.057 0.022 
30 3.348 1.212 1.559 1.475 2. 252 1.025 2.852 0.847 
0. 372. 0.127 0.121 0.091 0.114 0.104 0.150 0.069 
45 7.500 3.117 3.920 3.890 4.812 2.857 5.810 2.091 
0.638 0.316 0.157 0.172 0.154 0.211 0.222 0.140 
60 12.595 5.828 6, 778 6.944 8.149 5.335 8.926 3.707 
0.814 0.485 0.282 0.318 0.359 0.437 0.370 0.195 
90 23. 213 12.922 13.386 14.058 14. 966 ·. 10.605 15.362 7.734 
1.140 o. 816 0.572 0.538 0.517 0.763 0.530 0.357 
120 31.812 21.117 19.518 20.532 21. 536 15 .577 20.695 12.267 
1.242 0.943 o. 725 0.471 0.523 0.898 0.596 0.454 
150 38.797 29.082 24.848 26.401 26.882 19.863 25.008 17.267 
1.152 1.006 0.806 0.341 0.435 0.965 0.732 0.611 
180 44.160 36.312 29.168 30.886 31. 288 24.515 28.955 22.461 
1.160 1.067 0.808 0.342 0.405 0.903 1.006 0.581 
210 47.948 42.440 32.588 34.609 34.887 28.433 31.371 27.159. 
1.293 1.124 0.841 0.494 0.443 0.791 0.900 0.553 
240 51. 308 47.398 35.214 37. 018 37.702 31.587 33.994 31. 530 
1.283 1.132 0.888 0.661 0.452 0.906 0.990 0.635 t-' N 
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TABLE 11 (cont'd) 
SELECTED STATISTICAL COMPARISONS OF DATA FROM GROUPS OF RATS SHOWN IN TABLE 11 
Groups Comparedj 
k A-B A-C A-E A-G A-K A-U A-W A-Y B-D B-F Degrees of Freedom 16 15 i6 15 15 16 16 15 16 15 
Weight befored 1.3111 0.123 1.311 0.569 1.210 2.267 4.683 1. 742 0.917 0.415 
o.203m 0.904 0.208 0.578 0.245 0.038 0.001 0.102 0.372 0.684 
Weight on daye 1.081 0.766 1. 081 0.403 1. 612 2.436 3.143 1. 966 1.221 0.268 
0. 296 0.438 0.296 0.692 0.128 0.027 0.006 0.069 0.237 0.793 
Change in weigh~f 0.366 0.687 0.366 0.919 4.906 0.212 1.233 0.283 1.079 0 .106 
o. 719 0.503 o. 719 0.373 0.001 0.835 0.235 o. 781 0.297 0.917 
% Recovery after 
C-14-Glucoseg 
15 min. 4.414 2.416 4.414 2.166 2.114 1.398 8.103 9.959 1.071 3.111 
O. OOln 0.029 0.001 0.047 0.052 0.181 0.001 0.001 0.300 0.007 
30 min. 4.509 0.942 4.509 5.393 0.563 0.087 3.803 6.229 0.575 3.145 
0.001 0.361 0.001 0.001 0.582 0.931 0.002 0.001 0.574 0.007 
45 min. 5.448 1.226 5.448 8.683 0.003 0.150 2.884 5.520 0.437 3.739 
0.001 0.239 0.001 0.001 0.997 0.882 0.011 0.001 0.668 0.002 
60 min. 5.053 1.637 5.053 9.524 0.619 0.504 2.104 3.506 0.526 3.893 
0.001 0.122 0.001 0.001 0.545 0.621 0.052 0.003 0.606 0.001 
90 min. 7.501 0.965 7.501 12. 079 1.364 1.563 0.441 0.953 1.634 6.858 
0.001 0.350 0.001 0.001 0.193 0.138 0.665 0.356 0.122 0.001 
120 min. 10.392 0.662 10.392 12.256 2.112 2.376 0.449 1.333 3.120 12.327 
0.001 0.518 0.001 0.001 0.052 0.030 0.660 0.202 0.007 0.001 
150 min. 8. 711 1.960 8. 711 11.177 2.321 2.514 1.092 2.477 4.144 14.756 
0.001 0.069 0.001 0.001 0.035 0.023 0.291 0.026 0.001 0.001 
180 min. 9.748 3.668 9.748 10. 777 2.643 3.028 1.625 2.889 6.209 17.366 
0.001 0.002 0.001 0.001 0.018 0.008 0.124 0.011 0.001 0.001 
210 min. 9.372 3.818 9.372 10.370 3.254 3.679 2.338 4;451 7.488 14.064 
0.001 0.002 0.001 0.001 0.005 0.002 0.033 0.001 0.001 0.001 
240 min. 9.355 4.732 9.355 9.944 3.688 4.179 2.848 4.827 8.780 13.762 
0.001 0.001 0.001 0.001 0.002 0.001 0.012 0.001 0.001 0.001 
I-' 
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TABLE 11 (cont'd) 
Groups Comparedj B-H B-L B-X B-Z C-E C-Q D-F D-R E-S F-T 
Degrees of Freedomk 14 14 13 14 14 13 15 13 12 12 
Weight befored 0.964 0.374 4.905 2.495 1.404 1.031 0.644 0.573 3.213 0.414 
0.351 o. 714 0.001 0.026 0.182 0.321 0.529 0.578 0.008 0.686 
Weight on daye 1.852 1.302 3.424 1.648 0.145 0.799 1.456 1.369 1.517 1.341 
Change in weightf 
0.085 0.214 0.004 0.122 0.887 0.438 0.166 0.194 0.155 0.205 
2.235 2.939 0.120 0~404 1.152 0.120 1.153 2.182 0.954 o. 717 
0.042 0.011 0.914 0.692 0.268 0.906 0.267 0.048 0.359 0.487 
% Recovery after 
C-14-Glucoseg 1.090 0.174 0.914 2.095 5.474 7.416 2.267 1.830 1.302 1.343 
15 min. 0.294 0.864 0.377 0.055 0.001 0.001 0.039 0.090 0.217 0.204 
30 min. 9.540 3.'383 1.508 0.168 8.415 2.933 2.832 0.577 0.750 1.663 
0.001 0.004 0.156 0.869 0.001 0.012 0.013 0.574 0.468 0.122 
45 min. 10. 021 4.643 1.676 1. 928 11.103 2.966 3.407 o. 272 1.132 2.146 
0.001 0.001 0.118 0.074 0.001 0.011 0.004 0.790 0.280 0.053 
60 min. 7.341 2.903 1.573 2.194 9.017 3.238 3.629 0.266 0.928 2.133 
0.001 0.012 0.140 0.046 0.001 0.006 0.002 0.794 o. 372 0.054 
90 min. 9.157 1.835 1.743 2.073 8.626 3.078 4.790 0.190 0.431 2.580 
0.001 0.088 0.105 0.057 0.001 0.009 0.001 0.852 0.674 0.024 
120 min. 9.556 0.757 2.690 0.757 9.235 4.058 5.432 0.434 0.501 2.241 
0.001 0.461 0.019 0.462 0.001 Q.001 0.001 0.671 0.625 0.045 
150 min. 8.518 0.845 2.214 0.132 7.557 4.149 5.325 1.027 0.350 1.409 
0.001 0.412 0.045 0.897 0.001 0.001 0,001 0.323 0.732 0.184 
180 min. 7.500 0.960 3.120 1. 720 5.819 4.289 3.945 1.462 0.068 0.273 
0.001 0.354 0.008 0.107 0.001 0.001 0.001 0.167 0.947 0.790 
210 min. 5.569 1.168 3.472 2.749 5.695 6.034 2.335 2.049 0.078 1.413 
0.001 0.262 0.004 0.016 0.001 0.001 0.034 0.061 0.939 0.183 
240 min. 4.290 1.440 3.250 3.627 4.702 6.780 1.099 2.091 0.172 1. 797 
0.001 0.172 0.006 0.003 0.001 0.001 0.289 0.057 0.866 0.098 
t-' 
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TABLE 11 (cont'd) 
Groups Comparedj G-I G-K H-J H-L K-M L-N 0-P u-v W-Y x-z 
Degrees of Freedomk 11 14 10 12 13 11 13 15 15 11 
Weight befored 0.263 0.519 o. 725 0.374 0.618 0.070 1.670 1.151 1.681 1.564 
0.798 0.612 0.485 o. 715 0.547 0.945 0.119 0.268 0.114 0.146 
-Weight on daye 0.434 0.859 1.470 0.399 2.131 1.352 0.544 1. 683 0.894 1.432 
Change in weightf 
0.673 0.405 0.172 0.697 0.053 0.204 0.596 0.113 0.486 0.180 
0.607 2.845 0.913 0.846 4.083 2.075 0.048 0.536 1.181 0.430 
0.556 0.013 0.383 0.414 0.001 0.062 0.962 0.600 0.256 0.676 
% Recovery after 
C-14-Glucoseg 
15 min. 2.376 3.195 1.546 1.232 3.608 2.575 2.513 1.038 2.555 1.242 
0.037 0.006 0.153 0.242 0.003 0.026 0.026 0.316 0.022 0.240 
30 min. 1.168 4.499 1.592 3. 771 3.496 3.296 0.695 0.553 3.187 1.422 
0.268 0.001 0.142 0.003 0.004 0.007 0.499 0.588 0.006 0.183 
45 min. 0.336 5.051 0.302 4.247 3.720 4.262 1.176 0.129 3.699 3.021 
0.743 0.001 0.769 0.001 0.003 0. 0,01 0.261 0.899 0.002 0.012 
60 min. 0.223 5.257 0.155 4.258 3.583 4.473 2.826 0.391 1.508 3.404 
0.828 0.001 0.880 0.001 0.003 0.001 0.014 0.701 0 .152 0.006 
90 min. 0.460 5.924 1. 394 5.836 3.793 4.604 2.318 0.856 0.536 3.408 
0.655 0.001 0.194 0.001 0.002 0.001 0.037 0.406 0.()00 0.006 
120 min. 0.076 6.260 0.700 6.296 3.473 4.179 1.846 1.174 1.060 3.288 
0.941 0.001 0.500 0.001 0.004 0.002 0.088 0.259 0.306 0.007 
150 min. 0.057 6.574 0.058 6.285 3.072 3.385 1.684 1. 774 2.203 2.272 
0.956 0.001 0.955 0.001 0.009 0.006 0.116 0.096 0.044 0.044 
180 min. 0.255 6.078 0.075 5.293 2.167 2.103 1. 701 1. 960 2.151 1. 913 
0.804 0.001 0.942 0.001 0.049 0.059 0.113 0.069 0.048 0.082 
210 min. 0.076 6.187 0.047 3.982 1.585 0.860 1.409 2.072 3.504 1.320 
0.940 0.001 0.963 0.002 0.137 0.408 0.182 0.056 0.003 0.214 
240 min. 0.129 6.020 0.249 2. 771 0.909 0.191 1.241 1.629 3.407 0.051 
0.900 0.001 0.808 0.017 0.380 0.852 0.236 0.124 0.004 o. 9.60 
I-' 
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Footnotes to Table 11 
a. Group symbol of treatment protocol as given in Table 10. 
b. Dose of carrier D-glucose given with 20.)<.Ci of uniformly labeled C-14-D-glucose at time zero 
c. Number of animals contributing to all mean values in that column 
d. Weight on evening before overnight fast or before streptozotocin treatment for groups 0 and P 
e. Weight on morning of experiment after overnight fast 
f. Change in weight during overnight fast except for groups 0 and P where mean blood glucose 
after overnight fast is presented. 
g. Percent of C-14 label recovered as C-14 C02 at each specified time 
h. Mean value of indicated number of rats 
i. Standard error of mean 
j. Groups compared using unpaired two tailed Student's 11 t" tests for each corresponding pair of 
data points 
k. Degrees of freedom for Student's "t" test 
1. t value 
m. p value of significant difference 
n. 0.001 indicates "p" value equal to or less than 0.001 
I-' 
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Recovery of expired 14co2 in saline treated control groups 
given either a tracer dose (Group A) or a 400 mg load (Group B) was 
significantly greater in Group A at each sampling time (Figure 13). 
Similar treatment with 1 mg endotoxin and tracer ~,lucose injection 
(Group C) resulted in no difference from Group A before the 150 min. 
samples; however thereafter significantly more la~el was recovered. 
Endotoxin with a 400 mg glucose load (Group D) redulted in signifi-
cantly more label recovered such that at 240 min. 43.1% of the glu-
cose dose was recovered as expired 14coz. When glucose injection and 
C02 collection were withheld until 2 hr after the 1 mg endotoxin dose 
(Groups E and F), increased recovery was manifest and all values were 
significantly greater than the corresponding values for Groups A and 
B, respectively (Figure 14). The marked increase in glucose oxida-
tion after endotoxin (Table 11) was completely abolished by manno-
heptulose suppression of insulin secretion (Groups G vs I and H vs J. 
Figure 15). Using a 4 hr pretreatment protocol without endotoxin 
(Groups K and L) mannoheptulose was less effective in reducing glu-
cose oxidation when compared to 1 hr pretreatment (Groups G and H) 
for both the tracer dose (Figure 16) as well as the glucose load 
(Figure 17). In contrast, glucose oxidation was actually depressed 
in ~ndotoxemic rats if mannoheptulose was administered 4 hrs prior 
to glucose (Groups Mand N, Figure 18). In further support of an 
insulin involvement, streptozotocin induced diabetes both suppressed 
glucose oxidation (Group O, Figure 19) and prevented the endotoxin 
mediated increments in glucose oxidation (Groups P vs O, Figure 19). 
Since low lethality occurs in overnight fasted rats given 
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EFFECT OF ACUTE ENDOTOXEMIA ON RECOVERY OF GLUCOSE CARBON LABEL AS C02 
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Groups of rats were treated as described in Table 10. Im-
mediately following the specified dose of carrier glucose plus 20j(Ci 
of uniformly labeled C-14-D-glucose the collection of respiratory C02 
was begun. The mean values plotted are those listed in Table 11 where 
the standard error of mean and the significance of difference of the 
mean values for pairs of groups at corresponding times are indicated. 
Duplicate samples were collected from each rat at each of the times in-
dicated on the figure. The legend in the upper left identifies the 
groups as specified in Tables 10 and 11. 
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EFFECT OF PREVIOUS ENDOTOXIN TREATMENT ON 
RECOVERY OF GLUCOSE CARBON LABEL AS C02 
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Legend as in Figure 13. 
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FIGURE 15 
EFFECT OF MANNOHEPTULOSE TREATMENT ON RECOVERY OF GLUCOSE 
CARBON LABEL AS COz IN RATS ACUTELY TREATED WITH ENDOTOXIN 
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FIGURE 16 
GLUCOSE CARBON LABEL RECOVERY AS C02 USING A TRACER DOSE OF 
GLUCOSE AND TWO PROTOCOLS OF MANNOHEPTULOSE TREATMENT 
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FIGURE 17 
GLUCOSE CARBON LABEL RECOVERY AS COz USING A 400 mg DOSE 
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FIGURE 18 
EFFECT OF PREVIOUS ENDOTOXIN TREATMENT ON RECOVERY OF 
GLUCOSE CARBON LABEL AS COz IN 
MANNO HE PTULOSE TREATED RATS 
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FIGURE 19 
RECOVERY OF GLUCOSE CARBON LABEL AS COz IN 
STREPTOZOTOCIN DIABETIC RATS TREATED WITH ENDOTOXIN 
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1 mg endotoxin (Table 1), the influence of a high dose of endotoxin 
(3 mg per rat) on glucose oxidation was evaluated (Figures 20 and 21). 
Enhanced glucose oxidation was manifest earlier in response to 3 mg 
endotoxin using a tracer glucose dose (Group Q, F5gure 20) when com-
pared to 1 mg endotoxin (Group C); however, statistical signi_ficance 
was not achieved when a glucose load was used (Gr0ups R vs D, Figure 
20). No differences in glucose oxidation occurreJ when endotoxin at 
either 1 or 3 mg per rat iv was given 2 hr prior to either a tracer 
glucose dose or a load (Groups E vs Sand Groups F vs T, Figure 21). 
It should be noted that while 3 mg endotoxin + tracer glucose resulted 
in 77% lethality (N=29), glucose (400 mg) treatment increased le-
thality to 100% (N=l8). 
Dexamethasone acetate significantly depressed glucose oxida-
tion in both saline iv controls (Groups A vs U) and endotoxemic rats 
(Groups C vs V) such that no differences were measurable in the dexa-
methasone treated groups (Groups U vs V, Figure 22). 
In order to extend these observations from endotoxin to trau-
matic shock,glucose oxidation was evaluated after Noble-Collip tumbling 
stress. In contrast to the enhanced glucose oxidation of endotoxemia, 
tumbling trauma actually depressed label recovery at the tracer dose 
(Groups Y vs W) but had only minimal influence when a glucose load 
was used (Groups Z vs X, Figure 23). 
E. Carbon Clearance in Insulin Hypoglycemia 
To assess the possible influence of blood glucose on the 
phagocytic activity of the RES the clearance of colloidal carbon 
from the blood was studied (Tables 12 and 13, Figures 24 and 25). 
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FIGURE 20 
COMPARISON OF GLUCOSE CARBON LABEL RECOVERY AS COz IN 
RATS ACUTELY TREATED WITH 1 OR 3 mg OF ENDOTOXIN 
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FIGURE 21 
COMPARISON OF GLUCOSE CARBON LABEL RECOVERY AS co2 IN 
RATS PREVIOUSLY TREATED WITH 1 OR 3 mg OF ENDOTOXIN 
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INFLUENCE OF DEXAMETHASONE TREATMENT ON GLUCOSE CARBON LABEL 
RECOVERY AS C02 IN CONTROL AND ENDOTOXEMIC RATS 
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FIGURE 23 
RECOVERY OF GLUCOSE CARBON IABEL AS COz 
IN IMMOBILIZED AND TRAUMATIZED RATS 
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The insulin treated rats were divided into two groups using 30 mg per 
dl as the hypoglycemic criterion. In addition, the data of all in-
sulin treated rats was combined and treated as one group (Table 12, 
Group 2 + 3). 
In control rats treated with saline a significant negative 
correlation between carbon clearance half-time and blood glucose was 
observed (Figure 24). Insulin treated rats which had blood glucose 
values above 30 mg per dl had carbon clearance half-times signifi-
cantly longer than in saline controls, i.e., 19.9 min. vs 16.8 min. 
(Table 12). Figure 25 depicts a linear regression of carbon clearance 
half-time on blood glucose. This relationship was not different from 
that shown in Figure 24. Insulin hypoglycemia markedly prolonged the 
intravascular carbon half-time i.e., 30.8 min. vs 16.8 min. (Table 
12). The correlation of half-time on blood glucose was not signifi-
cant in this restricted blood glucose range. A significant correla-
tion of clearance half-time and blood glucose occurred when all the 
insulin treated rats were grouped together; with a slope of -26 min. 
per 100 mg glucose per dl (Table 13 and Figure 25). This regression 
line is significantly different from that of the saline treated con-
trols (Table 13). 
F. Endotoxin Clearance in vivo 
This phase of the study focused on the influence of hypo-
glycemia on the disappearance of biologically active endotoxin from 
the vascular compartment. However, initial experiments were required 
in order 'to substantiate the use of the lead sensitized rat bioassay 
for measurement of intravascular endotoxin clearance. In particular 
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Carbon clearance half-time is plotted against the mean blood 
glucose for the 40 saline treated rats shown in Table 12. The best 
line through the points was computed by the method of least squares. 
TABLE 12 149 
CARBON CLEARANCE IN INSULIN TREATED RATSa 
Mean Carbon 
Body Blood Clearance 
Weight Glucose Half-time 
Group Treatment N (gm) (mg/dl) (min) 
Saline 40 306.45f 90.57 16.80 
+3.14g +2.29 +o.39 
2c Insulin 16 309.81 45.44 19.94 
+3.20 +4.70 +0.80 
Insulin 15 308.07 21.00 30.80 
+4.47 +1. 78 +l. 71 
Insulin 31 308.91 34.84 25 .19 
+3.41 +3.61 +1.34 
Student's t tests of above datah 
Degrees of Blood 
Groups Compared Freedom Glucose Half-time 
1 VS 2 54 8.632i 3.528 
<O. OOlj <0.001 
1 vs 3 53 23.986 7.982 
..c:: 0.001 <O. 001 
1 vs (2 + 3) 69 13. 044 6.012 
<0.001 <:0.001 
2 vs 3 29 4.863 5.752 
<0.001 <.0.001 
a. Carbon clearance was evaluated at a dose of 8 mg per 100 gm body 
weight. Forty fed or fasted control rats treated with saline were 
paired with the insulin treated rats, each pair was treated with 
the same injection volume at the same time before the carbon 
clearance test. The insulin dose ranged from 0.5 to 4.0 units 
and was given at 0 to 4 hrs before the carbon clearance test to 
produce a wide spectrum of blood glucose values. 
b. All saline treated rats 
c. Insulin treated rats not hypoglycemic i.e., mean blood glucose> 
30 mg per dl 
d. Insulin hypoglycemic rats i.e., mean blood glucose of 30 or 
less mg per dl 
e. All insulin treated rats combined and analyzed as one group 
f. Mean 
g. Standard error of mean 
r 
h. 
i. 
j. 
Footnotes to Table 12 (cont'd) 
Two tailed Student's "t" test for non-paired data 
Value of Student's "t" 
p value for corresponding value of t at specified number of 
I degrees of freedom 
150 
Groupb 
TABLE 13 
REGRESSION OF CARBON CLEARANCE HALF-TIME ON BLOOD 
GLUCOSE IN CONTROL AND INSULIN TREATED RATSa 
Degrees 
Pearson's of pC 
N r Freedom Value Md 
151 
Be 
1 40 -0.3911 38 0.0126 -0.0666 22.8347 
2 16 -0. 5893 14 0.0163 -0.0952 24.4868 
3 15 -0.2435 13 0.3818 <>. 2335 35.7042 
(2 + 3) 31 -0.6423 29 0.001 -0.2560 33.8238 
Statistical Comparison of above Regression Lines f 
Groups Degrees of Student's 
Compared Freedom t p Valueg 
1 vs 2 52 1. 1514 0.2549 
1 vs (2 + 3) 67 6.1230 <0.001 
a. Regression and correlation parameters for data from groups shown 
in Table 12 and in Figures 24 and 25. 
b. Groups as designated in Table 12 
c. p value associated with indicated value of Pearson's coefficient 
of correlation at specified number of degrees of freedom 
d. Slope in 100 min x ml per mg for regression equation 
Carbon Clearance Half-time (min = (M 
(MxBlood glucose in mg per 100 ml)+B 
e. Y axis intercept in min. for regression equation 
Carbon Clearance Half-time (min) 
(:MxBlood glucose in mg per 100 ml)+B 
f. Evaluation of significance of difference of regression lines 
using program given in the Appendix. 
g. p value associated with indicated Student's "ttt value for 2 
tailed test at the indicated number of degrees of freedom 
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CARBON CLEARANCE IN INSULIN TREATED RATS 
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Carbon clearance half-time is plotted against mean blood glucose 
for the 31 insulin treated rats. Rats with a mean blood glucose value of 
or below 30 mg/dl are represented by~; rats with a mean blood glucose 
value above 30 mg/dl are represented by e. The broken line extending 
across the figure is the best fit line through all 31 points. The cross 
slashed line extending to the right of the 30 mg/dl line is the best fit 
line through the 16 points corresponding to rats with blood glucose values 
of 30 or more mg/dl. Both lines were fitted by the method of least squares. 
The 2 uppermost /l's are off the scale of the axis at values of 43 and 45 
minutes. 
r 
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it was necessary to establish the relationship between endotoxin dose 
and lethality. Two hundred rats were divided into 5 groups and given 
0.4, 0.5, 0.6, 0.75, or l.<J<gm of endotoxin simultaneously with a 
sensitizing dose of lead. As shown in Figure 26 ~ significant linear 
relationship was found between the logarithm of the dose and the pro-
bi t of the assay group lethality in the range of rrobits 4 to 6 i.e., 
16% to 84% lethality. 
The clearance of a 500xgm endotoxin dose from the vascular 
compartment of non-pretreated 300 gm fed rats is presented in Table 
14 and Figure 27; in this study tail blood for analysis was obtained 
by serial sampling. The half-time for disappearance of endotoxin from 
the blood was 68 min. and demonstrated a significant (p<0.001) linear 
relationship of the logarithm of blood endotoxin concentration to 
time (Figure 27). A more extensive series of experiments using only 
one blood sample from each clearance rat was designed to evaluate this 
method of determining the clearance of endotoxin (Table 15). Figure 
27 compares the results obtained in the single sample experiments 
with a 500;i.gm endotoxin dose with the results obtained in the serial 
sampling experiments (Table 14). The half-time using the single sam-
ple technique was comparable to that of the previous experiment -
58 vs 68 minutes - and the coefficient of correlation was significant 
at the 0.01 level (Figure 27). For comparison with other clearance 
groups the clearance line for the single sample rats receiving 500.xgm 
endotoxin appears on Figures 28 through 31. ·when the dose was doubled 
to 1,000.f<gm per rat, endotoxin disappearance appeared proportional to 
the blood endotoxin concentration in the period from 60 to 240 min. 
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FIGURE 26 
DOSE-LETHALITY CURVE FOR 5 DOSES OF 
ENDOTOXIN IN LEAD SENSITIZED RATS 
for Probit range 4-6 
N=200 
r=+0.9935 
P<0.001 
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The probits of the lethality of 5 groups of lead sensitized 
assay rats are plotted against the dose of endotoxin. The coefficient 
of correlation and the significance are indicated in the upper left 
for the probit range of 4.0-6.0 
\ 
TABLE 14 
ENDOTOXIN CLEARANCE in vivo USING A 
A SERIAL SAMPLING TECHNIQUEa 
Endotoxin Assay Standards 
Dose 
Y<g/rat) 
0.25 
0.50 
Unknown Diluted 
Time after 
Endo toxin 
(min)d 
15 
30 
60 
120 
240 
Blood 
60 
72 
Samples 
Number of 
Clearance 
Ratse 
3 
3 
4 
5 
5 
% 
Lethality 
36.7 
70.8 
Probitc 
4.660 
5.548 
Number of f 
Assay Rats 
25 
26 
41 
50 
50 
155 
Blood 
Endo toxin 
Y<,gm/ml)g 
31.2 
25.6 
18.0 
9.8 
3.0 
a. Normal fed rats of 300 gm body weight were given SOO~m of endo-
toxin in 1 ml of saline iv at time zero. Aliquots of tail blood 
were collected serially from each of the 5 rats at the 5 in-
dicated times. The blood was diluted in normal saline and bio-
assayed for endotoxin in. lead sensitized rats. To permit exti-
mation of the amount of endotoxin 132 rats received known doses 
·of endotoxin. 
b. Number of assay rats given specified dose of endotoxin. 
c. Probit transform of lethality 
d. Time after iv endotoxin at which blood samples were collected 
from clearance rats· 
e. Number of clearance rats from which blood samples were bio-
assayed for endotoxin. 
f. Number of rats used to assay diluted blood from indicated number 
of clearance rats. 
g. Endotoxin content calculated from probit of assay rats and di-
lution factor. 
FIGURE. 27 
ENDOTOXIN CLEARANCE in vivo AT A DOSE OF 500 MICROGRAMS PER RAT 
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Blood endotoxin content is plotted against time after injection 
of a 500 mg test clearance dose in 300 gram rat. X = clearance rats from 
which tail blood samples were obtained serially. 0 = clearance rats from 
which single samples were obtained by cardiac puncture. Ne = number of 
clearance rats. NA= number of assay rats used for clearance samples. 
T~ = calculated half-time of disappearance of endotoxin from the blood 
assuming monoexponential clearance and using the slope of best line through 
the points fitted: by the method of least squares. The dashed line appears 
on Figs. 28-31 for comparison with other groups. 
TABLE 15 
ENDOTOXIN CLEARANCE in vivo USING SINGLE CARDIAC BLOOD SAMPLESa 
Endotoxin Assay Standards 
Dose % 
{p.._gm/rat) N Lethality 
0.25 70 37.l 
0.50 100 57.0 
1.00 100 82.0 
Unknown Diluted Blood Samples 
Clearance 
Group 
Normal 
Normal 
Normal 
Tolerantf 
Dose per 
Clearance 
Rat Vtgm) 
500 
1,000 
250 
500 
Correlation (Probit analysis)b 
Probit re td Pe 
4.671 0.9942 9.2444 0.0686 
5.176 
5. 915 
Time after Number of Number of 
iv endotoxin Clearance Assay 
(min) Rats Rats 
60 9 90 
120 9 90 
180 6 60 
240 9 90 
60 4 40 
. 
120 4 40 
240 3 30 
60 4 40 
120 4 40 
240 4 40 
15 3 30 
60 3 30 
120 2 20 
... ...., 
Blood 
Endo toxin 
~gm/ml) 
20.2 
11.4 
4.4 
2.5 
26.0 
14.4 
3.0 
7.3 
4.0 
2.1 
2.42 
2 
2 
I-' 
Vl 
....... 
Clearance 
Group 
16-18 hr 
after 500 g 
endotoxing 
4 hr after 
500 g h 
endotoxin 
Dose per 
Clearance 
Rat ~gm) 
500 
500 
TABLE 15 (cont'd) 
Time after 
iv endotoxin 
(min) 
15 
60 
120 
15 
60 
120 
240 
Number of 
Clearance 
Rats 
3 
3 
3 
4 
5 
5 
3 
Number of 
Assay 
Rats 
30 
30 
30 
40 
50 
50 
30 ~ 
Blood 
Endo toxin 
V<gm/ml) 
5.14 
2 
2 
26.0 
8.9 
5.1 
2.9 
a. Rats were given the specified dose of endotoxin iv in saline at a concentration of 500 gm per ml 
in saline at time zero. At the indicated times the clearance rats were bled by cardiac puncture 
and their blood was diluted to 25 to 100 1 of blood per ml in normal saline and bioassayed for 
endotoxin as described in lead treated rats. Symbols used in the t1bl~ are tP0 sams as those 
in Table 22 with the following additions. 
b. Linear correlation of probit of lethality and logarithm of endotoxin dose. 
c. Pearson's r for correlation 
d. t value corresponding to indicated value of r 
e. p value corresponding to indicated t value 
f. Treated with 1 mg endotoxin on days 1, 3, and 5 with clearance evaluated on day 7. 
g. Treated with 500,;.<.gm endotoxin 16-18 hr prior to administration of the test dose. 
h. Treated with 500_..t<.gm of endotoxin 4. hrs prior to the test dose of endotoxin. 
t--' 
V1 
00 
, 
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after endotoxin (Figure 28); there was a significant correlation of 
the logarithm of blood endotoxin and time. The half-time was 57 min. 
which was almost identical to the 50~m dose clearance vale. At a 
lower dose of 25().i{gm endotoxin no significant linrar relationship was 
obtained on a semi-logarithmic plot. From the points plotted and the 
expected blood level of endotoxin at zero time it appeared that the 
rate of disappearance decreased with time, at an ::-stimated half-time 
of 103 min. To further evaluate this method of endotoxin clearance 
measurement, rats were pretreated with endotoxin prio~ to analysis 
(Table 15 and Figures 29 and 30). Tolerance induced by 3 injections 
of 1 mg endotoxin on alternate days resulted in no detectable endo-
toxin after 15 min. (Figure 29); this finding is in agreement with the 
well-known rapid clearance of endotoxin in the t;olerant state. Further-
more endotoxin pretreatment only 16 to 18 hr before a 500/{gm test dose 
resulted in only 5,A(gm per ml of bioassayable endotoxin at 15 min. As 
in the tolerant rats less than 2 gm per ml of blood were found at 60 
and 120 min; the slope of the line between the 15 min. value and the 
maximum value at 60 min. corresponded to a half-time of 33 min. 
Lastly, rats were pre-treated with 50~gm endotoxin 4 hr before the 
clearance study. In this group clearance appeared to be multiphasic 
and the slope of a line between the 15 and 60 min. points corresponded 
to a half-time of 30 min., in the 60 to 120 min. interval the apparent 
half-time was increased to 75 min., and in the 120 to 240 min. period 
the slope of a line connecting the points corresponded to a 151 min. 
half-time. Since endotoxin sensitivity accompanies adrenal in-
sufficiency, endotoxin clearance was also studied after acute 
FIGURE 28 
ENDOTOXIN CLEARANCE in vivo AT THREE DOSES OF ENDOTOXIN 
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Blood endotoxin contents at 60, 120, and 240 minutes after 
a dose of 1,000 micrograms or 250 micrograms per 300 gm rat were 
used to determine the line of best fit (least squares). The "Single· 
Samples" group given a 500 microgram dose is shown for comparison 
(----). 
FIGURE 29 
INFLUENCE OF TOLERANCE AND PRIOR ENDOTOXIN TREATMENT 
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X = tolerance induced by 3 injections of 1 mg endotoxin on 
alternate days with a 500 microgram test clearance dose administered 
on day 7. 
0 = 500 microgram endotoxin at 16 to 18 hrs prior to a 500 
microgram test clearance dose. 
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FIGURE 30 162 
INFLUENCE OF ENDOTOXIN PRETREATMENT ON 
ENDOTOXIN CLEARANCE in vivo 
Pre-Treated 4 hr. Prior 
r =-0.9263 P >0.05 
Ti12=75min . 
• 
• 
0 15 30 60 120 180 240 
TIME AFTER l.V. ENDOTOXIN (minutes) 
•= 500 micrograms of endotoxin 4 hrs prior to a 500 microgram 
test clearance dose. 
j) = estimated blood endotoxin content at time zero based on 
500 microgram control group of Table 15. 
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adrenalectomy (Table 16 and Figure 31). Sham-adrenalectomy resulted 
in no significant change in endotoxin clearance a~ compared to un-
treated controls. In contrast, adrenalectomy significantly augmented 
endotoxin clearance as reflected in a half-time of 38 min. (Figure 31). 
The influence of insulin hypoglycemia on endotoxin clearance is de-
picted in Figure 32 and Table 17. As depicted, ingulin hypoglycemia 
depressed endotoxin clearance as evidenced in the blood endotoxin con-
centration at 3,hr of 3 times control values. Fasted controls had a 
half-time for endotoxin clearance similar to fed rats i.e., 51 min. 
G. Endotoxin Clearance by the Perfused Rat Liver 
As a complement to the in vivo studies of endotoxin clearance 
(Section F, Chapter 4) the uptake of bioassayable endotoxin by the 
isolated perfused rat liver was also studied. In order to quantitate 
endotoxin a 5 point standard dose lethality curve was employed and 
the probit transform of the lethality scores with 95% confidence limits 
about the best line (least squares fit) through the points is shown 
in Figure 33. The line and the confidence limits were computed as 
described by Finney (212). The coefficient of correlation for this 
line is significant at the p<0.001 level. 
Endotoxin clearance during liver perfusions with balanced salt 
solution are shown in Table 18. The probit of lethality for the 
initial perfusate before addition to the perfusion apparatus was not 
different than would have been expected for an endotoxin dose of 
¥<.gm per assay rat; this corresponds to ~m per ml of perfusate 
since each perfusate sample was diluted two-fold with normal saline 
before assaying 1 ml aliquots in lead sensitized rats (Sample 1). 
J 
TABLE 16 
ENDOTOXIN CLEARANCE AFTER SURGICAL STRESS OR ACUTE ADRENALECTOMYa 
Endotoxin Assay Standards 
Dose % 
~m/rat) N Lethality 
0.125 50 36.7 
0.25 50 52.b 
0.50 50 74 .o 
1.00 50 88 .0 
Unknown Diluted Blood Samples 
Clearance 
Group 
Acute Sham 
Adrenalectomy 
Acute 
Adrenalectomy 
Dose per 
Clearance 
Rat V<gm) 
500 
500 
Probit 
4.660 
5.050 
5.643 
6.175 
Time after 
iv endotoxin 
(min) 
60 
120 
180 
60 
120 
150 
180 
Correlation (Probit analysis) 
r t p 
0. 9968 17.6353 0.0032 
Number of Number of Blood 
Clearance Assay Endo toxin 
Rats Rats ~m/ml) 
4 40 17.2 
4 40 9.5 
4 40 2.3 
5 50 15.5 
6 60 5.6 
4 40 3.0 
5 50 1.8 
a. Rats were either adrenalectomized or sham operated 1 hr before the test dose of endotoxin. 
All other symbols as in Table 23. 1--" 
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FIGURE 31 
INFLUENCE OF SURGICAL TRAUMA AND ACUTE ADRENALECTOMY 
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~ = surgical sham adrenalectomy 1 hr prior to a 500 microgram 
test clearance dose of endotoxin. 
X = acute adrenalectomy 1 hr prior to a 500 microgram test 
clearance dose of endotoxin. 
r 
TABLE 17 
ENDOTOXIN CLEARANCE IN FASTED AND INSULIN HYPOGLYCEMIC RATSa 
Endotoxin Assay Standards 
Dose 
Y-tg/rat) N % Lethality 
0.10 20 15 
0.25 50 32 
0.50 60 70 
1.00 50 82 
Unknown Diluted Blood Samples 
Dose per Time after 
Clearance Clearance iv endotoxin 
Group rat Ytgm) (min) 
Fasted + 500 60 
Saline 180 
Fasted + 500 60 
Insulin 120 
180 
Correlation (Probit analysis) 
Pro bit r t p 
3.964 0.9843 7.8866 0.0157 
4.532 
5.524 
5.915 
Mean Blood Number of 
Glucose Clearance 
(mg/_dl) Rats 
154 2 
87 5 
30 3 
30 6 
32 7 
Number of 
Assay 
Rats 
20 
50 
30 
60 
70 
Blood 
Endo toxin 
Ytgm/ml) 
10.3 
2.04 
19.9 
17.4 
6.5 
a. Rats weighing 300 + 1 gm were fasted overnight~ At 1 hr prior to the clearance dose of 500 gm 
endotoxin rats were given either 500 milli Units of Lente insulin sc or 12.5..,tLl of saline. 
All symbols are as indicated in Table 23. 
b. Mean blood glucose at time sample was obtained for endotoxin bioassay. 
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FIGURE 32 
ENDOTOXIN CLEARANCE in vivo IN INSULIN HYPOGLYCEMIC RATS 
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.A.= 500 milliunits of insulin sc 1 hr prior to a 500 microgram 
test clearance dose of endotoxin. 
ct= saline control group, 12.5 microliters of saline sc 1 hr 
prior to a 500 microgram test clearance dose of endotoxin. 
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FIGURE 33 
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The 95% confidence limits about the best line for the 5 endo-
toxin standards is depicted. Two hundred rats were distributed in the 
5 dosage groups of 0.4, 0.5, 0.6, 0.75, and 1.00 micrograms per assay 
rat. Endotoxin dose per assay rat is plotted on a logarithmic scale. 
r 
TABLE 18 
ENDOTOXIN CLEARANCE in vitro BY RAT LIVER PERFUSED WITH BALANCED SALT SOLUTIONa 
Number of Number of % Probite Endotoxinf 
Sample Assayed Livers Perfused Assay Rats Lethality J!<gm/ml) 
1 Initial perfusateb 6 60g 90.0 6.282 (2.0) 
2 Circulated 1 hrc 
without liver in 
apparatus 6 61 80.3 5.852 1.81 
3 After 1 hr ofd 
perfusion through 
liver 6 60 56.7 5.169 1.19 
Chi-Square Test of above groups 
Groups Compared Chi-Square p 
1 vs 2 1. 5361 0.2152 
1 vs 3 15.3835 c::O. 0001 
2 vs 3 6. 8010 0.0091 
a. Rat livers were perfused using an initial volume of 150 ml of Schimassek's balanced salt 
solution containing 2 micrograms per ml of endotoxin. The perfusate was circulated in 
·the perfusion apparatus for 1 hr prior to addition of a liver. All samples were diluted 
with an equal volume of saline before assay for endotoxin in lead-sensitized rats. This 
table incorporates data from the first hour of perfusion of the livers which were also 
perfused with 10% rat serum (Table 19). 
...... 
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, 
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Footnotes to Table 18 (cont'd) 
b. Samples of perfusate evaluated prior to addition to the liver perfusion apparatus. 
c. Perfusate samples evaluated after circulating in the apparatus 1 hr in the absence 
of a rat liver. 
d. Perfusate samples evaluated ~fter 1 additional hour of perfusion through the rat liver. 
e. Probit value corresponding to assay group lethality. 
f. Endotoxin concentration estimates from probit of assay lethality; for initial perfusate 
the known amount of 2 micrograms per ml is indicated in parentheses. 
g. Ten or eleven assay rats per sample 
t-' 
~ 
0 
~ 
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In addition, the mere circulation of the perfusate in the perfusion 
apparatus ~ se had no significant effect on bioassayable endotoxin, 
i.e., a probit analysis endotoxin content of l.8l){gm per ml which is 
within the 95% confidence limits of 2.0)(gm per ml (Sample 2). After 
1 hr of liver perfusion the perfusate endotoxin concentration was sig-
nificantly reduced to an estimated mean concentration of l.19f<Zm per 
ml and the 95% confidence for the observed lethality were 1.01 to 
l .38~m per· ml (Sample 3). Chi-square comparisons confirmed that the 
endotoxin concentration of the 1 hr perfusate was significantly less 
than observed with either Sample 1 or 2 (Table 18). During the entire 
experiment an estimated 142~m of biologically active endot·oxin dis-
appeared from the perfusate and 115xgm of thi.s loss wa·s attributed to 
liver uptake. Additional experiments employed 10% rat serum in the 
perfusion media (Table 19). No significant effect of serum on endo-
toxin clearance was demonstrated (Sample 4 vs 3, p~0.4). Furthermore, 
incubating the endotoxin with 10% rat serum in balanced salt solution 
had no significant effect on bioassay lethality (Sample 5 vs 3, p~O. l). 
Lastly, livers were perfused with 50% heparinized rat blood and endo-
toxin clearance ~valuated (Table 20). The lethality of the initial 
perfusate was not different from 2.0~m per ml (Sample 1). During 
the 1 hr of circulation of the endotoxin containing blood perfusate 
no loss of bioassayable endotoxin was evident (Sample 2). After 30 
min. or 90 min. of perfusion of the liver no loss of endotoxin from 
the perfusate was measured (Samples 3 and 4); though the probit value 
I 
of the 90 min. blood perfusate was near the 95% confidence limit of 
2.0J.(gm per ml of perfusate. Study of blood detoxification indicated 
r 
Sample 
Assayed 
TABLE 19 
ENDOTOXIN CLEARANCE BY THE RAT LIVER PERFUSED WITH 10% RAT SERUMa 
Number of 
Per fusions 
or Incubations 
Number of 
Assay 
Rats % Lethality Prob it 
Endotoxin 
V(gm/ml) 
·~ 
,. 
TABLE 19 (cont'd) 
Chi-Square Tests of Above Groups 
Groups Compared Chi-Square p 
a. 
1 vs 2 1.0800 0.2987 
1 vs 3 14.3590 0.0002 
1 vs 4 
·8.2079 0.0042 
2 vs 3 6. 8571 0.0088 
3 vs 4 0.6027 0.4376 
3 vs 5 1. 6667 0.1967 
4 vs 5 0.0679 0.7944 
After perfusion for 1 hr with balanced salt solution, two 10 ml aliquots were withdrawn 
from the reservoir; one for endotoxin bioassay, and the other for incubation after the 
addition of 1.1 ml of pooled rat serum. Fourteen and one half ml of rat &erum con-
taining 2 micrograms per ml of endotoxin was then added to the remaining 130 ml of per-
fusa te and the liver was perfused for an additional 1 hr. All samples were diluted with 
an equal volume of saline and bioassayed in lead sensitized rats. The remainder of the 
legend is as for Table 18. 
b, Sample of perfusate evaluated after second hour of perfusion with pooled rat serum (10%) added. 
c. Sample evaluated after first hour of liver perfusion--10% pooled rat serum added and in-
cubated 1 hr at 37oc prior to bioassay in lead sensitized rats. 
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TABLE 20 
ENDOTOXIN CLEARANCE BY THE RAT LIVER PERFUSED WITH 50% HEPARINIZED RAT BLOODa 
Number 
of Livers 
Perfused Number of 
Sample or Samples Assay Endotoxin 
Assayed Incubated Rats % Lethality Probit "1< gm/ m 1) 
1 Initial 
50'7o blood 
perfusate 3 31 77.4 5.752 (2.0) 
2 Circulated 
1 hr without 
liver in 
apparatus 3 2ob 95 6.645 c 
3 After 30 min 
of 7.50 blood 
f . ' per us1on 3 30 90.0 6. 282 
4 After 90 min 
of blood 
perfusion 3 JO 73.3 5.622 1.57 
5 50% blood-
50% balanced 
salt solution 
incubated for 
2 hr 3 30 90 6.282 
6 100% blood 
..... 
incubated 2 hr 3 30 86.7 6 .. 112 --
""" +:-
r . _, ~ 
TABLE 20 (cont'd) 
Chi-Square Test of Above Groups 
Groups Compared Chi-Square p 
1 vs 2 1. 6672 0.1966 
1 VS 3 o. 9623 0.3266 
1 vs 4 0.0053 0.9420 
1 vs 5 0. 9623 0.3266 
1 vs 6 0.3673 0.5445 
2 vs 3 0.0113 0.9153 
2 vs-4 2.4898 0.1146 
3 vs 4 1. 7811 0.1820 
4 vs 5 1. 7811 0.1820 
4 vs 6 0.9375 0.3329 
5 vs 6 0.0001 0.9920 
a. Perfusion of livers with 50% fresh heparinized rat blood in Schimassek's balanced salt 
solution containing 2 micrograms of endotoxin per ml of perfusate. Tl.~ initi~~ perfusate 
(150 ml) was circulated in the perfusion apparatus 1 hr prior to addition of a rat liver 
after which a 10 ml aliquot was withdrawn for endotoxin bioassay. The rat liver was per-
fused for 90 min. with a 10 ml aliquot taken at each 30 and 90 min. from the perfusion 
reservoir. Ten ml of additional perfusate was incubated for 2 hr at 37oc. An additional 
10 ml of undiluted rat blood containing 20 micrograms of endotoxin was incubated ~t 37°c 
for 2 hr. All samples were diluted with an equal volume of saline before bioassayed for 
endotoxin in lead sensitized rats. The remainder of the legend is as for Table 18. 
b. Ten assay rats per one sample; 5 rats each for the remaining two. 
c. Probit beyond range at which linear relationships of probit of assay lethality and 
logarithm of endotoxin dose was demonstrated. 
t-"' 
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no detectable change in bioassayable endotoxin when endotoxin was in-
cubated in either 50% rat blood in Schimassek's solution or incubated 
in whole rat blood for 2 hr at 37oc (Samples 5 and 6). 
Throughout these experiments the viability of the liver was 
evaluated by observing its gross appearance, recording its changes in 
perfusion resistance and perfusate flow, recording the rate of bile 
production, and examination of histological slides prepared from each 
liver. ·The mean rate of bile production for each of the 3 groups of 
experiments is listed in Table 21. The gross appearance and perfusate 
flow were not noticeably different than observed in livers perfused in 
the absence of added endotoxin. The histological appearance of the 
livers perfused in these experiments were not different from livers 
of.control rats fixed at the time of removal from the body except for 
the absence of blood cells and slightly lighter staining cytoplasm in 
H and E stained sections. 
r 
TABLE 21 
BILE PRODUCTION BY RAT LIVER PERFUSED wITH ENDOTOXIN CONTAINING PERFUSATEsa 
Cumulative Bile Collected ( 1 per liver) 
Balanced Salt 50% Rat Blood 
Time Perfused Balanced Salt Solution followed in Balanced 
(min) Solution Onlyb by 10% Rat SerumC Salt Solutiond 
15 186e 184 156 
+ 7f + 8 +44 
30 394 374 344 
+22 +42 +104 
45 598 590 592 
+16 +12 +128 
60 768 729 821 
+20 + 5 +140 
75 849 1,134 
+21 +220 
90 929 1,354 
+35 ! I') -
-r """"""' 
105 1,017 
+ 44 
120 1,121 
+ 58 
I-' 
........ 
........ 
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Footnotes to Table 21 
a. The bile duct of each rat was cannulated near the porta hepatis with a blunt piece of 27 
gauge needle cannula attached to a length of PE-20 tubing (Clay-Adams Intramedic) just 
prior to surgical isolation of the liver for the perfusion experiments shown in Tables 
18, 19, and 20. Bile was collected in macro-Wintrobe hematocrit tubes during the per-
fusions. · The hematocrit tubes were calibrated for volume by weighing before and after 
addition of mercury to various division marks. Cumulative bile production was re-
corded at 15 min. intervals. 
b. C umulatiVe bile production in 6 livers from which data is shown in Table 18. 
c. Cumulative bile production in 3 livers from which data is shown in Table 19. 
d. Cumulative bile production in 2 of the 3 livers from which data is shown in Table 20. 
e. Mean bile production in microliters per liver. 
f. Standard error of mean 
t-' 
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
The present studies were undertaken to a~3ess the relationships 
between host resistance to lethal endotoxemia, the marked alterations 
of carbohydrate metabolism characteristic of endotoxicosis, and endo-
genous insulin secretion. Three primary questions were posed: 
1.) How is resistance to lethal endotoxin shock influenced 
by the insulin state? 
2.) How does insulin affect and relate to the characteristic 
carbohydrate depletion of lethal endotoxin shock? and 
3.) How does insulin affect the host-defense functions of 
the reticuloendothelial system during endotoxemia? 
The ensuing discussion will focus on each of these three primary ques-
tions and relate the findings of this study to the results of previous 
investigators. Lastly a hypothesis which presents a unifying schema 
of the role of insulin in endotoxin shock is presented and discussed. 
179 
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RELATION OF ENDOTOXIN SHOCK RESISTANCE AND THE INSULINEMIC STATE 
The first major question posed in this study was - How is the 
insulinemic state related to resistance to lethal endotoxin shock? This 
question arose as a result of previous findings (57, 182, 200, 204, 574, 
575) that the hypoglycemia of both lead-sensitized and non-sensitized 
animals given a lethal dose of endotoxin was so severe as to suggest a 
casual relationship to death. In a logical approach to remedy the hy-
poglycemia attempts were made to protect rats from lethal endotoxin 
shock by treatment with glucose. Although some subjective improvement 
in clinical condition occurred during the time of glucose therapy and 
indeed while glucose treatment may have lengthened the median survival 
time, a protective effect of glucose was not demonstrated by any of 
several protocols employed. The p~eliminary results suggested that 
glucose treatment may have actually increased endotoxin shock lethality; 
perhaps due to its insulinogenic actions. However, in connnon with pre-
vious investigators who failed in their attempts to protect animals 
from endotoxin by glucose replacement (45, 50, 57, 182, 574) the con-
trol lethality was so high (80-100%) that differences did not reach 
statistical significance. A second observation which suggested an in-
sulin involvement was that overnight fasting resulted in significant 
protection from lethal endotoxin shock (83, 84, 204). Lastly, mani-
pulations such as treatment with lead acetate or adrenalectomy, which 
acutely sensitize animals to endotoxemia (198, 199, 318, 571) and 
accentuate the hypoglycemic response to endotoxin (45, 200, 318) also 
sensitize to the hypo$lycemic effect of insulin (78, 84, 151, 409). 
Based on these observations as well as the published reports of others 
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(50, 56, 57, 138, 167, 210, 514, 515, 574, 577, 598) lethality experi-
ments were conducted to assess the role of insulin in endotoxin shock. 
A. Effect of Glucose Injection, Fasting, and Mannoheptulose 
Treatment on Endotoxin Shock Lethalit1 
Overnight fasting, which markedly depresses insulin secretion 
(92, 460, 519, 528, 644, 669) provided a significa~1t protection from 
lethal endotoxin shock (Table 1, Figure 1). This finding is consistent 
with the original reports from this laboratory (83, 84, 204) dealing 
with effects of fasting on endotoxin shock lethality. Since glucose is 
the dominant regulatory influence on insulin secretion (92, 103, 216, 
224, 368, 400, 429, 519, 528, 609, 635, 669) both fed and fast~d rats 
were treated with an insulinogenic dose of glucose. Glucose treatment 
increased endotoxin shock lethality in both fed and fasted rats whether 
it was given at the same time as endotoxin or later in the shock syn-
drome (Tables 1 and 2, Figures 2,3, and 5). The increases in lethality 
were statistically significant only when the control shock lethality 
was not excessively elevated. As compared in Figures 2 and 3, the in-
crease in lethality wa~ greater and more consistent in the overnight 
fasted rats treated with glucose. This may be due to a greater rela-
tive effect of glucose on insulin levels in fasted rats, since fasting 
depresses control insulin levels and may attenuate the endogenou~ hy-
perglycemic response to endotoxin injection. These results with glu- -
cose sensitization and fasting resistance suggested that endotoxin 
shock lethality could be increased by stimulating insulin secretion. 
To gain further insight into the possible role of insulin in 
animals .treated with only endotoxin, mannoheptulose was employed to 
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depress insulin secretion. It should be noted that mannoheptulose se-
lectively and reversibly depresses insulin secretion in vivo (223, 509, 
588-590) in the rat and the degree of suppression is a function of the 
dose (369). However, this sugar is not metabolized in the rat (479). 
Furthermore, in vitro studies have shown that this inhibition of in-
sulin secretion is a direct action on the pancreatic islets (128, 422, 
424, 588, 645). Although most effective in suppressing glucose stimu-
lated insulin release (588) mannoheptulose is also effective in depres-
sing the insulinemic response to non-carbohydrate metabolites (415, 
588). Mannoheptulose does not influence the metabolism of non-pan-
creatic rat tissues even at a 3:1 molar ratio to glucose and has no 
influence on the action of insulin of rat tissues (115). Thus any in-
fluence of mannoheptulose on endotoxin shock lethality would be expected 
to be a result of depressed insulinemia. Mannoheptulose treatment was 
found to significantly protect rats from lethal endotoxemia (Tables 1 
and 2; Figures 4 and 5). The greatest protective effect was seen in 
fasted rats where the depressed hyperglycemic response to endotoxin 
(204) would not as strongly counteract mannoheptulose suppression of 
insulin secretion (588). To further evaluate the interpretation that 
glucose treatment sensitized rats to lethal shock by stimulating in-
sulin secretion, the results of combined glucose and mannoheptulose 
treatment were evaluated (Table 2 and Figure 5). In this experiment 
with a larger number of animals the sensitization produced by glucose 
at the 2 mg endotoxin dose was found to be statistically significant. 
As in the previous experiment mannoheptulose protected rats from en-
dotoxin shock. In the group which received both mannoheptulose and 
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glucose, a significant protection was observed which suggests mannohep-
tulose to be the dominant component of the combination. The.se results 
indicate glucose treatment had no significant effect on endotoxin shock 
lethality in rats in which insulin secretion had b~en suppressed by 
mannoheptulose treatment, and considerably strengthen the hypothesis 
that insulin is a key mediator in the mechanism by which glucose treat-
ment leads to increased sensitivity to endotoxin shock. 
In agreement with these studies Shands et al. (577) using mice 
made hyper-reactive to endotoxin by systemic BCG infection reported that 
an iv dose of glucose (10 mg/20 gm) given 90 min. after endotoxin pro-
duced a severe reactive hypoglycemia from which the mice did not re-
cover. These workers (577) found that while mannoheptulose treatment 
(200 mg/100 g) prevented the severe reactive hypoglycemia, no increase 
in long term survival was observed in their infected mice. However, as 
stressed by Berry (50) and evident in the published data (56, 574, 575, 
577, ·623) endotoxin shock in BCG infected animals differs considerably 
from that in non-sensitized animals. BCG infected mice usually die 
within 4 hrs with hypoglycemic convulsions accompanying death; normal 
mice seldom die before 12 hrs after endotoxin (50). Shands et al. 
(575) concluded that these early convulsive deaths were due to impaired 
gluconeogenesis which was thought to be a result of acute hepatic nec-
rosis following endotoxin treatment of BCG infected mice (576). In 
our experiments glucose treatment did not cause a reactive hypoglycemia 
(Table 6) and glucose treated animai"s seldom died before 12 hrs after 
endotoxin treatment; this sequence was similar to the time when the 
saline treated animals in these experiments died. This time of death 
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is also comparable to previous reports (198, 202). Thus although Shands 
et al. (577) found glucose to sensitize BCG infected mice to lethal 
endotoxemia, the above cited differences suggest that the mechanism was 
different from that observed in our experiments. 
Boruchow et al. (74) found that tryptophan given in glucose 
solution orally increased endotoxin shock lethality from 52% to 100%, 
whereas the same dose of tryptophan had no effect when given iv (56% 
mortality). However, these authors attributed the difference to the 
route of administration of the amino acid and did not consider: (i) 
the variables involved with glucose administration, (ii) that trypto-
phan directly sti~ulates insulin secretion (180, 214) and potentiates 
glucose stimulated insulin secretion (40, 180, 519, 669), nor (iii) 
that amino acids elicit a greater insulin response when given orally 
than intravenously (180, 215, 669) due to the secretion of gastroin-
testinal hormones (18D, 519, 669). Agarwal (6) has also shown that ip 
treatment of ~ice with leucine significantly increases endotoxin shock 
lethality. Agarwal's (6) finding also supports the hypothesis that 
increased insulin secretion sensitizes animals to lethal endotoxin 
shock; this is of special interest since as well as a potent stimulus 
to insulin release (170, 180, 181) leucine is unique in that it is 
not a gluconeogenic amino acid. 
Theiss and Beller (629) found that when endotoxin was either 
infused into rats with glucose solution or if the endotoxin injection 
was followed by a dextrose infusion both treatments resul te-d in a de-
crease in plasma fibrinogen and an increase in plasma fibrin breakdown 
products compared to saline infused controls. These findings may be 
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a reflection of a more severe shock syndrome. Alternately the apparent 
increase in activation of intravascular coagulation may play a role in 
the pathogenesis of lethal shock in glucose treated rats. 
Smith and Dubos (597) assessed the influEnce of fasting on the 
resistance of mice to lethal infection and found a significant effect 
in that glucose treatment of fasted mice decrease~ their resistance to 
lethal infections while lactate protected the mic~. Glucose treatment 
did increase the number of bacteria which were recovered from the liver 
and spleen which suggested a possible defect in reticuloendothelial 
bactericidal function. 
B. Effect of Insulin and Beta-cytotropic Agents on Endotoxin 
Shock Lethality 
The findings of investigations cited above and the results 
presented in Tables 1 and 2 indirectly, suggested a role of insulin in 
resistance to lethal shock; therefore the influence of insulin per se 
on endotoxin shock sensitivity was examined. The experiment shown in 
Table 3 and Figure 6 assessed the sensitivity of ehdotoxin treated 
rats to insulin under conditions independent of any influence of feeding 
or treatment with glucose or mannoheptulose. Endotoxin shock lethality 
was increased at least four-fold to near 100% by treatment with either 
of the 2 beta-cytotropic sulfonylurea agents; exogenous insulin simi-
larly augmented lethality. These agents proved effective at doses 
which were never lethal to control rats treated with iv saline (Table 
3) or sodium acetate (84). These results suggested that endotoxin 
shock lethality could be strikingly increased by endogenously secreted 
insulin and demonstrated that small doses of insulin markedly sensitized 
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rats to lethal endotoxin shock. However, when pharmacological manipu-
lations are used to assess physiological mechanisms due consideration 
must be given to the actions of the drug on the systems under study as 
well as other influences in the body. The most prominent pharmacological 
effect of tolbutamide and tolazamide is their stimulatory influence on 
beta-cell insulin secretion which most effectively increases the in-
sulinemic response to a glucose stimulus (411, 635). Extra pancreatic 
effects have been described in both in vivo and in vitro experiments. 
However, as revealed in the reviews of Feldman and Lebovitz (186), 
Madsen (420), and Loubatieres (411) the extra-pancreatic effects of 
sulfonyi.ureas which have been demonstrated in vivo in acute experiments 
appear to be all either attributable to an insulin-like effect of these 
agents or to a sensitization of tissues to-the actions of insulin. 
Also, experiments which have shown extra-pancreatic effects of sulfony-
lureas have almost exclusively used either adrenalectomized, pancrea-
tectomized, or diabetic animals or patients (186, 187, 411, 420). It 
is thus unlikely that the sensitization due to tolbutamide was due to 
extra-pancreatic effects; and since no such effects of tolazamide have 
been observed in similar in vivo experiments, it is likely that the 
sensitization produced by these agents was a direct result of their 
stimulation of endogenous insulin secretion. The similar results with 
small doses of exogenous insulin lend support to this view. 
The finding of an influence of sulfanilamide derivatives on 
shock lethality has been previously reported. In 1942 Hunter and 
Zahl (331) investigated the influence of a number of such agents on 
endotoxin shock lethality in mice and suggested that these compounds 
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may compete for the enzymes concerned in the detoxification of bacterial 
toxins. More recently, Kovacs and coworkers (365, 366) found tolbutamide 
·increased the sensitivity of rats to a number of vasoactive amines which 
have been postulated to be mediators of endotoxin :oxicity (253, 314, 
476, 530, 650, 651). Kovacs et al. (365, 366) postulated that the sen-
sitizing action of tolbutamide was a direct conseq~ence of insulin se-
cretion. Pieroni and Levine (514) were the first to report that treat-
ment with insulin sensitized animals to endotoxin. Using a dose of 33 
Units per kg they observed increases in endotoxin lethality comparable 
to those observed in this study using a dose of 0.8 to 1.6 Units per 
kg. They suggested that the sensitization produced by insulin was the 
result of the combined hypoglycemic activity of endotoxin being poten-
tiated by the well known hypoglycemic activity of insulin. The results 
of the present study do not support this contention since no insulin 
like activity of endotoxin was found in vivo when the insulinemic re-
sponse to endotoxin had been inhibited by treatment with either strepto-
zotocin or mannoheptulose (see below). Shands et al. (577) found that 
BCG infected mice were sensitized to insulin and that insulin sensitized 
BCG infected mice to lethal endotoxin shock. Unfortunately, no data 
were presented concerning the insulin sensitivity of non-infected mice 
treated with endotoxin. Finally, since endotoxin shock has long been 
known to resemble in many ways the .hypersensitivity response to a com-
mon bacterial antigen (49, 612) and indeed has been postulated to be 
the result of the liberation of the same endogenous mediator substances 
(143, 253, 314, 450, 451, 476, 485, 530, 650, 651), these results might 
be interpreted in this frame of reference. The correlation between 
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glycemia and immune responses was first carefully defined by Adamkiewicz 
(3) in his provocative review of this literature and analysis of the 
complex relationships. Endotoxin shock would correspond to a parahyper-
sensitivity phenomenon or "anaphylactoid shock" re3ction in his classi-
fication and it was in this type of reaction that the correlation be-
tween glycemia and resistance were most strongly l~nked. Also included 
in this class is the sensitization produced by BoLdetella pertussis 
vaccination and the shock-like states produced by histamine and sero-
tonin. Adamkiewicz (3) suggested that procedures which increase the 
glycemic state such as growh hormone, cortisol, glucagon and adrenaline 
treatment or diabetes inhibit anaphylactoid reactions whereas decreased 
glycemia resulting from fasting, adrenalectomy, or insulin treatment 
sensitize to anaphylactoid reactions. It is interesting to note that 
those procedures which increase resistance to parahypersensitivity re-
actions also produce resistance to endogenous insulin (169, 669) and 
that adrenalectomy sensitizes to insulin (78, 151, 170, 403, 409). 
Adamkiewicz (4) also showed that endogenous insulin sensitized to 
anaphylactoid reactions and through the .employment of tolbutamide he 
presented strong evidence against any non-beta cell effects by showing 
that it did not sensitize alloxan diabetic rats while insulin treatment 
was effective in sensitizing diabetic rats. Leme et al. (397) have 
recently affirmed Adamkiewicz's suggestion that the mechanism of tol-
butamide sensitization was a result of insulin secretion in a ~tudy 
showing that insulin intensified the microcirculatory derangements of 
parahypersensitivity reactions. These findings are supported by 
Koltai et al. (364) who also found insulin to aggravate the disruption 
r 
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of microcirculatory function as did the other endotoxin sensitizing 
agents, actinomycin D and cycloheximide (50, 513, 572). Gulbenkian 
and coworkers (284, 370, 624) have studied the metabolic basis by which 
pertussis vaccination sensitizes to anaphylactoid reactions and have 
suggested a prominent role of hyperinsulinemia accompanied by depressed 
glucose release in this phenomenon. Muszbek and ~ssociates (140, 471-
474) also suggested a role of increased insulin secretion in the severe 
hypoglycemia observed in pertussis vaccinated rats in shock. These 
investigators suggested an increased sensitivity to endogenous insulin 
hypoglycemia to be an important mechanism in pertussis sensitization. 
Pierbni and Levine (515) suggested that the mechanism by which insulin 
treatment sensitized mice to anaphylactoid reactions was the same as 
that of pertussis vaccination. The striking increase in sensitivity 
of pertussis vaccinated animals to endotoxin was first observed by 
Parfentjev (505) and has since been repeatedly confirmed (50, 213, 470, 
574, 575, 577, 623) however, metabolic studies in pertussis sensitized 
animals given endotoxin have not been reported (50). Since a sig-
nificant factor in endotoxin-toxicity is believed to be the hypersen-
sitivity-like response, the finding of a relationship between insulin, 
glycemia, and sensitivity to anaphylactoid reactions in the above 
cited literature lends credence to the postulated role of insulin in 
endotoxin shock and support the interpretation given the experimental 
results shown in Figures 4 and 6. 
Although it is suggested that insulin enhances endotoxin shock 
lethality at least in part by potentiating the endotoxin induced de-
rangements in carbohydrate metabolism (see below), other actions of 
--
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insulin may also contribute to the pathogenesis of endotoxin shock. 
Endotoxin is known to activate the coagulation cascade (121, · 
461) and disseminated intravascular coagulation may thus play a role 
in shock (304, 320, 321, 476); this view is supported by the observa-
tion that heparin treatment protects rats from endotoxin (206, 320). 
As summarized by Martin and Tilsner (431) a growing body of evidence 
indicates that insulin increases thrombokinase ac~ivity and increases 
platelet aggregation. Insulin also depresses fibrinolytic activity in 
the rat (382, 383). These effects would be expected to potentiate the 
defects in coagulation observed in endotoxemia. This is not a pharma-
cologic effect or stress induced response. Insulin induced alterations 
in the coagulation - fibrinolysin system can be observed during oral 
glucose tolerance tests in non-diabetic patients (299). 
Insulin treatment also causes intensive secretory activity of 
the adrenal medulla cells of the rat with increased in vitro endocytic 
activity (1), elevated levels of catecholamines are thought to be one 
of the mediators of endotoxin toxicity while their eventual depletion 
has been suggested to be one factor responsible for the terminal hy-
potensive phase (209, 253, 314, 476, 501). 
In~ulin is also the most potent natural inhibitor of the lung 
and plasma enzymes responsible for the degradation o.f bradykinin and 
conversion on of angiotensin I to II (332). Insulin may thus depress 
the degradation of bradykinin which is thought to be an important me- . 
diator of endotoxin shock (253, 314, 450, 451, 476, 485) and is known 
to cause severe circulatory derangements. Also, insulin may prevent 
the conversion of angiotensin I to II and the beneficial effects of 
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exogenous angiotensin I infusion (476) could not be expressed by ele-
vated renin activity in shock. A potential positive feedback system 
exists since while insulin inhibits bradykinin degradation (332), brady-
kinin also inhibits insulin degradation by the inrulin specific pro-
tease (81, 82) responsible for the degradation of insulin in the rat 
(87, 161, 363). The possible role of vasoactive substances in the de-
velopment of lethal endotoxemia receives strong Support from the labo-
ratory of Fine (143, 144) where it has been shown that infusions of 
bradykinin or biogenic amines initiate the perpetuation of the shock 
syndrome and result in lethal endotoxemia. 
Insulin may also play a role in the elevation of lysosomal 
enzymes observed in endotoxin shock. Insulin increases the activity 
of hippuryl-L-lysine hydrolase in the plasma of shocked dogs and this 
action can b.e suppressed by corticosteroid treatment (477). Insulin 
also increases the permeability of the blood brain barrier (22, 674, 
691) and this increase in cellular membrane permeability may be a 
factor in the altered neurotransmitter metabolism observed in the 
brains of rats given endotoxin (518). Finally as well as aggravating 
the injuries produced by endotoxin insulin may also impair restorative 
processes since it delays wound healing in rats (546). 
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MECHANISM OF INSULIN SENSITIZATION TO LETHAL ENDOTOXIN SHOCK 
The second major question posed in this study was, how does 
insulin depress endotoxin shock resistance and impair the maintenance 
of carbohydrate homeostasis in shock? Based on two well-documented 
hepatic effects of endotoxin and insulin,. a worki·1g hypothesis was 
constructed and experimentally evaluated. The two key premises of 
this hypothesis were as follows: First, Berry and coworkers (49, SO, 
Sl, S4, SS, 542) as well as others (598) using in vivo models and 
Agarwal and his associates (5, 6) using the isolated perfused liver 
have demonstrat'ed an "actinomycin D-like" action of endotoxin. In 
the context of Berry this action alludes to the ability of endotoxin 
to inhibit the expected increases in hepatic enzyme activity in re-
sponse to either physiological or pharmacological stimuli. Recent 
studies haveconfirmed that this inhibition of hepatic enzyme "induction", 
like that due to actinomycin D treatment, is largely due to a depression 
of specific enzyme protein synthesis (51, 542). However, unlike ac-
tinomycin D, endotoxin selectively inhibits the synthesis of enzymes 
with half-lives of as short as 2 hrs and which are normally at ele-
vated levels after treatment with hormones which increase hepatic 
gluconeogenesis.(50, 51, 542). Phosphoenolpyruvate carboxy kinase 
(PEPCK), a probable rate limiting enzyme of hepatic gluconeogenesis 
in the rat (173, 483, 567, 657), is an example of such a short half-
life enzyme which is both stimulated by either treatment with hormones 
which increase gluconeogenesis (294, 357, 511) or by fasting (512, 
620) and whose synthesis in response to these stimuli is prevented 
by prior endotoxin treatment (50, 51, 55, 167). It is important to 
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note that the inhibition of hepatic gluconeogenic enzyme synthesis is 
not· an immediate effect of endotoxin but develops over a period of 
several hours (49, 50, 51, 54, 55). Furthermore, other enzymes such 
as tyrosine- ketoglutarate-transaminase and py1uvate kinase, which 
are stimulated by insulin treatment (250, 251, 357, 367) show increased 
levels after endotoxin treatment (49, 50, 54, 55 598). 
Second, insulin is known to be a suppre~sor of the biosynthesis 
of a series of hepatic gluconeogenic enzymes which are induced by treat-
ment with hormones which increase hepatic gluconeogenesis (294, 661, 
657-659). Insulin also prevents the normal rise in PEPCK in the post 
absorptive state (620). Insulin at concentrations as low as 2 x lo-11 
molar -- i.e., in vivo concentrations -- inhibits both the dibutryl 
cyclic AMP and dexamethasone stimulation of hepatic PEPCK activity 
(661). Insulin's influence on hepatic gluconeogenic enzyme levels is 
not limited to altering their rates of synthesis, since glucose treat-
ment is more effective than puromycin in depressing hepatic PEPCK ac-
tivity in vivo. Foster et al. (219) ascribed this to an increased 
rate of enzyme degradation. This possibility has only recently been 
assessed by Hopgood et al. (322) and it now appears that the degra-
dation rate of PEPCK in the liver is subject to hormonal-metabolic 
regulation; the fed state was associated with a 60% decrease in the 
enzyme's biologic half-life. The increased degradation rate could 
not be reversed for several hours despite treatments which increase 
the rate of synthesis (322). More recently Tilgham et al. (631) have 
shown that endogenous insulin is requited for the alterations in PEPCK 
metabolism. 
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Given the above observations that (i) endotoxin will prevent 
the induction of hepatic gluconeogenic enzymes some hours after its 
administration and (ii) that insulin rapidly depresses the synthesis 
of hepatic gluconeogenic enzymes and increases t 1ie rate of degradation 
of preformed enzyme protein for a period of several hours, a mechanism 
by which insulin plays a role in the development of the altered car-
bohydrate metabolic homeostasis characteristic 0£ endotoxemia was for-. 
mulated. It was hypothesized that if increased levels of insulin oc-
curred early in endotoxemia either in response to endogenously generated 
hyperglycemia or following treatment with glucose or other insulinemic 
stimuli, then carbohydrate metabolism would be perturbated in at least 
two important ways. First, in the early phase, elevated insulin levels 
would increase the rate at which the body pool of carbohydrate stores 
would be depleted, and second, at this early time insulin would also 
depress the synthesis of gluconeogenic enzymes and the existing enzyme 
protein would be more rapidly degraded be fore the onset of the secondary 
inhibition of enzyme synthesis due to endotoxin would become manifest. 
Thus an increase in insulin levels would depress the gluconeogenic 
capacity of the challenged host even after the insulin levels are no 
longer elevated. As will become evident the metabolic and endocrine 
alterations in endotoxemia are probably much more complex. However, 
this working hypothesis served as a conceptual basis in assessing 
the possible role of insulin'in the pathogenesis of th~ altered car-
bohydrate metabolism secondary to endotoxemia. 
A. The Influence of Glucose Treatment on Hepatic 
Gluconeogenesis and Glycogenesis in vivo 
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This hypothesis was first examined by an assessment of the 
effect of glucose treatment on gluconeogenesis and hepatic glyco-
genesis. A parallel study in non-endotoxin treated rats was required 
(Table 4) not only as an adequate control for tPe experimental groups 
but also since the effectiveness of glucose in suppressing these 
functions under the conditions of these experime~ts has not been pre-
viously reported. The first point worthy of note is that a significant 
acute reduction in liver weight was observed in endotoxemia (Table 4). 
Therefore, in order to assess the total contribution of the liver in 
host defense to endotoxemia the data in this study were reported both 
on the basis of total liver weight as well as in the more conventional 
per gram basis. In the glucose control rats (Group 2, Table 4) the 
significant incre?se in liver weight is attrtbuted to glucose treat-
ment since in all other ways they were treated as the Group 1 controls 
which received saline rather than glucose. The glucose treated rats 
which had received endotoxin showed no increase in liver weight over 
their endotoxemic controls (Group 3) which was consistent with .their 
failure to exhibit significant increases in liver glycogen. The 
fasting blood glucose in the saline controls (Group 1) was ~omparable 
to that previously reported from this laboratory (83, 204)_and other 
experiments in this study (Table 6). The significant rise in blood 
glucose following alanine treatment is consistent with previous 
studies using this and similar models (130, 204, 305, 594). In con-
trast to Group 1 the pretreatment of saline iv rats with glucose 
(Group 2) 2-3 hrs before the alanine produced the following changes: 
(a) hyperglycemia was present at the time of alanine injection--to 
r . . 
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the same degree as in the experiment shown in Table 6, (b) alanine 
treatment caused no increase in blood glucose, (c) incorporation of 
alanine carbon label into blood glucose and blood glucose specific 
activity was depressed, and (d) a marked depresJion in liver glycogen 
spec_ific activity occurred due to the high glycogen levels with un-
altered incorporation of alanine carbon label. Most of these changes 
are attributable to the hyperglycemia and conccillitant elevated insulin 
levels. The above data are consistent with the early observation of 
Bach and Holmes (30) in 1937 when they reported insulin to be a potent 
inhibitor of alanine gluconeogenesis in rat liver. The depressive 
effect of insulin on hepatic gluconeogenesis has been repeatedly con-
firmed (150, 173-175, 260, 339, 418, 443, 449, 452, 463, 475, 506, 507, 
595, 609, 657) and dose-response studies have shown physiological 
levels are effective (116, 173, 418, 595, 609, 643). Another impor-
tant mechanism by which insulin depresses hepatic gluconeogenesis 
in ~ is by lowering the plasma levels of gluconeogenic amino acid 
substrates (173, 192, 194-196, 609), as first reported by Luck, Morrison 
and Wilbur (414) in 1928. Since in our experiments depressed gluco-
neogenesis was observed after an exogenous alanine load, an insulin 
mediated inhibition of substrate release from peripheral tissues (93, 
94, 173, 337, 524) is unlikely; however, an increased uptake of amino 
acids into extrahepatic tissues (20, 92, 541, 618) and the stimula-
tion of protein synthesis (218, 407, 449, 681) may have influenced 
the fraction of the alanine load available for gluconeogenesis. The 
finding of depressed gluconeogenesis (Group 2, Table 4) in conjunction 
with no difference in alanine carbon label incorporation into hepatic 
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glycogen may be attributed to the hyperglycemia as well as the ex-
pected insulinemia. Glucose, even in the absence of increased in-
sulin can depress the net release of glucose from the perfused liver 
(86, 90, 550) as well as activate glycogen syn~hetase in vivo and 
promote the deposition of glycogen (154, 173, 260, 288, 307, 434) 
independent of changes in cyclic AMP levels (90, 621). Furthermore, 
glucose-6-phosphatase is inhibited by glucose (29, 39, 327, 328) 
which in turn preferentially directs hexose phosphates toward gly-
cogen formation and depresses net glucose release by the liver (26, 
27, 327, 328). 
B. Influence of Endotoxin on Hepatic Gluconeogenesis and 
Glycogenesis in vivo 
Blood glucose values at both the time of alanine injection 
and 30 min. after alanine were significantly depressed when rats 
were treated with endotoxin (Group 3 vs Group 1, Table 4). However, 
the blood glucose activity and specific activity were elevated by 
endotoxin treatment. At least two general mechanisms may account 
for these divergent results (288): (i) an increased turnover rate 
of blood glucose with relatively greater incr~ase in the rate of 
disappearance than the rate of appearance occurred in endotoxemic 
rats, or (ii) a preferential utilization of the injected alanine 
as a gluconeogenic substrate occurred in the endotoxin treated rats. 
When both insulin and gluconeogenic hormones are elevated the turn-
over of blood glucose is markedly increased (116). Our data show 
that insulin levels are elevated at this time after endotoxin (Table 
7) and increases in glucagon in stress (67, 68, 296, 380, 406, 416, 
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439, 643, 671) including infections (41, 544, 560) and endotoxemia 
(67, 68) and shock (406) are well documented. Similarly, elevations 
in sympathetic activity and circulating catecholamines are believed 
to occur in endotoxin shock (208, 209, 253, 314, 476, 530). The com-
bination of elevated insulin, glucagon, and epinephrine would be ex-
pected to contribute to an increased rate of glv~ose turnover in shock 
and experimental evidence supports this contention (120, 160, 287, 
319, 408, 410, 490, 605, 606, 664-666). Insulin is probably a necessary 
component of the increased uptake of glucose by peripheral tissues in 
shock as first -reported in muscle by Drucker and DeKiewiet (160) since 
insulin is required for anoxia stimulated glucose permeation of muscle 
(275). Epinephrine also increases glucose turnover (312, 313) and it 
has recently been shown that epinephrine directly increases the per-
meability of muscle cell membranes to glucose through an alpha-adre-
nergic mediated mechanism (555). The possibility of preferential uti-
lization of alanine as a gluconeogenic substrate is suggested by the 
observation that although alanine label incorporation into blood glu-
cose was elevated, a significant hypoglycemia occurred at the time of 
alanine injection and persisted 30 minutes after alanine injection 
(Table 4). Further experiments would be required to assess the pos-
sibility that endogenous substrate supply to the liver was a factor 
limiting gluconeogenesis prior to alanine treatment. As expected 
from previous studies in this laboratory (130, 204) liver glycogen 
was near totally depleted in endotoxemic rats (Table 4). Similar 
findings in mice have been reported by Mccallum and Berry (434). 
In the Group 4 rats the finding of a significant hypoglycemia 
r . . 
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2 to 3 hrs after glucose treatment was unexpected (Table 4). The 
possibility that the hypoglycemia was due to depressed gluconeogenic 
capacity was supported by the finding of no significant increase in 
blood glucose after alanine injection and a dep:essed incorporation 
of label into blood glucose. Since liver glycogen values were not 
different from those in Group 3 (Table 4) the f~te of the 400 mg glu-
cose load was not evident and conversion to lactate and/or oxidation 
were suggested. The data in Table 4 were interpreted as demonstrating 
that glucose treatment impaired gluconeogenic capacity in endotoxemic 
rats. As discussed above with respect to the hyperglycemic Group 2 
rats insulin could produce such effects. 
C. Insulin Immunoassay 
An assessment of the radioimmunoassay used in this study is 
shown in Table 5. The method used was essentially that of Velasco 
et al. (648) and employed anti-insulin-antibody covalently coupled 
to Sephadex as originally developed and described by Wide and co-
workers (662, 663). Recently Bolton and Hunter (73) evaluated this 
technique and compared it with others and suggested it to be the 
method of choice for a number of radioimmunoassay procedures. Por-
cine insulin was used as the standard due to the limited availability 
of purified rat insulin. Possible differences in cross-reactivity of 
antisera were prevented by using a single batch of antiserum in all 
experiments reported in this study. The intra-assay coefficient of 
variation for the serum samples shown in Table 5 is comparable to 
that reported-by others (136, 648) and lower than that found by 
Przybyla (527). The consistency of this technique was evident in 
r 
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the observations that the standard curves were near identical and that 
the inter-assay coefficient of variation was not different from the 
intra-assay values. The inter-assay coefficient of variation of ap-
proximately 8% for the serum samples was similer to that reported by 
Velasco et al. (648) and markedly better than that reported by Cryer 
et al. (136). As has been previously reported there appeared to be 
an influence of hep,arinized plasma which was nrt manifest using serum 
(34, 185, 630). 
D. Blood Glucose Levels in Endotoxemia 
The data in Table 6 demonstrate that overnight fasted rats 
develop a significant hyperglycemia in the early response to endo-
toxin. The slow onset of the hyperglycemia as well as the known de-
pletion of liver glycogen in overnight fasted rats suggests that the 
hyperglycemia was probably due to enhanced gluconeogenesis or depressed 
glucose utilization. The data in Table 4 support the former and 
discount the latter at least later in the shock syndrome :when blood 
glucose returns toward control values. The rapid recovery of the 
blood glucose values in the endotoxemic rats given glucose revealed 
no apparent change in glucose tolerance after endotoxin treatment. 
Although glucose tolerance does not appear to have been previously 
assessed in the acute phase of endotoxemia, the observation of a 
transient hyperglycemia followed by a return to ~ormoglycemia even 
following glucose treatment is consistent with the findings of 
others (280, 285, 286, 342, 503, 526). It may be noted that pro-
nounced hypoglycemia was not evident in this experimental design. 
Probably at least two factors biased this experiment against such 
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a finding. First--at the dose of endotoxin employed, death and the 
accompanying profound terminal hypoglycemia do not usually occur until 
after at least 12 hrs or more after endotoxin even when the rats are 
sensitized by glucose treatment. Second--blooi samples were col-
lected only from rats which survived until their pre-designated 
sampling time and rats were not substituted between sampling times. 
E. Serum Insulin Levels in Endotoxe~ia 
Endotoxemic rats given ip saline or glucose revealed a 
striking elevation of insulin levels and an exaggerated insulin re-
sponse to. glucose following endotoxin treatment (Table 7).. It is 
important to note that serum insulin remained elevated in endotoxemic 
rats_long after blood glucose had returned to or below control values. 
The possibility that elevated levels of irnrnunoreactive insulin were 
an artifact of the assay system appeared remote for several reasons. 
(a) Endotoxin added to serum or to buffer in vitro had no measurable 
influence irnrnunoassayable insulin values, (b) the insulinemic response 
paralleled the blood glucose elevations and dropped as blood glucose 
dropped, even if a second peak in blood glucose was provoked by glu-
cose treatment, and (c) dilution of serum of endotoxemic rats showed 
the same dilution curve obtained with pooled rat serum. 
The finding of elevated insulin levels in endotoxin shock 
carries profound implications concerning the metabolic-humoral re-
sponse to endotoxemia. As recently stressed by Schumer (564) ~he 
evidence of a role of metabolic adaptation in determining survival 
to potentially lethal shock is increasing and the evidence of al-
terations in insuiin and glucagon·secretion, as playing a role in 
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resistance to lethal shock is now evolving. As recently as 1969 
Cuthbertson and Tilstone (146) reviewed the literature on "Metabolism 
During the Postinjury Period" and only one reference to altered pan-
creatic hormone secretion appeared. One year lrter Kinney (359) found 
that conflicting reports had appeared concerning insulin secretion in 
shock. However, despite the growing interest in endocrine pancreatic 
function in shock our findings of elevated insu:in levels in endo-
toxemia can not be compared to any existing literature since insulin 
levels in experimental endotoxemia have not previously been reported. 
However, a number of reports have indicated altered insulin 
levels under conditions which are pertinent to the present study. Im-
munoreactive insulin levels in shock were first studied by Halmagyi 
et al. (240) using a hemorrhage model and it was reported that serum 
insulin levels were not necessarily related to fluctuations in blood 
glucose. Moss and coworkers (464, 465) have found serum insulin le-
vels depressed in both dogs and baboons early in hemorrhagic shock. 
Cerchio et al. (105) confirmed the earlier results of Moss and co-
workers and showed that tolbutamide had only a minimal effect on in-
sulin levels in hemorrhaged baboons. However, in another study 
Cerchio et al. (104) found plasma insulin returned above the base-
line values during the second hour of hemorrhage despite the main-
tenance of hypovolemia; a decrease in blood glucose accompanied the 
rise in plasma insulin. The mean half-time for cle.arance of exo-
genous immunoreactive insulin from the plasma was lengthened which 
suggested to Cerchio et al. (105) that insulin secretion was depressed. 
Vigas and coworkers (652-654) found that the insulin response to 
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glucose was depressed in tumbled rats and the suppression of insulin 
secretion diminished upon establishing trauma tolerance (654). Insulin 
levels were also depressed in humans during surgical stress (9, 10, 
427, 683), after myocardial infarction (9, 162, ~27) during experimental 
hemorrhage (293), and following traumatic shock (101). Cryer and co-
workers (136-139) have reported depressed insuli~ levels in fulminating 
· rapidly lethal E. coli sepsis in the baboon. EgJahl and coworkers 
(309-311, 435, 436) measured the actual rate of pancreatic insulin 
secretion and insulin clearance by the kidney in hemorrhagic shock and 
found that peripheral levels of insulin were not well correlated with 
the actual rate pf insulin secretion and on this basis criticized the 
interpretation that increased plasma insulin always reflects increased 
beta-cell insulin secretion. A partial explanation for this discrepancy 
may lie in the depression of the absolute rate of insulin clearance by 
the kidney observed in their studies. Hiebert et al. (309) also re-
ported the insulin secretory response of adrenalectomized baboons to 
iv glucose was maintained even during epinephrine infusion; however, 
the insulin response was diminished when intact animals were hemorrhaged. 
In contrast to the above cited findings of depressed insulin 
secretion in acute shock, increased insulin levels have been measured 
in shock and stress situations under conditions which may more closely 
resemble the slower, progressive shock syndrome characteristic of en-
dotoxemia under the conditions of the present investigation. Ross 
et al. (547) found much higher levels of plasma insulin and an in-
creased insulinemic response to a glucose stimulus in post operative 
patients; this finding was. corroborated by Johnston et al. (341) who. 
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also attributed the insulinemia to increased ACTH secretion. Elevated 
insulin levels and a correlation of blood glucose and serum insulin 
have also been reported following acute myocardial infarction (375, 649) 
and in patients with cardiac disease (168). The insulin responses 
during hypovolemic shock are controversial. Bauer et al. (38) found 
that the hyperglycemia of acute hypotension was ~ccompanied by ele-
vations of serum insulin and that insulin levels were elevated during 
iv glucose tolerance testing. McCormick et al. (435) also observed 
increased insulin levels and hyperglycemia during hemorrhage in the 
dog and a portion of the elevation was attributed to depressed clearance 
of insulin. Lau et al. (384, 385) reported hyperinsulinemic incident 
to hemorrhage and noted a dissociation of insulin secretion and blood 
glucose in shock. Stake et al. (607) maintain that the hyperglycemia 
of acute hypovolemia is characteristically accompanied by an increase 
in insulin secretion. Increased insulin has also been found in trauma 
(107, 487). Hyperinsulinemia has consistently been observed in ex-
perimental infections in human volunteers and rhesus monkeys (247, 532, 
533, 573) and in a recent review, Beisel (40) stressed the role of 
pancreatic hormones in the regulation of .hepatic metabolism in infec-
tions. Clowes et al. (120) and O'Donnell et al. (490) have also dem-
onstrated hyperinsulinemia in gram negative sepsis in pigs; septic 
patients in the "high flow" state also had marked hyperinsulinemia 
whereas after septic shock had progressed to the "low flow" state 
insulin levels were normal. Insulin levels were also found elevated 
in gram negative sepsis in dogs (280) especially in those animals 
which later developed hypoglycemia and those in which death ensued. 
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Gump and coworkers (285) studied insulin levels and iv glucose tolerance 
in patients very early in the course of sepsis before cardiovascular 
instability developed and found that control insulin levels were ele-
vated and that iv glucose widened hepatic vein-arterial insulin gra-
dients; the latter finding suggested increased insulin secretion. 
Two additional factors which may account for some of the dis-
parities in previous studies of insulin secretio11 in shock were the 
use of heparin and the influence of anaesthetic agents. Recently Orosz 
et al. (496) confirmed previous studies (495) and showed that heparin 
inhibition was a direct pancreatic effect. The use of anesthetics in 
many previous studies may have also influenced insulin secretion. 
Greene (277) recently concluded that many anaesthetics depressed in-
sulin secretion in vivo. In a recent editorial Brunner (80) called 
attention to the depressive actions of anaesthetics on insulin secre-
tion. The sympatho-excitatory and depressive action of anaesthetics 
on insulin secretion is well known (8, 29, 59, 60, 119, 277, 281, 353, 
433, 497, 500). 
F. Possible Factors Underlying Hyperinsulinemia in Endotoxemia 
The hyperinsulinemia accompanying endotoxicosis in undoubtedly 
multi-factorial but six primary determinants are dominant and merit 
detailed discussion. 
i) Depressed Insulin Clearance. One factor which may have 
contributed to the elevated serum insulin levels observed in endo-
toxemic rats is depressed insulin clearance. Using the immunoassay 
technique which accurately reflects endogenous insulin metabolism 
(224, 245, 335, 580) insulin clearance has been studied mainly in 
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hemorrhagic shock. McCormick et al. (435) found that the half-life of 
innnunoreactive insulin was increased in hemorrhagic shock and the 
fractional clearance across the liver was unchanged. It was also re-
ported that the arterial-venous difference acrosr the kidney was un-
influenced by acute hemorrhage but the actual amount of insulin removed 
was severely depressed due to the large decrease in renal plasma flow 
(436). Similarly, Cerchia et al. (105) found thdt the half-life of im-
munoreactive insulin was doubled in baboons subjected to hemorrhagic 
hypotension and noted an important difference in the metabolism of in-
sulin in hemorrhaged as compared to control baboons. While insulin 
steadily declined to control values after insulin infusion in control 
baboons, plasma insulin reached a plateau of about 75J<.U per ml -over 
control values in the shocked baboons. It was suggested that this was 
due to increased insulin secretion as shock progressed (105). The ele-
vated plateau observed following treatment of rats with glucose (Figure 
8) may be related to a similar depression of insulin clearance and 
increase in insulin secretion.· Cryer et al. (138) also studied iv 
insulin during lethal septicemia in baboons and noted an increased mean 
half-time for insulin disappearance from 15.7 min. in controls to 33.1 
min.; however, the.se results may have been influenced by the more rapid 
and severe hypotension, hypotension, and earlier deaths in the insulin 
treated septic baboons. In general the studies of insulin clearance 
in shock are readily explicable since the major organs responsible for 
insulin clearance are the liver (197, 345, 548) and kidneys (232, 354, 
544, 669) and it is well known that blood flow to these organs is re-
stricted in shock (476). Insulin extraction by the liver is also 
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altered by changes in blood glucose (197, 345) however, the possible 
influence of changes in blood glucose in insulin clearance in shock 
has not been investigated. Since epinephrine treatment prevents the 
changes in insulin clearance attributable to charges in blood glucose 
(493), the epinephrine response to shock may similarly suppress glucose 
mediated alterations in hepatic insulin extraction. Sepsis and trauma 
also alter the capacity of various tissues to de~rade insulin (668). 
Since the reticuloendothelial cells of the liver are a major site of 
insulin accumulation (682) and RES activity is depressed in shock, 
the postulated involvement of RES elements in insulin degradation (682) 
may well contribute to the impaired insulin clearance found in shock 
(105, 138, 435). 
ii) Alterations in Beta-Cell Responses to Metabolites. As 
reported in Table 7 insulin was elevated as early as 45 min. after en-
dotoxin--a time when the cardiovascular decompensation incident to en-
dotoxemia in the rat would not be expected to be severe ·(253). Insulin 
levels were also significantly correlated to blood glucose both when 
the hyperglycemia was endogenously generated or when accentuated by 
treatment with exogenous glucose (Table 9 and Figures 11 and 12). 
However, the insulin· response in endotoxemia was probably abnormal 
since the regression analysis (Table 9) showed the increase in serum 
insulin per increase in blood glucose was significantly different in 
endotoxemic rats (Groups 3 and 4 vs Group 2). Beta-cell secretion of 
insulin is influenced by glucose as well as a variety of other meta-
bolites, viz, amino acids (24, 180, 181, 214, 519, 669), free fatty 
acids (33, 102, 133, 134, 419, 519), and ketone bodies (298, 445, 516, 
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519), and these metabolites also potentiate the insulinogenic response 
to glucose (180, 224, 368, 422, 519, 669). However, the roles of 
these metabolites in regulating insulin secretion in shock has not 
been assessed despite the fact that changes in the plasma levels of 
these metabolites occur in shock and therefore they may well play a 
role in the regulation of·insulin secretion in s~ock. Since it is 
well documented that proteolytic and lysosomal r.n.zymes are released 
from the pancreas in shock (257, 292, 293, 295, 296, 604), it is in-
teresting to note that Orci et al. (494) found that mild treatment of 
isolated pancreatic islets with proteolytic enzymes doubled the insulin 
secretory response to glucose and it may well be that enzymes released 
from hypo-perfused tissues such as the pancreas sensitize the beta-
cells to glucose in vivo. 
iii) Altered Hormonal Regulation of Insulin Secretion in 
Shock. Insulin secretion is influenced by alterations in hormonal le-
vels--viz, gastrointestinal hormones, gut glucagon, pancreatic glucagon, 
or ACTH (85, 135, 180, 224, 368, 398, 519, 529, 535, 638, 669). The 
influence of gastrointestinal hormones in altering insulin secretion 
in shock has not been explored; however, the possibility exists that 
these hormones may well be released during splanchnic ischemia. A 
possible role of pancreatic glucagon as a mediator of the increased 
insulin secretion in shock is suggested by the observation that plasma 
pancreatic glucagon is elevated in stress (67, 68, 296, 380, 416, 417) 
including endotoxemia (67, 68), and sepsis and shock (67, 406, 439, 544, 
560, 643, 671, 680). While glucagon is a potent stimulus to insulin 
secretion (180, 224, 264, 368, 519, 643, 669) and hyperglucagonemia 
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may therefore be a stimulus to insulin secretion in endotoxemia; no 
data however exists to substantiate this effect. Lastly, it is well 
recognized that acute stress rapidly evokes ACTH release (148, 172, 
234, 267, 356, 403, 540, 562, 655). It is now recognized that ACTH 
may have acute effects on insulin secretion in vivo (246, 361, 362, 
388, 491, 669) and in vitro (246, 413, 622). GPauth and Lebovitz (246) 
and others (388) found increases as great as teu-fold in plasma insulin 
within 20 min. after ACTH treatment which were antagonized by manno-
heptulose (246). Unlike the responses with multiple doses of gluco-
corticoids which produce hyperglycemia (362, 562) the elevated 'insulin 
levels following acute ACTH treatment are accompanied by hypoglycemia 
(246, 388) suggesting that ACTH directly stimulates insulin release 
in vivo. Since shock (48, 330) as well as endotoxemia and sepsis (42, 
91, 517) and putative mediators of endotoxin toxicity (82,· 153, 562) 
stimulate ACTH release, insulin release may be altered by this mechanism; 
no evidence exists however to support this notion. 
iv) Serotonin Modulation of Insulin Secretion. Similar to 
the possible role of hormones in modulating insulin secretion in 
endotoxemia, serotonin may play a role in stimulating insulin secre-
tion. Numerous investigators have demonstrated that serotonin modifies 
insulin secretion (184, 188, 233, 389, 399, 628, 642, 672, 680) and 
hypothesized that serotonin may play a physiological role in regulating 
insulin secretion (389, 628, 632, 642, 672). Since doses of serotonin 
as low as 0.5 mg per kg per min. increase the insulin. response to hy-
perglycemia (184), the finding of plasma levels as high as 30ftgm 
per liter in shock (618) might be expected to produce a substantial 
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insulin response. The exact role of serotonin in the insulinemic re-
sponse to endotoxemia however remains to be investigated. 
v) Alterations in Autonomic Regulation of Insulin Secretion. 
The autonomic nervous system has profound influence on the endocrine 
functions of the pancreas (169, 224, 225, 270, 27l, 368, 519, 633, 669, 
680). Since profound alterations in autonomic acti.vity occur in endo-
toxemic stress and shock (143, 208, 209, 302, 314, 315, 393, 395, 476, 
502, 518, 604, 634) the influence of these effects on insulin secretion 
is plausable. Adrenergic depression of insulin secretion was suggested 
as early as 1930 by Colwell and Bright (126; however Chidsey and Dye 
(117) concluded that epinephrine stimulated insulin secretion. La Barre 
(376) also recognized the role of the central nervous system in regu-
lating insulin secretion and attributed the effects to both the release 
of an insulinogenic hormone (377) and direct vagal stimulation (376). 
It was also recognized by Masson (432) that stress influenced the gly-
cemic response to both insulin and epinephrine. Cannon, Mciver, and 
Bliss (96) indicated that the glycemic state had profound influences on 
the activation of the autonomic. nervous system, however, the relation-
ships between autonomic regulation of insulin secretion, glycemia, and 
stress were first systematically investigated by Gellhorn and associates 
(157, 189, 190, 236, 237, 240-244, 258, 686). Hypoxemic stress was 
found to sensitize rats and dogs to insulin hypoglycemia (241, 258) and 
it was shown that hypoxia stimulates the autonomic nervous system (241, 
244). Subsequently it was concluded that stress stimulates the vago-
insulin (parasympathetic) system causing an acetylcholine mediated rise 
in insulin secretion; however in intact animals the sympathetic centers 
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were also activated (189). Furthermore, it was concluded that stress 
induced by a variety of means resulted in a stimulation of both divisions 
of the autonomic nervous system with the vago-insulin stimulation masked 
by the sympathetic activation under severe stress (189, 236~ 686). How-
ever, in later studies (243) it was suggested that insulin was a physio-
logical antagonist to stress and thereby inhibite0 alterations in car-
bohydrate metabolism characteristic of stress. Gd.lhorn et al. (242) 
suggested that hyperglycemia played a physiological role in stress by 
increasing the availability of glucose to the nervous system and thus 
prevented sympathetic dominance while insulin antagonized these adaptive 
changes and further disturbed homeostasis (157). In studies of the phy-
siological relationships of the sympathetico-adrenal and vago-insulin 
activation induced by stress, Gellhorn and coworkers (189) concluded 
that the response to stress was dependent on a "finely tuned" and balanced 
activation of both components of the autonomic nervous system and that 
reduced activity of either component produced a pathological alteration 
which was attributed to overdominance of the other division. Gellhorn's 
concepts of "autonomic tuning" and the simultaneous balanced activation 
of both divisions of the autonomic nervous system are still believed 
valid and have recently been extended (238, 239). The concept of re-
ciprocal innervation is not believed to be applicable to the central 
autonomic regulatory process (189, 238, 239). 
Despite the convincing demonstrations by Gellhorn and coworkers 
and LaBarre on the role of the autonomic nervous system in the regulation 
of the endocrine pancreas, this subject received little attention until 
sensitive radioimmunoassays were developed which permitted the measurement 
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of circulating plasma levels of insulin and glucagon. Porte and co-
workers (520, 521) first directly demonstrated that epinephrine infusion 
depressed the insulinemic response to the accompanying hyperglycemia. 
However, epinephrine infusion did not depress bas81 insulin levels (271). 
Although Porte et al. (520, 521) used pharmacological epinephrine doses 
in their studies (103) other studies have since established a probable 
physiological role of catecholamines in the regul?tion of insulin se-
cretion in vivo (25, 95, 103, 217, 221, 224, 345, 350, 351, 371, 684). 
Catecholamine suppression of insulin secretion is believed to be me-
diated by alpha-receptor activation leading to a depression in beta-
cell cAMP (25, 421, 522, 639, 640, 669). Similarly it has been shown 
that vagal stimulation and cholinergic agents increase insulin secretion 
(43, 149, 225, 226, 349-351, 412, 423, 480, 522, 679), and recent re-
views support the above generalizations (169, 170, 225, 271, 368, 519, 
/ 
523, 635, 669, 680). It should also be noted that the rat is not dif-
ferent from other species in that severe stress or the administration 
of catecholamines depress insulin secretion and plasma levels (217, 224, 
421, 523, 639, 640, 680, 684). From the above cited literature the 
serum levels of insulin might be expected to be depressed during the 
stress of endotoxemia, however as shown in Table 7 serum insulin levels 
were elevated in endotoxemia and insulinemic response to hyperglycemia 
was increased (Tables 8 and 9). Although unexpected, the finding of 
increased serum insulin levels following endotoxin treatment is not 
inconsistent with limited literature on this. topic. Feldman and 
Gellhorn (190) and Gellhorn (237) concluded that typhoid-paratyphoid 
vaccine caused an increase in serum insulin mediated by increased vagal 
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activity. More recently Bloom and coworkers (67, 68) reported no de-
pression of plasma insulin following a pyrogenic dose of endotoxin which 
did elicit an increase in plasma glucagon. Bloom et al. (70, 71) as-
cribed increased glucagon release to stimulation <f vagal efferents to 
the pancreas; a view supported by the observations of Iversen (333) and 
Kaneta et al. (349). It appears probable that in~reased parasympathetic 
activity may have contributed to the hyperinsulin~mia observed following 
endotoxemia. This interpretation receives support by additional studies 
which have demonstrated increased vagal activity in stress and shock 
including endotoxemia (347, 557, 618, 651). In fact, recently Fukuda 
and Hata (230) suggested that most of the toxic manifestations of en-
dotoxemia were a result of increased vagal activity and could be amelio-
rated by vagotomy. Strauss et al. (618) demonstrated that the large 
release of serotonin from the gastrointestinal tract of shocked dogs 
was vagally mediated; the possible role of serotonin as a .mediator of 
the altered insulin secretion in endotoxemia has been discussed above 
(page ). Vagal activation may also be in part responsible for the 
hyperglucagonemia of stress and shock (67, 68, 70, 71, 296, 349, 406) 
since 'cholinergic stimulation has been demonstrated to increase glucagon 
secretion (70, 71, 333, 349). However, it must be kept in mindthat 
there is also substantial evidence of adrenergic regulation of glucagon 
secretion (67, 69, 169, 170, 225, 248, 249, 296, 334, 390, 416, 417, 
430, 680). There may also be alterations in beta-cell neuroreceptor 
mechanisms which cause a reversal of epinephrine action on insulin 
secretion as have been described after treatment with Bordetella pertussis 
vaccine (140, 284, 370, 471-474, 624); however, this possibility has 
l 
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not been explored following endotoxin treatment. From the available 
evidence it appears that both glucagon and insulin levels may be ele-
vated in endotoxemia (Table 7, and 67, 68, 190, 237). 
G. Evidence of Insulin Resistance in EndJtoxemia 
The depressed glucose to insulin ratios in the endotoxin treated 
rats (Table 8) suggested the possibility of a resi~tance to insulin ac-
tion in endotoxemia; a view supported by the lite1ature on insulin action 
in infections and bacteremia (40, 41, 120, 125, 193, 247, 2_56, 285, 490, 
532, 533, 544, 560, 573) and shock and injury (109-111, 146, 286, 287, 
325, 340, 341, 408, 547, 614, 683). In accord with the above cited in-
vestigators, g1ucagon, epinephrine, norepinephrine, ACTH, glucocorticoids, 
growth hormone, elevated free fatty acids; or some other factor may have 
been in part responsible for this apparent resistance; the precise me-
chanism remains unresolved. The possibility of glucagon as an important 
insulin antagonist is intriguing and deserves further investigation. 
As noted above, this hormone is profoundly elevated in stress and shock. 
Frey et al. (222) showed insulin resistance after infusing patients 
with glucagon, and it has been reported that glucagon produces peripheral 
resistance to insulin (151, 216, 222, 609) although the mechanism may 
not be direct (216, 391, 404, 428, 599, 600, 609, 643, 669). The glu-
cose-insulin products calculated in Table 8 applies the· criteria of 
Levine and Haft (400) to the data from endotoxemic rats in that insulin 
level and the blood glucose concentration are both important factors 
influencing glucose utilization and the higher this product, the greater 
is the resistance to the hypoglycemic action of insulin. By these 
criteria it also appears that endotoxemia induces insulin reBistance. 
r 
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However, although the data in Table 8 suggest insulin resistance in en-
dotoxemic rats those in Table 3 paradoxically suggest that endotoxin · 
treated rats are sensitized to insulin. Cryer et al. (139) found similar 
insulin sensitivity in acute~· coli septicemia in baboons. As recently 
noted by Frey et al. (222) who found similar evidence of insulin re-
sistance at near normal blood glucose levels in patients given long term 
glucagon infusions the possibility exists that the insulin measured by 
the radioimmunoassay technique employed was not of full biological ac-
tivity. The apparent insulin resistance observed in this study may be 
due to the immunoassay rather than a defect at the tissue receptor level. 
Insulin may be altered by the proteolytic enzymes released into the ex-
tracellular fluid in shock or alternately the pancreas may release pro-
insulin or some other intermediates which crossreact with many anti-
insulin antibodies but have only a fraction of the biological activity 
of insulin in the rat (360, 690). This possibility can be assessed 
either by the radioreceptor assay of Neville and coworkers (274) or 
more rapidly by simple in vitro bioassay techniques. While no evidence 
exists to suggest that insulin in the serum of shocked animals is in 
any way different from that of non-stressed animals, the possibility 
remains to be explored. 
The analysis of the regression of serum insulin on blood glu-
cose (Table 9) suggested that the threshold blood glucose concentration 
for an insulinemic response was not altered in endotoxemia, in that 
the value of blood glucose at which serum insulin would be predicted 
to fall to zero was similar for.all three groups of rats. A three-fold 
increase in the slopes of the regression lines of the two endotoxin 
r 
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treated groups over that observed in the controls suggests that an in-
creased elevation in serum insulin per increment in blood glucose over 
basal was the cause of the elevated insulin levels in endotoxemia. Glu-
cose treatment of endotoxemic rats had no effect o~ the regression line 
which indicates that the insulinemic response to endogenously generated 
hyperglycemia was not different from that in response to glucose treat.:. 
ment. The relationship in the Group 1 rats which received saline iv 
followed by saline ip (Table 8) was not analyzed since there were no 
changes in blood glucose or serum insulin of the same order of magnitude 
observed in the other 3 groups. This method of comparing the insulinemic 
responses of rats treated with different agents was described by Froesch 
et al. (223), and their extrapolated zero insulin blood glucose inter-
cept was SO mg per dl in rats treated only with glucose; this is in 
close agreement to the values found in this study (Table 9). 
H. Glucose Utilization During Endotoxemia 
The preceding experiments suggested that glucose utilization 
might be increased in endotoxemia and it was expected that elevated in-
sulin levels may play a role in rapid disappearance of glucose in en-
dotoxemic rats. Irreversable glucose utilization as evaluated by the 
recovery of C-14 label as expired 14co2 from rats given uniformly la-
beled 14c-D-glucose was studied in endotoxemic rats and the effects of 
treatments known to influence insulin secretion or action was evaluated 
(Tables 10 and 11). These data (Figures 13 and 14, Table 11) suggest 
that endotoxin treatment induces a hypermetabolic state with respect 
to glucose oxidation. This finding is in contrast to the conclusions 
of other investigators who have used less direct approaches. Berry 
r 
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and Smythe (52) stated there was no evidence of an increase in carbohy-
drate utilization in endotoxemia and the hypothermia of lethal endo-
toxemia suggested a depressed metabolic rate; thus they elected to. 
search no further. Berry (50) has recently affirm-;d his earlier view 
on this topic. Shands et al. (575) considered the possibility that in-
creased glucose utilization may have contributed to the profound hypo-
glycemia which rapidly developed in BCG infected rrice given a lethal 
dose of endotoxin but found no significant influence of endotoxin treat-
ment on net oxygen consumption in either non-infected or ECG-infected 
mice and the disappearance of total 14c metabolites from the blood fol-
lowing iv 14c-U-glucose was not significa·ntly altered by endotoxin treat-
ment of either non-infected or ECG-infected mice. The oxygen consump-
tion experiment is inconclusive with respect to carbohydrate utilization 
and the 14c metabolite disappearance experiment is difficult to in-
terpret since 14c-glucose was not isolated from other labeled compounds 
and the disappearance of 14c-glucose from the blood does not adequately 
reflect 14c-glucose utilization (610). Finally, Shands et al. (575) 
collected 14co2 for 60 min. in non-infected and ECG-infected mice given 
endotoxin and reported that endotoxin did not significantly increase 
glucose oxidation. This finding is in accord with the results in 
Table 11 in that glucose oxidation using a tracer dose of glucose was 
not significantly elevated until after the 150 min. samples. However, 
using an acute septicemia model Long et al. (410) found a two-fold in-
crease in 14co2 recovery from C-14 glucose injection in dogs which 
lends support to our findings. 
When insulin secretion was acutely depressed by mannoheptulose 
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treatment, a significant depression in 14co2 recovery at both glucose 
doses occurred (Groups G vs A and Groups H vs B, Table 11). In insulin 
suppressed rats endotoxin treatment had no significant effect on glucose 
oxidation (Figure 15), a finding which lends support to the notion that 
endogenous insulin played a role in the increased glucose oxidation ob-
served in endotoxemia (Table 11). When rats were ~retreated with manno-
heptulose 4 hr before ip glucose the suppression 0f glucose oxidation 
in non-endotoxin treated rats was very much reduced (Groups K vs G, 
Figure 16 and Groups L vs H, Figure 17). However, the 4 hr mannoheptu-
lose pretreatment protocol was effective in suppressing endotoxin stimu-
lated glucose oxidation (Figure 18); the greater reduction in glucose 
oxidation of endotoxemic rats probably was attributable to a depressed 
excretion of mannoheptulose since glomerular filtration is reduced in 
endotoxemia .(53). The finding of no significant increase in 14co re-
covery following endotoxin treatment of streptozotocin diabetic rats 
(Figure 19) lends. further support to the hypothesis that increased 
serum insulin is a significant factor contributing to elevated rate 
of glucose oxidation observed in endotoxemic rats. The data in Figure 
20 demonstrated that increased glucose oxidation following endotoxin 
treatment was not a low dose phenomenon since the increased 14co2 re-
covery was observed earlier after a high lethality dose of 3 mg endo-
toxin. Although glucose oxidation was increased earlier after the 3 
mg dose than after the 1 mg endotoxin dose (Figure 20) no difference 
was observed when the glucose was given 2 hrs after either endotoxin 
dose (Figure 21); this suggests that the 1 mg endotoxin dose maximally 
stimulated glucose oxidation within 2 hrs after its administration. 
r r 
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Since glucocorticoids have been repeatedly shown to protect 
animals from lethal endotoxemia and it is believed that this protection 
is due at least in part to a inhibition of the carbohydrate depleting 
actions of endotoxin (49, 50, 52, 57, 319, 434, SE+), glucose oxidation 
was studied in endotoxemic rats treated with dexamethasone (Figure 22). 
Dexamethasone alone in saline controls (Group U) c~pressed glucose oxi-
dation--a finding in agreement with the insulin r~sistance secondary to 
glucocorticoid treatment (169, 271, 403, 426, 467, 468, 469, 519, 635, 
669). When dexamethasone treated rats were given endotoxin (Group V) 
no significant increase in glucose oxidation above the depressed value 
observed in dexamethasone treated contrbls was observed (Groups V.vs U, 
Figure 22). This finding suggests that a depression of glucose oxidation 
may be a significant factor in the mechanism by which g~ucocorticoids 
protect animals from the carbohydrate depleting actions of endotoxin 
and thereby prevent lethal endotoxin shock. From the data obtained 
using Noble-Collip drum traumatized rats (Figure 23) it was concluded 
that elevated glucose oxidation was not a common factor in the patho-
genesis of the hypoglycemia observed in this shock model (481). This 
finding is supported by the observation of more severely and rapidly de-
pressed gluconeogenic capacity in this shock model than in endotoxin 
shock (Filkins, unpublished observations) and by the reports of de-
pressed insulin secretion in tumbled rats (652-654). The results ob-
tained in the endotoxemic rats showing increased glucose oxidation in 
shock are supported by recently published results of others who have 
found increased glucose utilization in sepsis (120, 280, 358, 410, 490, 
687, 688) trauma (481, 614), endotoxemia (605, 606), severe hemorrhage 
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(160, 664-666) and surgical stress (408). As noted above (p. ) the 
observation of increased glucose oxidative turnover is consistent with 
the hypothesis that there is a simultaneous elevation of both insulin 
and glucagon levels; a condition shown by Cherrin~ton and Vranic (116) 
to produce similar alterations in blood glucose levels and blood glu-
cose turnover. 
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INFLUENCE OF INSULIN ON THE HOST-DEFENSE FUNCTION OF THE RETICULO-
ENDOTHELIAL SYSTEM 
The third major question approached in this study was: does 
insulin and the resultant hypoglycemia of endotox•mia play a role in 
the perpetuation of the shock syndrome and to an ultimate demise of 
the challenged host. Since the reticuloendotheliP.l system plays a 
role in resistance to lethal shock, the influence of insulin hypogly-
cemia on reticuloendothelial function was assessed. 
The granulopectic activity of the RES was first studied by 
measuring the rate of carbon clearance (Table 12 and 13). In saline 
treated controls (Group 1) there was a significant negative correlation 
between blood glucose and carbon clearance half-time suggesting that 
blood glucose may be an important physiological regulator of RES 
functional activity. When rats were made moderately hypoglycemic 
(blood glucose greater than 30 mg per dl) by insulin treatment there 
was a significant impairment. of carbon clearance (Group 2, Table 12) 
and the significant correlation between blood glucose and clearance 
half-time indicated that the severity of the hypoglycemia was a sig-
nificant factor in the depression of RES phagocytic activity. In 
rats which were hypoglycemic (blood glucose of 30 or less mg per dl) 
the carbon clearance half-time was markedly increased to 183% of the 
saline control value indicating severely depressed RES phagocytic 
function. When the insulin-treated groups were combined regression 
analysis indicated that for each 10 mg per dl decrease in blood glu-
case carbon clearance half-time would be expected to be increased by 
an average of 2.6 minutes (Table 13). The depressed rate of removal 
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of carbon from the blood of insulin hypoglycemic rats was probably due 
to a direct action of insulin on macrophage function ~ se since in 
control experiments insulin had no significant influence on carbon 
clearance when blood glucose was maintained by glv:ose treatment. These 
experiments suggested that hypoglycemia is a significant depressant of 
RES functional activity as reflected by the depres~ed rate of removal 
of colloidal carbon from the blood. Hypoglycemia may thus increase sus-
ceptibility to lethal shock and play a role in the perpetuation of the 
shock syndrome at this level of host defense. The influence of hypo-
glycemia on the phagocytic activity of the RES in vivo does not appear 
to have been previously investigated. However, the influence of star-
vation has been studied (155, 343, 344, 438, 554) and depressed RES 
phagocytic activity has been found in all studies. In addition RES ac-
tivity is depressed when animals are made hypoglycemic and insulin-sen-
sitive by hypophysectomy (170, 355). RES function is also stimulated 
by steroidal analogues (484, 636) which have been reported to cause in-
sulin resistance (169, 669). In addition metabolic defects which im-
pair glucose utilization are known to ~ave profound influences on RES 
function and host defense (31, 46, 159, 669) and it is believed that 
glucose may be necessary and play a key role in regulating of normal 
macrophage phagocytic function (283) as has been shown using polymor-
phonuclear leukocytes (558, 616). The results of this study and the 
above cited literature are consistent with the hypothesis that hypo-
glycemia may reduce host resistance to lethal shock by depressing 
RES activity. 
To further assess the role of hypoglycemia in the progression 
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of the shock syndrome, a technique was devised to measure the clearance 
of biologically active endotoxin from the blood of rats in vivo and 
after this technique had been evaluated for its validity, the method 
was applied to measure endotoxin clearance in hypcglycemic rats. The 
bioassay employed was that of Filkins (198). However, to achieve truely 
quantitative estimates of biologically active endotoxin the method of 
data analysis was modified. Of several lethality transforms tested in 
combination with a number of potential metametric dose scales, the pro-
bit transform described by Finney (211,212)appeared to provide the most 
linear relationship when the probits were plotted against the endotoxin 
doses on a logarithmic scale (Figure 26). The significant linear re-
lationship between the probit of lethality and the logarithm of the 
endotoxin dose in the probit ran&e of 4 to 6 was also tested and veri-
fied in later experiments (Tables 15,16, and 17). The establishment 
of this relationship permitted direct computation of unknown doses 
from lethality scores in the range of 16% to 84% (211, 212). 
When normal fe'd rats were given a 500 gm endotoxin dose and 
, I 
5 samples of tail blood were collected at 15 to 240 min. after iv 
injection, the concentration of biologically active endotoxin in the 
blood was adequately described as a monoexponential function of time 
as shown by the significant correlation of the logarithm of blood en-
dotoxin and time (Figure 27). This relationship i.e., the absolute 
rate of disappearance proportional to the blood concentration, is 
characteristically found when a sufficiently large dose of a material 
removed by the RES is administered (61, 553). The rate of disappearance 
corresponded to a half-time of 68 min. (K = 0.0044). The estimated 
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blood endotoxin concentration innnediately after the iv injection was 
calculated by extrapolating the curve back to time zero and a value of 
34.8 gm per ml was obtained. This concentration corresponds to an en-
dotoxin distribution space of 14.4 ml per 300 gm rody wt or 4.9 ml per 
100 gm body wt. This value is very near to the r~ported blood volume 
of similar size rats (13, 47, 326, 504, 574) which suggests that the 
endotoxin distribution space following iv injection is limited to the 
vascular compartment is also suggested by Milner, Rudbach and Ribi (453)~ 
When 509)\gm endotoxin dose was given and blood samples were collected 
by cardiac puncture results similar to those obtained using tail-blood 
were obtained (Table 15 and Figure 27). The half-time for endotoxin 
clearance was not increased when the test clearance dose was increased 
to 1,009'<,gm per rat (Figure 28). This would not be expected if endo-
toxin clearance followed the same kinetics as classical RE test sub-
stances (61, 553); however, these results may well be within the error 
of the estimate with the limited number of points examined on the 
clearance curve. When the endotoxin test clearance dose was reduced 
to 250f(gm per rat, clearance was multiphasic (Figure 28). By the cri-
teria of Saba (553) and Biozzi et al. (61) this suggests that the cri-
tical dose of endotoxin to evaluate RE function in 300 gm fed rats is 
between 250 and 50~)1'.gm per rat. Rats made tolerant to endotoxin by 
three 1 mg doses cleared endotoxin very rapidly (Table 15). This is 
in agreement with previous studies of endotoxin clearance in endotoxin 
tolerant animals in vivo (75, 100, 112, 113, 152, 301, 306, 459, 510, 
592). Accelerated endotoxin disappearance was also observed when rats 
were pretreated with endotoxin 16 to 18 hr before the test dose (Table 
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15); this finding is similar to that reported by Howard et al. (324) 
following a single endotoxin dose. Furthermore, resistance to lethal 
endotoxemia which accompanies accelerated endotoxin clearance is well 
documented following single dose pretreatment (11?). Endotoxin clearance 
was also influenced when rats were pretreated with endotoxin only 4 hrs 
before the test clearance dose (Table 15), however, although the initial 
rate of disappearance appeared accelerated the ra~e of clearance pro-
gressively decreased throughout the 4 hr observation period. Although 
these data are consistent with the literature on endotoxin clearance 
in vivo the interpretation of the studies in which rats were pretreated 
with endotoxin 16 to 18 hrs or 4 hrs before the test clearance endo-
toxin is at present complicated by recent findings in our laboratory 
dealing with the appearance of blood detoxification of endotoxin sub-
sequent to endotoxemia (201, 203). However, these data lend support to 
the validity of the technique used to measure endotoxin clearance in 
this study. Similarly, in acutely adrenalectomized rats the rate of 
endotoxin clearance was significantly increased over the non-treated 
controls (Table 16). This finding lends support to the data of Ribble 
et al. (539) which demonstrated cortisone depression of endotoxin clear-
ance in mice; similarly RES stimulation was observed by Reichard et al. 
(537) after adrenalectomy. It is well known that corticosteroids alter 
host d~fense functions in vivo and the results shown in Figure,31 sug-
gests that possibly endogenous corticosteroids alter endotoxin clearance. 
From the above results on endotoxin clearance in vivo using 
the lead sensitized rat lethality bioassay and comparisons with the 
findings of others, it was concluded that the method of assessing 
endotoxin clearance used in this study was a valid measure of the 
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rate of disappearance of biologically active endotoxin from the blood. 
However, it deserves comment that the absolute values obtained for the 
half-times of endotoxin disappearance from the blood of non-pretreated 
rats were longer than the values found by in most previous investiga-
tions which almost exclusively employed radiolabeled endotoxin prepa-
rations. At least 2 factors probably contributed to this apparent dis-
crepancy; (a) the majority of the previous studieti used much smaller 
doses of endotoxin, and (b) there may have been a dissociation .of ra-
diolabel from biological activity in some studies. The influence of 
decreasing the endotoxin dose on the rate of clearance is shown in 
Figure 28 and suggests that the initial rate of disappearance of a 
small dose is more rapid than for either larger dose. Braude and coworkers 
gOO)previously warned of this difference in clearance kinetics of a 
smaller or tracer dose as compared to a larger dose. The dissociation 
of biological activity of endotoxin froi;n endotoxin radiolabel has been 
demonstrated by Che did et al. (114) and others f592, 593 ) and such a 
dissociation has been suggested by many other studies. In fact re-. 
cently Prigal et al. (525) found that incubation of endotoxin with 
chromium ions actually detoxified the endotoxin as measured using a 
mouse lethality bioassay. However, if a sufficiently large dose of 
repurified high molecular weight radiolabeled endotoxin or native 
endotoxin is given, prolonged residence of bioassayable endotoxin in 
the blood similar to that observed in the present study has been re-
ported (75-;77, 114, 123,. 156, 202, 459, 513, 539, 572, 591, 592, 636, 667) • 
When rats were made hypoglycemic by treatment with insulin, 
endotoxin clearance was profoundly depressed (table 17, Figure 32). 
l 
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The finding of depressed endotoxin clearance by insulin hypoglycemia 
suggests that the hypoglycemia characteristic of endotoxin shock (605) 
may play a role in the perpetuation of the endotoxin shock syndrome by 
impairing the first line of host defense to uncontrolled endotoxemia, 
i.e., the ability of the challenged host to clear endotoxin from the 
blood. 
The perfused liver experiments on endotoxin clearance reported 
in this study were designed to further assess the method used fn studying 
endotoxin clearance in vivo and to evaluate the role of serum opsonins 
in endotoxin clearance in the rat. In accord with their previous hy-
pothesis (208, 209, 502) Fine and coworkers have recently presented 
endotoxin clearance data similar to those of this study and suggested 
that the systemic endotoxemia is not the result of slow RES clearance 
but rather is due to continual absorption of endotoxin from the gut and 
on into the systemic circulation (98; 141, 142, 145, 291, 675). The 
results of the perfused liver experiments do not support this inter-
pretation of Fine and coworkers. When livers were isolated from the 
potential intestinal source of endotoxin and perfused in vitro endo-
toxin clearance remained slow with a maximum of 115.Agm of endotoxin 
removed per hr (Table 18). The addition of 10% rat serum did not ac-
celerate endotoxin clearance but rather appeared to retard it (Table 
19). Even when 50% heparinized rat blood was used as the perfusate 
endotoxin clearance was not accelerated. These findings suggest that 
opsonins are not a significant factor in determining the rate of en-
dotoxin clearance by the perfused rat liver. In what appears to be 
t.he only other published study of endotoxin clearance by the perfused 
r ~- . . 
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liver, Goodman et al. (269) found slow endotoxin clearance even when 
5% normal rabbit serum was added to the perfusate used to assess endo-
toxin clearance by rabbit livers. More recently Moon has investigated 
endotoxin clearance by the perfused mouse liver u~lng purified Cr-51 
labeled endotoxin and also found extremely slow removal of endotoxin 
from the perfusate (Robert Moon, unpublished COllU1lt'11ication). Our 
findings and those of others using the perfused liver to measure endo-
toxin clearance support the notion that the rate of endotoxin clearance 
in vivo is not as 'rapid as if often stated and lend further support to 
ou in vivo studies of endotoxin clearance in the rat. 
r 
['" 
229 
PROPOSED ROLE OF INSULIN IN THE PATHOGENESIS OF ENDOTOXIN SHOCK 
A proposed mechanism of the role of insulin in the pathogenesis 
of lethal endotoxin shock is presented in Figure 34. The components of 
this schema which are directly supported by the rfsults of this disser-
tation appear in capital letters; those elements supported by'the li-
terature are shown in lower case type. The role r.f insulin and the con-
sequent hypoglycemia, as they contribute to the S..'verity of the shock 
syndrome, receive major emphasis. Each element of this schema is se-
quentially discussed below in the order indicated by the letters shown 
in the figure. For clarity not all of the inter-relations discussed 
and implied below are shown on Figure 34. 
A. Endotoxin injection was the immediate cause of endotoxemia in 
the experiments reported in this dissertation; however as indicated, en-
dotoxin absorption from the gut may also occur as a result of circula-
tory. impairment and splanchnic ischemia, especially if coupled with de-
pressed RES function (98, 141-145, 208, 209, 235, 291, 303, 501, 626, 
675, 689). 
B. Endotoxemia and shock lead to the release of bradykinin and 
possibly other vasoactive peptides (253, 314, 316, 450, 451, 461, 476, 
485, 530, 538) as well as peptides which specifically depress myocar-
dial contractility (257, 392-396, 492) and RES function (64, 65, 394). 
C. It is well known that endotoxemia and shock lead to the re-
lease of biogenic amines including serotonin and histamine (253, 314, 
476, 530, 618, 650, 651); a role of vagal discharge in the release of 
\. 
biogenic amines in shock has been suggested (618). 
D. Endotoxemia and shock also lead to intra-vascular coagulation 
l 
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FIGURE 34 
PROPOSED SCHEMA OF THE ROLE OF INSULIN AND HYPOGLYCEMIA IN 
THE PATHOGENESIS OF LETHAL ENDOTOXIN SHOCK 
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(17, 121, 302, 304, 320, 321, 461, 476); a derangement probably enhanced 
by elevated blood lactate (266, 378) and high levels of plasma free fatty 
acids )118, 656) produced by endotoxin treatment (641). Insulin may 
potentiate the coagulopathy of endotoxemia by increasing thrombokinase 
activity (431) and increasing platelet aggregatioYt while at the same 
time depressing fibrinolytic activity (382, 383). 
E. The stress of endotoxemia is known to ac~ivate the central 
nervous system producing a variety of neural and humeral responses (27, 
28, 67, 68, 190, 208, 209, 237, 476, 641). ACTH is released from the 
pituitary as well as extra-pituitary stores (19) which leads to stimu-
lated glucocorticoid secretion as well as effects· attributable to ACTH 
~~(see below). The sympatho-adrenal axis is activated (208, 209, 
253, 476) as is the vago-irisulin system (67, 68, 190, 237, 618, ~51), 
which lead to an activation of the endocrine pancreas (see below) and 
the secondary release of endogenous factors which influences the in-
sulin response subsequent to the autonomic activation in endotoxemia 
and shock (347, 557, 618, 651), e.g. serotonin and glucagon or gut 
glucagon (180, 184, 216, 224, 368, 519, 642, 643). 
F. It is well recognized that plasma pancreatic glucagon is ele-
vated in stress (67, 68, 296, 380, 416, 417) including endotoxemia (67, 
68) and shock and sepsis (67, 68, 406, 439, 544, 560, 671, 680). The 
hyperglucagonemia may then in turn enhance catecholamine secretion 
(561, 566, 617) as well as stimulate insulin secretion (180, 224, 368, 
519, 643, 669) both of which may be deleterious in resistance to lethal 
shock. 
G. Endotoxin induced ACTH secretion and subsequent adrenal 
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cortical activation are well recognized responses to endotoxin and 
shock (19, 148, 172, 234, 267, 356, 540, 562, 655). Elevated ACTH modu-
lates insulin secretion (246, 361, 362, 388, 413, 491, 622) which pro-
duces hyperinsulinemia and hypoglycemia (246, 388~. It is also well-
recognized that ACTH stimulates lipolysis and elevates plasma free fatty 
acids; elevated free fatty acids have severe toxic effects on tissues 
including destruction of immune-physiologic host-defense elements (637). 
H. The sympatho-adrenal response to endotoxemia and shock is so 
severe that the initial catecholamine response has been suggested to 
be a cause of many of the pathophysiological disturbances observed in 
lethal shock (136-139, 208, 209, 253, 302, 314, 315, 392, 393, 395, 
476, 501, 502, 641). The consequences of elevated catecholamine levels 
include: (i) altered insulin and glucagon secretion, (ii) glycogeno-
lysis, (iii) enhanced tissue glucose utilization, (iv) depletion of 
carbohydrate stores, (v) impaired tissue perfusion, (vi) lactic acidosis, 
and (vii) the production of a hypermetabolic state. Catecholamines 
also enhanced platelet aggregation and blood ~oagulation in 'vivo. 
I. The acute response to severe stress including endotoxemia is 
an initial hyperglycemia. Some factors contributing to this response 
include: (i) Glucagon induced hepatic glycogenolysis and gluconeo-
genesis (173, 177, 179, 216, 367, 368, 599, 600, 601, 643). 
(ii) Catecholamine induced glycogenolysis and lipolysis 
(35, 36, 79, 96, 97, 163-165, 178, 262, 263, 270, 292, 297, 312, 313, 
499, 559, 581-587, 685). 
(iii) Peripheral tissue insulin resistance (see below). 
(iv) Hepatic insulin resistance (285). 
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(v) Anoxic stimulation of glycogenolysis (568-570). 
(vi) Endotoxin activation of hepatic adenylate cyclase (62, 
254' 255). 
' (vii) Serotonin stimulation of hepatic gJycogenolysis (402). 
(viii) Release of cellular ATP into the extracellular fluid 
subsequent to tissue injury leading to hepatic glycogenolysis (401). 
In this context it is well to note that hyperglyc0mia is believed to 
exert a protective effect in impending shock (3, 4, 364, 397, 619) while 
hypoglycemia sensitizes to both lethal shock and the putative mediators 
of endotoxin toxicity (3, 4, 83, 84, 138, 210, 284, 364-366, 370, 397, 
481, 514, 515, 574, 575, 577). In fact, in assessing the relation-
ships between blood glucose and resistance to lethal hemorrhagic shock 
Stawitz and coworkers (619) concluded that "---ultimate death or sur-
vival of an animal in hemorrhagic shock is independent of its initial 
glucose reserves, but seems somehow to be related to its ability to 
maintain itself in a hyperglycemic state." 
J. Insulin levels are increased in endotoxemia (67, 68, 190, 237). 
Some factors which may contribute to elevated insulin levels in endo-
toxin shock include: 
(i) Depressed insulin clearance secondary to diminished per-
fusion of the major organs responsible for insulin degradation (105, 
138, 435, 436, 556). 
(ii)· Failure of RES uptake of insulin. 
(iii) Stimulated insulin secretion in response to the hyper-
glycemia of shock (38). 
(iv) Alterations in levels of non-carbohydrate metabolites 
l 
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including amino acids, free fatty acids, and ketone bodies. 
(v) Inhibition of insulin degradation due to bradykinin in-
hibition of the protease responsible for insulin destruction. 
(vi) ACTH stimulation of insulin secretioP. 
(vii) Glucagon stimulation of insulin secretion. 
(viii) Serotonin modulation of insulin secretion. 
(ix) Vagal stimulation of insulin secretirn. 
(x) Epinephrine stimulation of insulin secretion (99, 117), and 
(xi) Pancreatic ischemia, cellular lysis and the release of 
insulin secretory granules. 
In the context of the proposed role of insulin in the pathogenesis of 
shock, especially that directly associated with endotoxemia, we can 
not agree with the suggestion of Gunnar and coworkers (673) that in-
sulin is a miscellaneous drug of no consequence when given to bacteremic 
patients with cardiovascular instability and clinical shock. The car-
diovascular effects of insulin merit further investigation (see below). 
K. It is well documented that a state of insulin resistance is 
observed in infection and bacteremia (40, 41, 120, 125, 193, 247, 256, 
285, 490, 532, 533, 544, 560, 573, 647) and iri shock and injury (110, 
111, 146, 183, 286, 287, 325, 340, 341, 408, 547, 614, 683). Although 
the mechanism has not been resolved, recent studies suggest it is in-
dependent of either epinephrine secretion or elevated levels of gluco-
cbrticoids (110). Elevated free fatty acids produce such insulin re-
sistance (32, 317, 528, 551) as do a number of hormonal factors (169, 
669) including the stress induced insulin antagonist of Vargas (647) 
or the insulin binding alpha-2-macroglobulin found after thermal 
r 
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injury (183). Furthermore, cellular injury may lead to insulin resis-
tance through increased cell membrane permeability. ATP inhibits in-
sulin stimulated but not basal glucose transport in both adipose tissue 
and striated muscle (106, 108) by a mechanism inv<lving phosphorylation 
of a membrane protein (106). In fact this may be the mechanism by 
which iv ATP treatment increases resistance to lethal shock; a finding 
which has been repeated confirmed in controlled studies (578) since it 
was reported by Talaat et al. (625). 
L. However, despite the apparent insulin resistance an enhance-
ment of glucose utilization occurs in shock and sepsis (120, 408, 410, 
490., 606, 664, 665, 666) and an accompanying hypermetabolic state en-
sues (289, 478). The results presented in this dissertation provide 
strong evidence that insulin is involved in the development of the 
state of enhanced glucose utilization observed following endotoxin 
treatment since this response was aborted either by treatment with 
mannoheptulose or by rendering the rats diabetic prior to endotoxin 
challenge. It should also be noted that insulin is required for anoxia 
stimulated glucose transport (275) as is believed to occur as a con-
sequence of the tissue hypoperfusion of shock. A further mechanism by 
which insulin increases glucose utilization is by stimulating hepatic 
glucose·oxidation (272, 273, 447) which will depress net hepatic glu-
cose production. This mechanism reinforces the increase in peripheral 
tissue glucose utilization secondary to elevated insulin levels in 
plasma and extracellular fluid (300). Catecholamines may also play 
a role in the enhanced glucose utilization observed in shock through 
their effect on skeletal muscle alpha-adrenergic receptors (555). 
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M. Depressed hepatic gluconeogenesis is well documented in endo-
toxemia and shock (SO, 200, 204, 319, 381, 434, S7S, S76, S77, 670); 
however the mechanisms responsible for this response are not entirely 
understood. The results presented in this dissertdtion have shown that 
the insulin response to glucose treatment depressed hepatic gluconeo-
genesis in endotoxemic rats. It is not surprisin~ that the glucose in-
duced insulin response was effective in depressin~ gluconeogenesis in 
endotoxemia since the rat liver is sensitized to insulin inhibition of 
glucose production by hypoxia (4S7) and moderate elevations of gluco-
neogenic hormones (173, 177, 2S9, 4S7, 463) as occurs following endo-
toxin treatment. 
N. It is well known that shock and endotoxemia lead to a severe 
depletion of body carbohydrate stores including both tissue glycogen 
and blood glucose (49, SO, 57, 160, 204, 280, 434, 619). Some factors 
enhancing glycogenolysis in endotoxemia may include: 
(i) elevated plasma glucagon levels (67, 68) 
(ii) elevated plasma serotonin (402) 
(iii) catecholamine stimulation of glycogenolytic hormone re-
lease (178, 179, 248, 249, 296, 430, S99, 600, 601) 
(iv) direct catecholamine stimulated muscle glycogenolysis, and 
(v) elevated activity of the hepatic sympathetic nerves (3S, 
163-16S, S81-S87). 
Regarding the depletion of hepatic glycogen stores and the hypoglycemia 
associated with endotoxemia it should be emphasized that the rat liver 
does not respond to hypoglycemia with increased glucose release either 
in vivo (124) or in vitro (602). Increased hepatic glucose release 
l 
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is dependent on neural and hormonal stimulation as has been shown to 
occur in endotoxemia. 
0. Hypoglycemia and lactic acidosis, the hallmarks of endotoxin 
shock (605), are the final results of the above di~cussed factors in-
cluding (J) hyperinsulinemia, (L) enhanced glycolysis, (M) depressed 
hepatic gluconeogenesis, and (N) the depletion of carbohydrate stores. 
The remainder of the discussion of the hypothesis presented in Figure 
34 focuses on the question of how the combination of (N) depletion of 
carbohydrate stores and (O) hypoglycemia and lactic-acidosis lead to 
a perpetuation of the shock syndrome and ultimate demise of the challenged 
host. At this point it should be noted that it is unlikely that glu-
cose treatment will avert the lactic-acidosis and hypoglycemia secondary 
to hepatic damage in endotoxemia. Patients in shock with recurrent hy-
poglycemia have been given as much as 2.5 kg of iv glucose over a 24 hr 
period at which time they were stuporous with a blood glucose of 40 mg 
per dl; a subsequent 0.6 kg of glucose over the next 2 hr only raised 
glucose to 60 mg per dl while plasma insulin reached a level of 250 
microunits per ml. There was no significant glycosuria (556). Hypo-
glycemia may also explain the hypothermia observed in endotoxemia in 
the rat (207) or after traumatic shock (613) for it is now well es-
tablished that CNS glucopenia produces hypothermia due largely to 
peripheral vasodilation and increased heat loss (220). 
P. Endotoxemia initially depresses RES function as the macro-
phages engulf the toxic lipopolysaccharide. Depletion of carbohydrate 
stores is believed to depress macrophage function (283), and depletion 
of Kupffer cell glycogen has been documented in patients with a hepatic 
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impairment in gluconeogenesis (193). Hypoglycemia also depressed RES 
function as assessed using colloidal carbon. Furthermore, hypoglycemia 
impairs the ability of rats to clear lethal endotoxin from their blood 
and, as stressed by Fine and coworkers 08, 141-45, 208, 209, 291, 501, 
502, 626, 675) any defect in RES clearance of endotoxin leads to in-
creased absorption of endogenous endotoxin and ram~ant endotoxemia 
which results in lethal shock. Thus, the RES failure secondary to the 
hypoglycemia of shock may perpetuate the shock syndrome by limiting 
RES clearance of endotoxin as well as other substances which it clears 
from the blood (e.g. fibrin, enzymes, tissue debris collagen, bacteria, 
etc). Fine is not alone in his belief that the unaltered RES activity 
is of paramount importance in resistance to lethal shock (14, 16, 18, 
64, 65, 132, 308, 536, 694). 
Q. Hypoglycemia and the depletion of carbohydrate stores may also 
be an important factor in the terminal failure of sympathetic nervous 
system function believed to occur in irreversible shock (208, 209, 253, 
314, 476). It is well known that the function of the nervous system 
is dependent on adequate carbohydrate supplies and it has been shown 
that rat sympathetic ganglia first begin to fail in their role of trans-
mitting neural impulses at the time they become depleted of glycogen 
stores (295). Alternately, sympathetic failure may lead to hypogly-
cemia. Since insulin release by the beta-cells of the pancreas is 
supposedly under constant alpha-adrenergic inhibition (95), a decrease 
in sympathetic activity may permit a release of insulin which causes 
hypoglycemia to which the hypoxic brain can ho longer respond with a 
normal increase in blood flow (58) and thereby suffers irreversible 
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damage. In this context it is well to note that sympathectomy as a 
result of cervical spinal cord section or destruction causes profound 
hypoglycemia (646), inhibits the hyperglycemic response to epinephrine 
(178), and sensitizes to hypoglycemia (79). As nr,ted above, central 
nervous system glucopenia will also lead to vasodilation a deleterious 
event in relative hypovolemia. 
R. Tissue hypoperfusion is believed to be a~ important mechanism 
by which endotoxemia and shock lead to cellular damage (253, 302, 314, 
315, 387, 476) and the generation of shock toxins (64, 65, 257, 314, 
392-396, 476). Deranged circulatory function secondary to cardiac de-
compensation also leads to spontaneous hypoglycemia (66, 437) and lac-
tic acidosis (437). The mechanism of the circulatory impairment secondary 
to endotoxemia is undoubtedly multifactorial. However, a role of in-
sulin and hypoglycemia in the tissue hypoperfusion of shock is sup-
ported by the findings indicated below. Glucopenia in vivo initially 
potentiates the mesenteric arterial response to sympathetic stimulation 
(425) and this may cause a more severe splanchnic ischemia with its 
attendent deleterious effects. However, later in the shock syndrome 
when blood glucose levels fall profoundly to only 0-15 mg per dl 
(200, 204, Buchanan and Filkins, unpublished observations) vascular 
smooth muscle contraction is probably inhibited. Aerobic glycolysis 
is essential for vascular smooth muscle contractions since oxidative 
phosphorylation and tricarboxylic acid cycle activity do not support 
contraction (276). It has been repeatedly reported that lack of suf-
ficient glucose inhibits vascular smooth muscle contractions 15, 122, 
329, and see 72). In this context, insulin increases the rate at 
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which vascular smooth muscle degrades its available glucose to lactate 
(482). In this way the hypoglycemia of shock may contribute to the 
circulatory disturbances. This suggestion of deranged cardiovascular 
function subsequent to hypoglycemia receives suppo:t from experimental 
as well as clinical observations (2, 11, 12, 23, 166, 171, 265, 534). 
Furthermore, endotoxemia has been reported to "reset" the baroreceptor 
reflex to a new hypotensive level (634) and endotoxin has been shown 
to produce a vasodilation which was reversed by acute hemorrhage (450). 
Insulin may also potentiate the circulatory derangements of endotoxin 
shock independent of blood glucose. It has been reported that insulin 
depresses the baroreceptor responses in patients (21, 446) and attenuates 
the pressor responses to carotid artery occlusion in dogs (88). In 
patients maintained hyperglycemic with iv glucose, insulin has been 
reported to cause syncope (446). By such effects on peripheral cir-
culatory control it is believed that the hyperinsulinemia of shock may 
add to the deranged tissue perfusion subsequent to endotoxemia. 
S. Splanchnic hypoxia is one of the many results of impaired 
tissue perfusion and may lead to the generation of any'of a number 
of "shock mediators" which have been descr.ibed. Splanchnic hypoxia 
may also be an important factor in the depressed hepatic gluconeogenic 
capacity of endotoxin shock. And, as repeatedly proclaimed by Fine and 
coworkers splanchnic hypoxia leads to increased intestinal permeability 
to endotoxin and by this action perpetuation of the shock syndrome 
leading ha.ck to endotoxemia which was the initiating event in this 
schema and the experiments described in this dissertation. 
...... 
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Based on the results and discussion thus far presented in this 
dissertation the relationships shown in Figure 35 are believed to be of 
key importance in the mechanism by which insulin plays a role in the 
pathogenesis of endotoxin shock and eventual deatr. 
Endotoxemia leads to increased levels of circulating insulin, 
probably as a result of both (i) increased insulir secretion in re-
sponse to early hyperglycemia of shock, and (ii) ~epressed insulin 
clearance, perhaps related to altered macrophage function. Elevated 
insulin levels depress hepatic gluconeogenesis both acutely and by a 
long lasting effect related to the suppression of hepatic gluconeogenic 
enzyme synthesis. Elevated insulin levels in endotoxemia are also a 
necessary component of the elevated rate of glucose utilization observed 
in endotoxin shock. The end result of depressed glucose synthesis and 
elevated glucose utilization is profound terminal hypoglycemia. In con-
junction with its other deleterious effects hypoglycemia leads to de-
pressed RES clearance function. When the phagocytic activity of the 
RES is depressed susceptibility to shock is increased; and as in the 
present experiments hypoglycemia may lead to depressed endotoxin 
clearance. When endotoxin clearance is depressed, the shock state is 
perpetuated by the actions of this toxic lipopolysaccharide remaining 
in the systemic circulation. 
In summary it is concluded that insulin plays a role in the 
pathogenesis of lethal endotoxin shock. Under the conditions of the 
present experiments serum insulin levels were markedly elevated early 
in endotoxemia and remained elevated for at least 12 hours, during 
which time depressed gluconeogenesis and elevated glucose utilization 
were observed. 
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CHAP1ER VI 
SUMMARY 
1. Endotoxin shock lethality was studied in rats treated so 
as to influence insulin secretion: 
A. Lethality was significantly increased when insulin 
secretion was elevated, viz, the fed state and treatment with ip 
glucose. 
B. Lethality was significantly reduced when insulin 
secretion was depressed, viz, by overnight fasting or mannoheptulose 
treatment. 
2. Glucose treatment per se did not sensitize rats to lethal 
endotoxin shock since when treatments with mannoheptulose and glucose 
were combined: 
A. Lethality in endotoxin treated rats administered both 
: . glucose and mannoheptulose was not different from rats treated with 
only mannoheptulose and endotoxin·. 
B. Lethality in both mannoheptulose treated groups 
irrespective of glucose treatment -- was significantly less than the 
lethality in control endotoxin treated rats. 
3. Both stimulation of endogenous insulin secretion with 
tolbutamide or tolazamide and treatment with small doses of insulin 
per se significantly increased endotoxin shock lethality above levels 
observed in controls treated with endotoxin and saline. 
r , 
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4. The influence of glucose treatment on in vivo gluconeo-
genie capacity and hepatic glycogenic function was studied in overnight 
fasted rats 4 to 5 hrs after iv endotoxin and 2 to 3 hrs after ip glu-
cose (400 mg) using a 100 mg alanine dose, and: 
A. In rats not given endotoxin, glucose treatment caused 
a hyperglycemia at the time of alanine injection w~1ile both endotoxin 
treated groups had blood glucose values significantly less than their 
saline controls. 
B. Glucose treatment prevented the significant rise in 
blood glucose levels observed 30 minutes after alanine in endotoxin 
treated rats not treated with glucose. 
C. Glucose treatment significantly depressed the incor-
poration of alanine carbon label into blood glucose. 
D. Hepatic glycogen reserves were not increased by glu-
cose treatment of endotoxemic rats. 
E. Gl~cogen synthesis from alanine was severely depre~sed 
in both endotoxin treated groups as compared to the iv saline control 
groups. 
5. Analysis of blood glucose and serum insulin responses in 
overnight fasted rats given iv endotoxin revealed: 
A. A transient hyperglycemia reaching a peak at almost 
twice fasting blood glucose at 90 minutes after iv endotoxin, 
B. A large increase in serum insulin accompanying the 
hyperglycemia and reaching a peak of 13o;tJ per ml at 90 minutes after 
iv endotoxin, 
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C. An elevation of serum insulin throughout the 12 hr 
r ( 
observation period despite the return of blood glucose to fasting 
levels by 240 minutes, and 
i 
D. A depression of the glucose to inralin ratio and an 
elevation of the glucose-insulin product. 
6. Evaluation of intraperitoneal glucose tolerance and the 
associated insulin response in overnight fasted ra~s 2 hr after endo-
toxin treatment revealed that: 
A. Compared to controls, endotoxemic rats had no im-
pairment in the rate of decline in blood glucose following a similar 
peak blood glucose concentration. 
B. Control rats -- not given endotoxin -- maintained 
significantly elevated blood glucose values for at least 6 hrs, while 
the endotoxemic rats returned to fasting blood glucose values within 
2 hrs. 
C. The insulin response to glucose was exaggerated in 
the endotoxin treated rats and insulin levels remained elevated 
throughout the 10 hr observation period despite the early return to 
normoglycemia. 
D. In endotoxin treated rats the increase in serum in-
sulin associated with a given increase in blood glucose was 3 times 
that observed in the glucose treated controls; treatment with exogenous 
glucose did not influence the significant linear relationship between 
blood glucose and serum insulin in endotoxemic rats, and, 
E. The depressed glucose to insulin ratio appeared to 
be the result of an increased insulin response to the existing blood 
r v. 
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glucose levei' with no change in the blood glucose threshold for a serum 
insulin response. 
7. The rate of glucose oxidation in vivo, as evaluated by 
the recovery of carbon label as 14co2 from unifonn'.y labeled 14c-D-
glucose, was studied over a 4 hr period innnediately following either a 
tracer dose or a 400 mg load of glucose and; 
A. Label recovery was significantly lncreased when rats 
were given 1 mg endotoxin at the same time as either dose of glucose. 
B. Label recovery was greater if endotoxin was given 
2 hr before either glucose dose. 
C. When insulin secretion was suppressed with mannoheptu-
lose, endotoxin treatment at the same time as either dose of glucose. 
did not influence the recovery of label. 
D. When mannoheptulose treated rats were given endotoxin 
2 hr before either glucose dose, there was no increase in label re-
covery. 
E. Endotoxin treatment of streptozotoc~n diabetic rats 
did not increase label recovery above the depressed level seen in 
saline-treated diabetic rats. 
F. Dexamethasone treatment depressed glucose oxidative 
turnover; endotoxin treatment did not increase label recovery above 
this depressed level. 
G. Increasing the endotoxin dose from 1 mg (approximately 
LD10-ZO) to 3 mg (approximately LD90) per rat further increased the 
recovery of label at both glucose doses and decreased the time before 
the values were significantly above control, and, 
L 
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H. Enhanced glucose oxidation did not appear to be connnon 
to all shock inducing stresses, since tumbling shock did not increase 
label recovery following either glucose dose. 
8. Evaluation of reticuloendothelial pha~ocytic function by 
the rate of removal of colloidal carbon from the blood following an 
8 mg per 100 gm dose revealed: 
A. A significant linear correlation between carbon 
clearance half-time and blood glucose in saline treated controls. 
B. A significant linear correlation between blood glu-
cose and carbon clearance half-time in insulin treated rats; the slope 
of the regression line of half-time on blood glucose was -26 mi~. per 
100 mg per .dl. 
C. A significant depression of intravascular phagocytosis 
in insulin hypoglycemic rats which was related to the severity of the 
hypoglycemia, and, 
D. No alterations in reticuloendothelial phagocytic 
function which could be attributed to insulin per se .. 
9. The use of t-he lead-sensitized rat for the bioassay of 
endotoxin was evaluated and the relationship between the probit of 
endotoxin shock, lethality and logarithm of the endotoxin dose was 
linear in the probit range of 4 to 6. This permitted accurate deter-
minations of sub-microgram quantities of biologically active endo-
toxin using a shock death endpoints in groups of lead-treated rats 
with lethality scores between 16% and 84%. 
10. Endotoxin clearance was studied in vivo by injecting 
endotoxin iv and measuring the amount of biologically active endotoxin 
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remaining in the blood at 15 to 240 min. after injection using the lead-
sensi tized rat bioassay and; 
A. In normal fed rats given a 500.J<gm endotoxin dose a 
linear relationship existed between the logarithm · ,f the blood endo-
toxin concentration and time throughout the period of 15 to 240 min. 
The half-time for disappearance of this dose was 63 min. in serially 
sampled rats and 58 min. ~n a single sampling protocol. 
B. Increasing the endotoxin dose to,A{_l,000 gm had no in-
fluence on the half-time for endotoxin clearance and the semi-logarithmic 
plots were still linear. 
C. Decreasing the endotoxin dose to,l({.250 gm produced mul-
tiphasic clearance curves with rapid clearance soon after the endotoxin 
injection and a progressive decrease in the clearance rate with time. 
D. In rats made tolerant to endotoxin by three 1 mg doses 
on alternate days the rate of disappearance was markedly accelerated 
and corresponded to a half-time of about 4 min. in the 0 to 15 min. 
period. 
E. In rats pre-treated with 500)t'8Ill of endotoxin 16 to 
18 hr before the 500;<gm clearance dose, the rate of endotoxin dis-
appearance was almost as fast as in the 3 dose tolerant rats. 
F. In rats pre-treated with 50()-l{gm of endotoxin 4 hrs 
before a subsequent dose of 500,<{gm, clearance was multiphasic with 
the rate of disappearance .increased over controls in the first 60 min. 
followed by a depressed rate of disappearance in the 120 to 240 min. 
period. 
G. Control experiments suggested that the disappearance 
l 
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of biologically lethal endotoxin from the blood of both normal rats and 
rats pre-treated with endotoxin was not the result of detoxification of 
endotoxin in the blood. 
H. Surgical stress 1 hr before a 50Q {gm test dose did not 
alter endotoxin clearance in the 120 min. following injection but did 
increase the rate of disappearance in the 120 to 130 min. period. 
I. In rats adrenalectomized 1 hr before a 500)£.gm test 
dose the rate of disappearance was proportional to the blood endotoxin 
level and corresponded to a half-time of 38 min. 
J. Blood endotoxin was compared in overnight fasted and 
insulin hypoglycemic rats .3 hrs after a 500f(gffi test dose; insulin 
hypoglycemia depressed the rate of disappearance of biologically active 
endotoxin with significantly more lethal endotoxin remaining in the 
blood. 
11. Endotoxin clearance by the isolated perfused rat liver 
was studied using the lead sensitized rat bioassay to quantitate en-
dotoxin. 
A. Livers perfused for 60 min. with only a balanced salt 
solution removed about 115..)tgm endotoxin from the 140 ml of perfusate. 
B. When livers were perfused with 10% rat serum in the 
balanced salt solution following 1 hr of perfusion with the salt so-
lution alone, no further loss of endotoxin from the perfusate occurred. 
C. When livers were perfused with 50% fresh heparinized 
rat blood in the salt solution no significant loss of endotoxin oc-
curred in the first 30 min. The decreased lethality of the 90 min. 
perfusate indicated the liver had removed about 55}{gm of endotoxin. 
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D. Control experiments showed the loss of biologically 
active endotoxin was not the result of inactivation of the endotoxin 
~ ' 
' by any of the perfusion media used independent of the liver. 
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LIST OF COMPUTER PROGRAMS IN APPENDIX 
Program Page 
Chi-Square Test with Yates Correction Factor Inclrded ...•...••..• A2 
Computation of "p" Value for Chi-Square Value at 
Specified Degrees of Freedom ...........•..................•...... A3 
Calculation of Mean Standard Deviation and Standard 
Error of Mean .....•......•.............••...•...........•.•...... A4 
Unpaired Student's "t" Test ................•...•................. AS 
Paired Student's "t" Test ............•.•.............•.• ~ .....•.• A6 
Insulin RIA Calculation; Sample Mean, S.D., S.E.M., and 
Coefficient of Variation .•.•..•.•...••.•.•••.•..•................ A7 
Computation of % Injected Dose Recovered as 14·co2 after 
14c-U-D-Glucose ......•..••.. · .•........... ; ....................... . AB 
Program to make Library Data Files for Unpaired 
Student's "t11 Test .•.•.•.........•.•••..•.••..•............•...•. A9 
Program for Unapired Student's "t" Test Using Data Files 
Stored on Tape Using Library Make Program .••........••.•...•..... AlO 
Computation of Pearson's R for Linear and Logarithmic Data ....... All 
Program "$LINE" Used in Computation for Program "$REGRESS". ; .•... Al2 
Computation of "p" Value for Pearson's R at (N-2) 
Degrees of Freedom •.••............... · ..........................•• Al3 
Interpolation of "x" from Slope and Intercept of Line 
and Value of "y" ...•....•.........•.•.••.•....•.•................ Al4 
Interpolation of "y" from Slope and Intercept of Line 
and Value of "x" ...........................................•..... Al5 
Computation of Parameters of Linear Regression Line •.•........•.. Al6 
Computation of Significance of Difference of Two 
Regress ion Lines ............•.•.•.............••.......... .- ...... Al 7 
Al 
CHI-SQUARE TEST WITH YATES CORRECTION FACTOR INCLUDED 
WRITE 
C F"OCAL-12 
01..01 T %9.03JE 
01.02 A "R"RJA "C"CJS DF"=CR•l>*CC•l>JS L=R•C 
01·03 S l=IJS J=IJS K=IJS RP=0JS RS=0JS CS=0JS T=0JS X2=0 
01.0.11 A "S"NCK>JS RP=RP+NCK>JS CSCJ>=CS<J>+NCK>JS k=K+I 
01·05 S J=J+I 
01·06 I CC-J>t.07•1·04•1•04 
01.07 S RS<I>=RPJS J=IJS I=l+IJS RP=0 
01.08 I CR-I>l.09,l.04,l.C'l4 
01.09 I CL-<K-1>>1·10.2.01,2.01 
01.t0 T l!;r "El"JT !!JG 1.01 
02.01 r J=l•l,RJS T=T+RS<J> 
02·02 S J=IJS I=IJS K=I 
02·03 S ECK>=CRSCI>IT>•CS<J>JS J=J+IJS K=K+I 
02.04 I <C-J>2.05,2.03,2.03 
02.05 S J=IJS I=I+I 
02~06 I <R-!>2.07,2.03,2.03 
02.07 I CL-CK-1>>2.08•3•01•3•01 
02.08 T !!JT"E2"JT !! 
03.01 r K=l·l·LJS X2=X2+C<rABSCNCK>-E<K>>-·5>t2)/ECK> 
04.01 T 
04.02 r 
04·03 T 
04.04 T 
04.05 r 
04·06 T 
04.07 T 
04.08 T 
04.09 A 
04>!0 Q 
05.01 T 
06 .01 T 
07. 01 T 
08.01 r 
09.01 T 
• 
!!JS K=IJS Y=IJS N=IJS I=IJD 8•0JT ! 
"•"JT !Jr J=l•l•CJO 5.0 
"*"JT •• "JT "RS"RSCN>JS N=N+IJT ! 
J=l•l•CJO 1.0 
"•"JTc!JO 8•0JT !JS l=I+IJI CR·I>4.07•4·02•4·02 
!Jr J=1.1.c10 9.0 
%JT" T"TJT !!JT "X2"X2JT" 
"M?•'ZJ I CZ-2>4o l0• 1 ·01• I •01 
•••" J T .. 
"*" J T .. "J T "O"NCK>JT .. .. J s 
"•"J T .. "J T "E"E<Y>JT .. "J s 
M=l•l•<C•IS+l>JT . .... 
.. 
"J T "CS"CSCJ>JT .. .. 
"JT %8·03JT "Or"DrJT !! 
KDK+I 
Y=Y+ I 
A 2 
CONPUTATION OF "P" VALUE FOR CHI-SQUARE VALUE AT SPECIFIED DEGREES OF 
FREEDOM 
'tlRI TE 
C FOCl\L-12 
, 01.Hl 0 SJO CJT "CHI SQ PROB",llJE 
01 • 2 0 A ? X?, 1 Dr?, I I J S BX= X 
02.10 S A=·5•XJS E=2•FITR<DF/2>-DF 
02.15 1 <E>2.2.2.21.2.2 
02.20 I <DF-2>2·3•2•3•2·27 
02.27 I <BX-40>2.29,2.3,2.3 
02.29 S YY=FEXP<-A> 
0?.30 I <E>2·4JS S=YYG 2·6 
02.40 S X=-FSQTCX>JD 10JI CX>2.45,2•45JS P=CZ+l)/2JG 2·5 
02.45 S P=Ct-Z>/2 
02.50 S S=2•P 
02.60 I <DF-2>2.1,2.1,3.1 
02.70 0 TJT %6.4o I! 1."P ,. .. ,s," FOR CHI2 :",sx, .. WITH",%4,0F." OF"•!!! 
02.90 G 
03. 10 s 
03.20 s 
03.30 I 
03.40 s 
03.50 s 
03.60 I 
03.70 G 
03.80 I 
03.85 s 
03.87 s 
03.90 I 
03.95 s 
HI .J0 I 
10. I I D 
10.20 s 
11•10 s 
11.20 I 
11•30 I 
II .40 s 
11.50 s 
I I .60 s 
I I. 70 s 
I I .80 R 
12. 10 s 
12 .20 s 
12. 30 s 
12·40 s 
12.50 s 
12.60 s 
12.10 R 
• 
X=·5•<DF-l>Jl <E>3.2JS Z=IJG 3•3 
Z=·5 
CBX-40>3•8Jl <E>3.4JS E=0JG 3.5 
E.:=. 572365 
C=FLOG<A> 
<X-Z>3.7JS E=E+FLOG<Z>JS S=FEXPCC•Z-A-E>+SJS Z=Z+IJG 3·6 
2.1 
<E>3o85JS E=IJG 3o87 
E=.56419/FSQTCA> 
Ca0 
CX-Z>3·95JS E=E•A/ZJS C=C+EJS Z=Z+IJG 3.9 
S=C•YY+SJG 2.7 
CX> 10• I I• l0•2JD 111 R 
11 JR 
Z=0.J R 
Y=FABSCX>/2 
<Y-3>tl.3JS Z=IJ R 
<Y-l>ll.4JD 1.2JR 
W=Y•Y 
Z=CC.000124819•W-.0010752>•W+.00519877>•W 
Z=C<<Z-.0191983>•W+.0590540>•W•ol51969>•W 
Z=CCCZ+.319153>•W-.531923>•W+.797885>•Y•2 
Y::Y-2 
Z=<<-.00004526•Y+.000152529>•Y-.0000195381>•Y 
Z=<<<Z-.000676905>•Y+.0013906>•Y-.00079462>•Y 
Z=CCCZ-.00203425>•Y+.00654979>•Y-.0105576>•Y 
Z=<<<Z+.0116308>•Y-·00927945>•Y+.00535358>•Y 
Z=C<Z-·00214127>•Y+.00053531>•Y+.999937 
A 3 
---:.:::.:-~'""L--------
CALCULATION OF MEAN STANDARD DEVIATION & STANDARD ERROR OF MEAN 
WRITE 
C rOCAL-12 
01·10 L 01r01F1TA810 
01.20 s S=0JS N=0JT ··x··r 
01·30 A X1!JS F0CN+l>=X 
01·40 I CX>l.511•611•5 
01.50 S N=N+lJS S=S+XJG 1.3 
01·60 S M=S/NJS S=0 
01.70 F J=l1NJS S=S+CM-F0<J>>t2 
01·80 S S=S/CN-1> 
01·90 I CS>2. t13e0512• l 
02·10 S S=0·5•FLOGCS>JS D=FEXP<S> 
02. 15 T ! !1"N="1N 
02·20 S N=0·5•FLOG<N>JS N=FEXPCN> 
02 • 30 G 3. l 
03·05 s 0=0 
03 • 10 T ! J T "MEN"1M 
03·20 T !JT "SD ",O 
03·30 T !JT "SE "10/NJT ! !I 
03.35 A AJI CA>3.4011.20,3.40 
03·40 L C1F0 
• 
;J:> 
+:--
UNPAIRED STUDENT'S "T" TEST 
WRITE 
C FOCAL-12 
01·10 D 7 
01·20 S C=.63661977 
01·30 S D=·S•FLOGCDF>JS D=FEXPCD> 
01•40 S TH=FATNCT/O>JS X=OF/CDF+Tt2> 
01·50 I <DF-1>1•6•1•612•1 
01·60 S A=C•THJG 4•1 
02•10 S TS=FITRCOF/2>JS TS=2•TS 
02.20 I CDF-TS>2.3,2.3,2.4 
02•30 S IX=lJG 2.5 
02 •40 S I X=2 
02·50 S A=lJS Y=tJS Z=IXJS W=Z+t 
02·60 I CDF-W>3·113•112•7 
02•70 S Y=X•Y•Z/W 
02.80 S A=A+YJS Z=Z+2JS W=W+2JG 2·6 
03•10 I <2-IX>3•213•2•3•4 
03·20 S N=·S•FLOGCX-Xt2>JS N=FEXPCN> 
03•30 S A=C•CTH+A•N>JG 4•1 
03•40 S N=.S•FLOG<t·X>JS N=FEXPCN>JS A=A•N 
04·10 S P=l•A 
05·10 T !!1"DF"1DF1!1"T''1T1!JT %10·08JT "P "1PJT %8.04.JG l•l 
07• 10 A ! ! !1"NX",,NX1"MX"1MX1"SE"1EX 
07 • 20 A ! ,, "NY",, NY,, "MY .. ,, MY,," SE",, EY 
07·30 S DF=NX+NY-2 
07•40 S T=FABSCMX-MY>/FSQTCEXt2+EYt2> 
* 
A 5 
PAIRED STUDENT'S "T" TEST 
WRITE 
C FOCAL-12 
01·10 S C1=0JS C2=0JS R=0 
01•20 A !!."NX"•N 
01·30 F J=l•NJA !.VJS Cl=Cl+VJS C2=C2+Vt2 
I 01.40 s MX=Cl/NJS K=CC2-Clt2/N)/CN-l>JS OX=FSQTCK> 
01·50 S EX=DX/FSQTCN>JS OF=N 
01~60 D l•lJA !!."NY"•NJD 1•3 
01•70 S MY=Cl/NJS K=CC2•Clt2/N)/CN·l>JS DY=FSQTCK> 
01·80 S EY=OY/FSQTCN>JS OF=DF+N-2 
01·85 A !!."PAIRED?".YJI CY-25>1.95.1.9.1.95 
01.90 A !."R".RJS DF=DF/2 
01·95 S T=FABSCCMX-MY>IFSQTCEXt2+EYt2-2*R*EX•EY>> 
02.10 S C=·63661977 
02.20 S D=F'SQTCDF> 
02·30 S TH=FATNCTID>JS X=DFICDF+Tt2> 
02·40 I CDF-1>2•5•2·5•3•1 
02.50 S A=C•THJG 4e5 
03·10 S TS=FITRCDF/2>JS TS=2•TS 
03.20 I CDF•TS>3•3•3•3•3•4 
03.30 S IX=tJG 3.5 
03.40 S IX=2 
03.50 S A=lJS Y=lJS Z=IXJS W=Z+l 
03.60 I CDF-W>4•1•4•1•3•7 
03·70 S Y=X*Y•Z/W 
03.80 S A=A+YS Z=Z+2JS W=W+2JG 3•6 
04•10 I C2-IX>4•2•4•2•4•4 
04.20 S N=FSQTCX-Xt2> 
04·30 S A=C*CTH+A•N>JG 4.5 
04·40 S N=FSQTCl-X>JS A:A•N 
04·50 S P=l-A 
05 • t 0 T ! ! • "'MX:•• • MX. ! • .. SD="• DX• ! •"SE="• EX 
05.20 T ! '•"MY="1MY. !~"SD=··.ov. !."SE="•EY 
05.30 T !!."DF'="•OF.!."T= "•T•!1"'P= ••,,P.!!!JQ 
* 
A 6 
INSULIN RIA CALCULATION; SAMPLE MEAN,S.D.,S.E.M.,& COEFFICIENT OF VARIATION 
WRITE 
C rOCAL-12 
01·10 A "M"1M1!1"8"181! 
01·20 A "BKG"1BG1! 
01·30 A "CPM H0"1H01!! 
02·05 A "N"1N1!Jl <N>2.J0112.9912.t0 
02·10 S CT=0JS UT=0JT" 
02.20 r I=l1NJD 6 
02·30 S UM=UT/NJS CM=CT/N 
02·40 T " , ", CM, UM, ! 
02. s0 r I=l1NJS X<I>=C<I> 
%H0 UG/ML"1!! 
02·60 S XM=CMJD SJS CD=SDJS CE=SEJF I=l1NJS X<I>=U<I> 
02.70 S XM=UMJD SJS UD=SDJS UE=SEJT " 
C?2·80 T " 11 1CE.iUE1100*UE/UM1!! 
02.99 G 2.05 
0s.10 s SX=0Jr I=l1NJS SX=SX+CX<I>-XM>t2 
0s.20 s SD=rSQTCSX/CN~1>> 
0s.30 s SE=SD/rSQTCN-1> 
"1CD1UD1100*UD/UM1! 
06.10 A "CPM",CPJS C<I>=100•<.CP-BG>/H0JS CT=C<I>+CT 
06.20 S Y=CCl>JD 10JS U<I>=XJS UT=UCl>+UT 
06.30 T C<l>,U<I>,!. 
10.10 S X=rEXP<<Y-B>/C0e4343*M>> 
12.99 Q 
• !J::. 
~ 
COMPUTATION OF %INJECTED DOSE RECOVERED AS 14co2 AFTER 14c~UtD-GLUCOSE 
WRITE 
C FOCAL-12 
01.10 S T=0JS SX=0JS V=52JA "ENTER TOTAL DPM'S INJECTED/RAT"1Z1!! 
01·20 A "ENTER COUNTING EFFICIENCY"1E1 !! 
0le25 A .. ENTER BACKGROUND COUNT",,BG1!! 
01.30 T .. T SCPM/ML TRVOL DPMO CUMDPMO DPMTR" 
01 .35 T " · TOTDPM %INJDOSE•• .. ! ! 
01.40 T %3•01TJA XJS X=X-BGJS X=l00•X/EJT %8e01 V,,2•XJS SX=SX+2•X 
01•50 T SX-2•X1 V•X1 V•X+SX-2•X1%4•02"" ••,, C V•X+SX-2*X > * 100/Zi ! ! 
01.60 I C240-T>1.s0 .. 1.a0 .. 1.65 
01.65 I CT-60>1.70JS T=T+15 
01·70 S T=T+ISJS V=V•2JG J.40 
01 ·80 Q 
* 
~ 
CP 
PROGRAM TO MAKE LIBRARY DATA FILES FOR UNPAIRED STUDENT'S 11 T" TEST 
WRITE 
C F'OCAL-12 
0lel0 A "HOW MANY DATA TRIPLETS?"1NT1! 
0le20 F' I=l1313•NTJT !JF J=012JA F0<I+J> 
01e25 F I=l1313•NTJT fJF' J=012JT F0<I+J>,,%~·011+J,,%S.04 
01·27 A AJI <A>t.3511•3011•35 
01·30 L C1F'0JQ 
01.35 
* 
::z:,. 
\Q 
PROGRAM FOR UNPAIRED STUDENT'S "T" TEST USEING DATA FILES STORED 
ON TAPE USEING LIBRARY MAKE PROGRAM 
WRITE 
C FOCAL-12 
01·10 S C=0·63661977 
01·20 A "HOW MANY PAIRS?",,NP,,!! 
01·30 F I=J,,3,,3•NPJD 2JD 3 
01·90 L c .. FJJL c .. F2 
01 .99 Q 
02·10 s 
02.20 s 
02.30 s 
03· 10 s 
03·20 s 
03·30 s 
03. 40 s 
03·50 s 
03·60 I 
03·70 s 
0Je80 I 
03.90 s 
03.95 s 
03e96 T 
03.97 T 
03·98 T 
* 
NCt>=FlCl>JS NC2>=F2CI>JS M<l>=Fl<I+l>JS MC2>=F2Cl+t> 
SC1>=Fl<I+2>JS S<2>=F2CI+2>JS OF=NC1>+NC2>-2 
ST=FSQTCS<J>t2+SC2>t2>JS T=FABSCMC1>-MC2>>/ST 
D=FSQT<DF>JS TH=FATNCT/D>JS X=DF/CDF+Tt2>JI COF-1>3·2,,3.2,,3.3 
A=C*THJG 3e96 
TS=FITRCDF/2>JS TS=2•TSJS IX=2JI <OF·TS>3•4,,3.4,,3.5. 
IX=l 
A=IJS Y=tJS Z=IXJS W=Z+t 
<DF-W>3.8 .. 3·8 .. 3•7 
Y=X•Y•Z/WJS A=A+YJS Z=Z+2JS W=W+2JG 3·6 
c2-1x>3.9,,3.9,,3.95 
N=FSQTCX-Xt2>JS A=C•CTH+A•N>JG 3·96 
N=FSQTCt-X>JS A=A•N 
"N t ••" N < 1 >,, ! ,, "M 1 .. ,, MC 1 >,, ! ""SE",, S < 1 >" I 
"N2 .... NC2),, !,,"M2",,MC2> .. ! .. "SE" .. SC2> .. ! 
"DF" .. DF .. ,,, .. r .... r .. ! .. "P" .. Cl-A> .. !! 
:i> 
f'--1 
0 
A 11 
COMPUTATION OF PEARSON'S.R FOR LINEAR & IJGARITHMIC DATA 
{PROGRAM $LINE IS USED BY THIS PROGP~ 
AND IS ON THE NEXT PAGE OF THE APPENDIX) 
WRITE 
C FOCAL-12 
01·05 L Q,F1,F,TAB,0 
01·10 S L=0JF J:J,28JS Ft<J>=0 
01·20 T !JA "N",NJS FlC29>=NJT !!JT "ENTER VALUES''JT 
0le30 T !JA "X",XJA "Y",YJS L=L+l 
01·40 S LX=.4343•FLOGCX>JS LY=·4343•FL0G(Y> 
02el0 S Fl<l>=Fl<l>+XJS FlC2>=FlC2>+LX 
02•20 S FlC3>=Ft<3>+Xt2JS FlC4>=FtC~>~LXt2 
02·30 S FlCS>=FlCS>+YJS FtC6>=FlC6>+LY 
02·40 S FlC7>=FtC7>+Yt2JS FlCB>=Ft<B>+LYt2 
02.50 S FlC9>=FlC9>+X•YJS F1Cl0>=F1C10>+X•LY 
02.60 S Ft<tt>=FlClt>+LX•YJS F1Ct2>=Ft<12>+LX•LY 
02·70 I CL-N>1.3,3.1,3.1 
03el0 S F1C13>=Fl<9>•F1Cl>•FtC5)/N 
03·20 S FtCt4>=FlC10>-Ft<t>•FtC6>/N 
03•30 S FlCtS>=FlCll>-Fl<2>•FlCS>/N 
03e40 S FlC16>=F1Ct2>-FtC2>•Ft<6>/N 
03·50 S F1Cl7>=<F1<3>·Fl<t>t21N>•<FtC7>-FtCS>t21N> 
03·60 S FtC18>=<Fl<3>-FtCl>t21N>•CF1CB>-FlC6>t2/N> 
03e70 S FlC19>=CFlC4>-FtC2>t21N>•CF1<7>-Ft<S>t2/N> 
03·80 S FlC20>=CF1<4>-Ft<2>t2/N>•CFl<B>-FtC6>tZIN> 
03·90 F J=t7,20JS FlCJ>=•S•FLOGCFt<J>>JS FlCJ>=FEXPCFlCJ>> 
0s.10 T !!!JT "R x,y '',F1C13>1Ft<t7> 
0s.20 T !JT "Rx.LY ",FtC14)/FtC18> 
05 • 30 T ! J T "R LX, Y ", F 1C15 >IF 1 C t 9 > 
05 • 40 T ! J T "R LX, LY", Ft< t 6 >IF t C 20 > 
0s.s0 T !!!JL c,FtJL G,$LINE.0JQ 
• 
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PROGRAM "$LINE" USED IN COMPUTATION FOR PROGRAM "$REGRESS" 
WRITE 
C FOCAL-12 
01.10 L Q,FJ,F,TA810 
01.20 S N=F1C29> 
0.4. 1 0 
04.20 
0.ll.30 
0.l!o40 
0.l!.50 
04.60 
04.70 
04.80 
04.90 
05. t 5 
05 .25 
05.35 
05.45 
0s.s0 
• 
• 
• 
• 
* 
* 
* 
• 
* 
* 
* 
·* 
s 
s 
s 
s 
s 
s 
s 
s 
s 
T 
T 
T 
T 
T 
Cl=Fl<3>-Ft<l>t~/NJS C2=F1Ci!>-Ft<2>t2/N 
FIC21>=<F1<9>-F1Cl>•F1C5>/N>/Cl 
Fl<22>=<FtC10>-FlC1>•Ft<6>/N)/Cl 
FtC23>=<FlC11>-FlC2>•Fl<S>/N>/C2 
~1C24>=<Fl<t2>-F1<2>•F1<6>/N>/C2 
FlC25>=CF1<5>-Fl<l>•FlC2t>>/N 
Fl C26>=<Ft <6>-Ft C 1 >•Fl <22> )/N 
F1<27>=<F1<5>-Ft<2>•F1<23>>/N 
F1<28>=<F1<6>-Ft<2>•Ft<24>>/N 
! j T "M", r 1 ( 21) J T ,, 8", F t'c 25) 
!JT "M",F1<22>JT •• 8"1FIC26> 
!JT "M"1FlC23>JT .. B",1'1<27> 
!JT "M"11'1C24>JT" B",Ft<28> 
!!!JL c,FJJL L,$REGRES,!!JJQ 
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COMPUTATION OF "P" VALUE FOR PEARSON'S RAT (N-2) 
DEGREES OF FREEDOM 
WRITE 
C F"OCAL-12 
01 • 10 A I ! > "N" .. N .. ! > "'R" .. R 
01·20 S DF"=N-2JS D=F"SQTCDF"> 
01·30 S T=F"SQT<l-Rt2>JS T=R•D/T 
02.10 5 C=·63661977 
02.20 S D=FSQT<DF> 
02·30 S TH=FATNCT/0)J$ X=DF/CDF"+Tt2> 
02·40 I <DF•t>2.5 .. 2.5,3.1 
02.50 S A=C•THJG 4.5 
03•10 S TS=F"ITR<DF/2>JS TS=2•TS 
03·20 I <DF"-TS>3·3 .. 3•313•4 
03·30 S IX=lJG 3.5 
03·40 S IX=2 
03·50 S A=lJS Y=IJS Z=IXJS W=Z+l 
03·60 I CDF-W>4•l .. 4•l .. 3•7 
03•70 S Y=X•Y•Z/W 
03·80 S A=A+YJS Z=Z+2JS W=W+2JG 3·6 
04.10 I <2~IX>4.2,.4.2,.4.4 
04·20 S N=FSQTCX-Xt2> 
04•30 S A=C•<TH+A•N>JG 4.5 
04·40 S N=FSQTCl•X>JS A=A•N 
04·50 S P=l-A 
05 • 10 T ! , "OF=",. OF .. ! .. "T= " .. T 
05·20 T r .. %10.10 .... P= •• .. P,%8·04 
05 • 30 G l • 1 
* 
INTERPOLATION OF "X" FROM SLOPE & INTERCEPT OF LINE & VALUE OF "Y" 
(USED FOR LINEAR,SEMILOGARITHMIC,&LOGARITHMIC RELATIONSHIPS) 
WRITE 
C FOCAL-12 
01•10 T I JA "M''1MJA 118 11 18 
01.20 T r ! JA "Y"1Y 
01·30 S A=<Y-8)/M 
01.40 S C=<·4343•FLOG<Y>-B>/M 
02 .10 T ! ! J T A 
02.20 T ! J T C 
02·30 T !JT FEXPCA/.4343> 
02·40 T !JT FEXPCC/.4343> 
02.50 G 1.2 
* 
:t:> 
1--' 
.i::-
INTERPOLATION OF "Y" FROM ~LOPE & INTERCEPT OF LINE & VALUE OF "X" 
(USED FOR LINEAR,SEMILOGARITHMIC,&LOGARITHMIC RELATIONSHIPS) 
WRITE: 
C F'OCAL-12 
01·10 T !JA "'M"',,MJA "8"18 
0f .20 T ! ! JA "X"1X 
0le30 S A=M•X+B 
01.40 S C=M•.4343•F'LOG<X>+B 
02.10 T !!iT A 
02.20 T !JT F'E:XPCA/.4343> 
02.30 T ! J T C 
02.40 T !JT F'E:XPCC/.4343> 
02 • 50 G 1 ·2 
* 
!I> 
I-' 
Vl 
A 16 
COMPUTATION OF PARAMETERS OF LINEAR ~GRESSION LINE 
WRITE 
C F"OCAL-12 
01·10 S Ct=0JS C2=0JS C3=0JS C4=0JS C5=0 
01 • 20 A ! ! , "N"', N 
01 •30 F J=l.1NJA !1"X".1X.1"Y"1YJD S 
02.10 S DX=C2-Clt2/NJS DY=C4-C3t2/N 
02·20 S NU=CS-Cl•C3/NJS R=NU/FSQTCDX•DY> 
02·30 S M=NU/DXJS B=CC3-Ct•M>IN 
02.40 S S=DY-DX•Mt2JS E=FSQTCS/CN-2>>. 
02.50 S XM=Ct/NJS YM=C3/N 
02.60 S XD=FSQTCDX/CN-t>>JS XE=XD/rSQTCN> 
02.70 S YD=rSQTCDY/CN-t>>JS YE=YD/FSQTCN> 
03.10 
03.20 
03.30 
03.40 
03.50 
03.60 
03·70 
03·80 
T ! !,, 0 LI N REG- Y=B+MX+E•• 
T 
T 
T 
T 
T 
T 
T 
! ! , ""SX .. , C 1, ! , •• SX2", C2, ! •••SY .. • C 3 
! ... sY2 ... c4. ! 1"SXY"1CS 
! !1 .. MNX .. 1XM1 l1"SDX"1X01 !.1''SEX''1XE 
!1''MNY"1YM1 !1 .. SDY"1YD1 !1"SEY"1YE. 
! !.1"DX .. ,ox. !1"DY "1DY·1 r ... s 
! ! ., .. M 
! 1"R 
Y,M,!1''8 ".181!1 .. E 
"1R.1 !1"Rt2"1R+2, ! ! ! 
"1S 
"1E 
05.10 S Cl=Cl+XJS C2=C2+Xt2JS C3=C3+Y 
05.20 S C4=C4+Yt2JS CS=CS+X•Y 
* 
COMPUTATION OF SIGNIFICANCE OF DIFFERENCE OF 
TWO REGRESSION LINES 
WRITE 
C FOCAL-12 
01 • 10 A ! ! " .. N l '',, N l,, ! ,, "N2",, N2 
01·20 A !1"DXJ"1Dl1!1"DX2"1D2 
01 • 30 A ! ""S 1""511 ! ""52 .. ,, 52 
01 • 40 A ! .1 "M 1••.1M1 .1 ! , "M2"" M2 
01•50 S Df=Nl+N2-4J5 5=C51+52>/DF 
01·60 S DI=F5QTC5/<0l+02>> 
01·70 S T=FABSCCM1-M2>/DI> 
02.10 5 c=.63661977 
02·20 S D=FSQTCDF> 
02a30 S TH=FATNCT/D>J5 X=Df/CDF+Tt2> 
02.40 I CDF-1>2.s,,2.5,3.1 
02.50 5 A=C•THJG 4•5 
03.10 s TS=FITRCDF'l2>3S TS•2•TS 
03·20 I CDF-TS>3.3,3.3,3.4 
03.30 s IX= 1J G 3 • 5 
03·40 s IX=2 
03a50 5 A= 1 JS Y= 1J5 Z=IXJS W=Z+1 
03·60 I · C DF-W > 4 • l "4 • 1, 3 • 7 
03.70 S Y=X•Y•ZIW 
03.80 5 A=A+YJS Z=Z+2J5 W=W+2JG 3·6 
04a 10 I C2•IX>4•214•214•4 
04·20 5 N=F5QTCX-Xt2> 
04e30 5 A=C•<TH+A•N>JG 4.5 
04·"0 5 N=FSQTC1-X>J5 A=A•N 
04.50 5 P=l-A 
0s.10 T !!.1"DF=".1DF.1!.1"T= •• .. r .. !,,"P= ".1P1!!! 
* 
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